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ABSTRACT
Mechanisms of (*^C) chloroquine accumulation and chloroquine 
resistance were studied in Plasmodium berghei (NK 65 and RC) 
in mouse erythrocytes in vitro.
The quantity of chloroquine taken up by erythrocytes infected 
with the chloroquine resistant RC strain was similar to that 
found for the sensitive NK 65 strain when percentage of 
erythrocytes parasitised was taken into account.
Chloroquine accumulation could be separated into saturable
specific (high affinity), and an unsaturable non specific
(low affinity) components. A specific receptor for chloroquine
— 9 — 8with a dissociation constant of 4.0 X 10 to 1.0 X 10 
mol/l was found to be associated with uptake into erythro­
cytes infected with both NK 65 and RC, but was absent in 
uninfected erythrocytes or reticulocytes.
TM s  receptor was 6 times more abundant in erythrocytes 
infected with NK 65 strain than in those infected with RC - 
where non-specific uptake accounted for up to 80% of the 
total chloroquine accumulation. It was tentatively concluded 
that non-specific uptake was mainly related to chloroquine 
binding by erythrocyte macromolecules; whilst specific 
uptake was related to receptors associated with the parasite 
itself.
Chloroquine uptake by NK 65 parasitised erythrocytes was 
highly dependent on glucose availability, which was not the 
case in uninfected erythrocytes. In parasitised erythrocytes, 
it seemed probable that only the specific component of 
uptake was dependent on D - glucose.
The ionophores Monensin and Nigericin inhibited chloroquine 
uptake non-competitively in high sodium and potassium buffer
5respectively. This inhibition of uptake was achieved 
without significant changes in glycolytic rate. Partial 
alleviation by ouabain of the inhibitory effect of 
Monensin but not of Nigericin, suggested that the 
internal proton concentration of the erythrocyte compart­
ment was involved in drug uptake. Valinomycin had much 
less effect indicating that membrane potential was a less 
important factor.
Mean internal pH values of NK 65 and RC infected 
erythrocytes were found to be about 0.2 units lower 
than uninfected erythrocytes and 0.55 units lower than 
the plasma.
It was concluded that chloroquine accumulation by 
P. berghei infected erythrocytes was dependent on several 
factors, but the basis of chloroquine resistance in RC 
strain was mainly a deficiency of specific receptor sites.
6TABLE OF CONTENTS 
CHAPTER I
Page Nos.
1. General Introduction 23 - 25
1.2 Review
1.2.1 Historical Account of chemotherapy
of Malaria 26 - 28
1.2.2 Vector control and Malaria eradication 28 - 29
1.3 Life cycle of malaria parasites and
drug interaction 29 - 31
1.3.1 Drugs effective against exoerythrocytic
forms 31 - 32
1.3.2 Drugs effective against erythrocytic
forms 32 - 33
1.3.3 Drugs effective against the gametocytes
and oocysts in Mosquito 33 - 35
1.4 Physiological adaptation of the
malaria parasite 35 - 37
1.4.1 Utilisation of Glucose 37 - 40
1.4.2 Utilisation of Haemoglobin 40 - 41
1.4.3 Synthesis of lipids 41
1.4.4 Synthesis of Nucleic Acids 41 - 44
1.5 Classes of antimalarial drugs and their
mechanism of action 45
1.5.1 Blood Schizontocides 45 - 52
1.5.2 8 - Aminoquinolines 52 - 54
7Page Nos.
1.5.3 The Antimetabolites 54 - 58
1.6 Resistance to antimalarial drugs 59 - 63
1.6.1 Mechanism of Resistance to
chloroquine 63 - 67
1.6.2 Mechanism of Resistance to Primaquine 68
1.6.3 Mechanism of Resistance to Antime­
tabolites 69 - 70
1.7 Mechanisms of Uptake of drugs across
membranes 71 - 75
1.8 Rodent Malaria as a model for study
of human Malaria 76 - 77
1.9 Aims of the Research Project 78
82.
2.1
2.2
2.3
2.3.1
CHAPTER 2
Materials and Method 
Chemicals and Drugs 
Incubation media 
Parasite lines 
Plasmodium berghei berghei
Page Nos
79
80
NK 65 81
2.3.2 Plasmodium berghei berghei
RC strain 81 - 82
2.4 Routine Passage Techniques
2.4.1 Blood Passage 82 - 84
2.4.2 Induction of Reticulocytosis
in mouse in vivo 84 - 85
2.5 Purification of Infected Red 
Blood cells
86 - 87
2.6 Determination of Packed Cell
volume of mouse blood 88
2.7 Analysis of size distribution
of Blood Cells 89
2.8 Assessment of Haemolysis of
Incubated Erythrocytes 90 - 91
2.9 Detection and measurement of
radioactivity 92 - 94
2.9.1 Estimation of trapped fluid
volume (Inulin space) 95
92.9.2
2 . 1 0
2 . 1 0 . 1
2 . 1 0 . 2
2.10.3
2.11
2 . 11 . 1
2 . 1 1 . 2
2.11.3 
2.1 2
2.13
14Determination of ( C) 
chloroquine uptake by infected 
and uninfected T.O. mouse 
erythrocytes
Effects of substrates and 
drugs on uptake of ( ^ C) 
chloroquine
Preparation of chemicals 
Dose response 
Time course of effect of 
ionophores
Kinetics of ( chloroquine 
uptake by uninfected and 
infected T.O. mouse erythro­
cytes
Time course of drug uptake 
Affinity of Uptake system 
for chloroquine
14Specifity of Uptake of ( C) 
chloroquine
Measurement of permeability 
of erythrocytes to (
L - gl ucose
Measurement of D-glucose 
utilisation and L(+) lactate 
production
Page Nos
96 - 97
98 - 99
100
101
102
103
104
105
106
10
Pag
2.13.1 Assay of D-glucose
2.13.2 Assay of L(+) lactate
2.14 Determination of H+ efflux
induced by ionophores 109
2.15 Measurement of internal pH
(pHi) of red blood cells
Nos
107
108
110
111 -  112
11
3.
3.1
3.2
3.3
3.4
3.5
3.6
3.6.1
3.6.2
3.6.3
3.7
3.7.1
CHAPTER 3
Pa£
Results
Variation of packed cell 
volume
Size distribution of red
blood cells 114
Development of malaria 
infection in mice infected 
with P. berghei 118
Time course of ( *^C) 
chloroquine uptake 120
Relationship of Parasitaemia 
to drug uptake 122
Effects of variation of
ionic composition of
incubation medium on uptake
of (l^C) chloroqu ine
Uninfected erythrocytes 126
P, berghei NK 65 infected
erythrocytes
P. berghei RC strain
infected erythrocytes 129
Effect of D-glucose on
uptake of (*^C) chloroquine
Uninfected erythrocytes
e No
113
- 117
- 119
- 121
■ 125
■ 127 
128
■ 131
132
12
3.7.2 P. berghei NK 65 infected
erythrocytes 133
3.7.3 P. berghei RC strain infected
erythrocytes 134
3.8 Effect of 2-deoxy-D-glucose 
on uptake of ( ^4C) chloroquine
3.8.1 Uninfected T.O. mouse
erythrocytes 135 - 139
3.8.2 P. berghei NK 65 infected
erythrocytes 140
3.8.3 P. berghei RC infected
erythrocytes 141 - 143
3.9 Effect of 3-o-methyl-D-glucose
on uptake of ( ^ 4C) chloroquine 144
3.10 Effect of L-glucose on uptake
of ( *4C) chloroquine 145
3.11 Effect of Ionophores on ( C) 
chloroquine uptake
3.11.1 Monensin and Nigericin 146
3.11.2 Dose Response Analysis 147 - 153
3.12 Time course of Inhibition of 
( 14C) chloroquine uptake
3.12.1 Monensin and Nigericin 154 - 155
3.12.2 Valinomycin 156
3.13.1 Effect of Ouabain on uptake of
( 14C) chloroquine 157 - 158
13
Page Nos
3.13.2 Effect of Biogenic amines on 
14uptake of ( C) chloroquine 159 - 161
3.13.3 Effect of Sulphydryl reactive 
agents on uptake of (^C) 162 - 166
3.14
3.14.1
chloroquine 
Kinetics of (^4C) 
chloroquine uptake 
Affinity of Uptake System 
for chloroquine 167 - 170
3.14.2 Specificity of Uptake of 
(14C) chloroquine 171 - 178
3.15 Entry of (^4C)-L-glucose 
into T.O. mouse erythrocytes 179 - 180
3.16 Utilisation of D-glucose 
and production of L(+) 
lactate by T.O. mouse 
erythrocytes 181 - 183
3.17 Proton efflux induced by
Ionophores
Internal pH (pHi) of T.O. 
mouse red blood cells
184 - 187
188 - 189
3.18
14
4.
4.1
4.2
4.3
*+.4
4.5
4.6
4.7
4.8
CHAPTER 4
Page
Discussion 
Characteristics of 
Infections of P. berghei 
in T.O. mouse and 
relationship to chloroquine 
uptake in vitro 190
Time course of uptake of 
( 14C) chloroquine 194
Influence of ionic com­
position of incubation medium 
on uptake of chloroquine 196
Role of D-glucose in uptake 
of (^4C) chloroquine 200
Uptake of L-glucose by T.O. 
mouse erythrocytes 
Variations in intracellular 
PH of T.O. mouse red blood 
cells 205
Role of Proton gradients in 
Uptake of chloroquine 209
Ionophores and (*4C) 
chloroquine uptake 212
Nos
- 193
- 195
- 199
- 203 
204
- 208 
-  211 
- 217
15
Page Nos
4.9 Interaction of Biogenic
14amines with ( C) chloroquine
uptake in vitro 218 - 220
4.10 Effect of Sulphydryl agents 
on drug uptake 221 - 222
4.11 Pharmacokinetics of Uptake 
of (14C) chloroquine 223 - 227
4.12 Model for chloroquine uptake 
and Resistance. 228 - 236
References 237 - 278
1.
Appendices
List of Abbreviations 279 - 280
2. Texas Tl-57 Programmes 281 - 287
3. Structural formulae 288
16
Table No» 
1
2
3
4,
5 & 6
7
8 ,
9 & 10
LIST OF TABLES 
Content
Variation of Haematological 
data of T.O. mouse blood. 
Comparison of ( ^C) chloro­
quine uptake in various 
ionic media.
Variation in drug uptake 
ratios.
Effect of D-glucose and 
2-Deoxy-D-glucose on the
,14uptake of (. C) chloroquine 
by uninfected, P. berjghei 
NK 65 and RC infected T.O. 
mouse erythrocytes.
Summary of Inhibition 
profile and variation of
14 ,uptake ratio of ( C) 
chloroquine by T.O. mouse 
erythrocytes.
Effects of various agents on 
uptake of (1ZfC) chloroquine 
by uninfected, P. berghei 
NK 65 and P. berghei RC 
infected T.O. mouse 
erythrocytes.
Page Nos.
115
130
131 
137
137 - 139
139
164
165 - 166
17
Table No. 
11
12
13
Content Page No.
14Uptake of ( C) chloroquine
by reticulocyte enhanced
red blood cells. 172
Variation of "specific"
14uptake of ( C) chloroquine. 173
Variation of External and 
Internal pH of T.O. mouse 
red blood cells. 189
18
Figure No. 
1
2
3
4
5
6
LIST OF FIGURES
Content Page Nq.
Illustrative points of attack 
in the Malaria transmission 
cycle. 25
Diagramatic representation 
of malaria parasite life 
cycle and drug Interaction. 30
Schematic representation of 
interaction of antimalarial 
drugs with blood, tissue and 
mosquito forms of malaria 
parasites. 34
Metabolic characteristics 
of Red blood cells at two 
stages of development. 38
Illustration of dependence 
of Parasite metabolism on 
supply of substrates from 
erythrocytes. 39
Summary of possible nucleo­
tide pathways for the 
synthesis of nucleic acids 
in malaria parasites. 43
Grouping of antimalarials 
and probable mechanisms 
of action. 57
19
8
9
10
11
12
13
14
15
16
17
18a
18b
Figure
20
Figure No. Content Page No•
19 Log-Dose response curve of
Monensin.
20 Log-Dose % response curve of
Monensin.
21 Log-Dose response curve of
Nigericin.
22 Log-Dose % response curve of
Nigericin.
23 Double reciprocal plot of 
uptake of radioactive 
chloroquine by P. berghei 
NK 65 infected T.O. mouse 
erythrocytes.
24 Effect of preincubation of
mouse erythrocytes in
5.0 x 10  ^mol/1 Monensin.
25 Effect of non radioactive
L-epinephrine on uptake of 
14C-chloroquine by P. berghei 
NK 65 infected T.O. mouse 
erythrocytes.
26 Double reciprocal plots of
Uptake of radioactive 
chloroquine by T.O. mouse 
erythrocytes as a function 
of medium concentration of 
chloroquine at equilibrium.
149
150
151
152
153
155
161
169
20
Figure No. Content Page No
19 Log-Dose response curve of 
Monensin. 149
20 Log-Dose % response curve of 
Monensin. 150
21 Log-Dose response curve of 
Nigericin. 151
22 Log-Dose % response curve of 
Nigericin. 152
23 Double reciprocal plot of 
uptake of radioactive 
chloroquine by P. berghei 
NK 65 infected T.O. mouse
24
erythrocytes. 153
Effect of preincubation of
mouse erythrocytes in
5.0 x 10  ^mol/1 Monensin. 155
25 Effect of non radioactive
L-epinephrine on uptake of 
14C-chloroquine by P. berghei 
NK 65 infected T.O. mouse
26
erythrocytes. 161 
Double reciprocal plots of 
Uptake of radioactive 
chloroquine by T.O. mouse 
erythrocytes as a function 
of medium concentration of 
chloroquine at equilibrium. 169
21
27 Effect of nonradioactive
quinine and chloroquine on 
uptake of radioactive 
chloroquine by P. berghei 
NK 65 infected T.O. mouse 
erythrocytes.
28 Uptake of (^C ) Chloroquine
over a range of free drug
concentrations in P. berghei 
NK 65 infected T.O. mouse 
erythrocytes.
29 Uptake of (^C ) Chloroquine
over a range of free drug
concentrations in P. berghei 
RC strain infected T.O.
mouse erythrocytes.
1430 Uptake of ( C ) Chloroquine 
over a range of free drug 
concentrations in 
uninfected T.O. mouse 
erythrocytes. , u31 Specific uptake of ( C) 
chloroquine over a range of 
free drug concentrations in 
T.O. mouse erythrocytes.
Figure No. Content Page No.
170
174
176
177
22
Figure
32
33
34
35
36
37
No. Content Page N o .
Transformation of Fig. 31 
to a "Scatchard plot".
Semilog plot of effect of 
Monensin on uptake of 
chloroquine and L-glucose 
by P. berghei NK 65 infected 
erythrocytes.
Production of L(+) lactate 
in P. berghei NK 65 and RC 
infected erythrocytes.
Effect of Ionophores on H+ 
efflux recorded by 
potentiometric flatbed 
recorder.
Effect of Monensin on rate of 
H+ efflux from T.O. mouse 
erythrocytes.
Schematic model for chloro­
quine uptake into P. berghei 
infected erythrocytes.
178
180
183
186
187
231
23
CHAPTER I
1. GENERAL INTRODUCTION
Malaria, one of the most important communicable diseases 
of man, is a principal health hazard in many countries. 
Presently, there are about 150 million cases of 
malaria annually. In Africa alone, more than one 
million children under the age of 14 die each year 
from malaria. It is a protozoan infection in which 
the causative agent,a member of the genus Plasmodium, 
undergoes a cyclical development both in the mammalian 
host and in the vector, the Anopheles mosquito. The 
genus Plasmodium is defined to include those parasites 
which reproduce sexually by sporogony in an anopheline 
mosquito, and asexually by schizogony in two cycles in 
the vertebrate host, one producing pigment in non- 
nucleated red cells and the other in parenchymal cells 
of the liver (World Health Organisation, 1963, Gamham, 
1966).
There are more than 200 recognised species of malarial 
parasites, with a large number of birds, reptiles and 
mammals serving as hosts. Only four species of 
parasites are generally infectious to man, namely 
Plasmodium falciparum. Plasmodium malariae. Plasmodium 
ovale and Plasmodium vivax.
The aetiology of malaria remained a mystery until the 
nineteenth century (Russell, 1955) Discovery of the 
malarial pigment by Lancisi in 1716, and subsequent 
appreciation of its association with the disease by 
Meckel in 1847 and Afanasiev in 1879, provided the 
foundation for Laveran's observation of the parasite 
in the blood (Garnham, 1966). Much of the proof of 
parasite growth and development within the insect is 
however due to Sir Ronald Ross, who first demonstrated
23
CHAPTER I
1. GENERAL INTRODUCTION
Malaria, one of the most important communicable diseases 
of man, is a principal health hazard in many countries. 
Presently, there are about 150 million cases of 
malaria annually. In Africa alone, more than one 
million children under the age of 14 die each year 
from malaria. It is a protozoan infection in which 
the causative agent,a member of the genus Plasmodium, 
undergoes a cyclical development both in the mammalian 
host and in the vector, the Anopheles mosquito. The 
genus Plasmodium is defined to include those parasites 
which reproduce sexually by sporogony in an anopheline 
mosquito, and asexually by schizogony in two cycles in 
the vertebrate host, one producing pigment in non- 
nucleated red cells and the other in parenchymal cells 
of the liver (World Health Organisation, 1963, Garnham, 
1966).
There are more than 200 recognised species of malarial 
parasites, with a large number of birds, reptiles and 
mammals serving as hosts. Only four species of 
parasites are generally infectious to man, namely 
Plasmodium falciparum. Plasmodium malariae. Plasmodium 
ovale and Plasmodium vivax.
The aetiology of malaria remained a mystery until the 
nineteenth century (Russell, 1955) Discovery of the 
malarial pigment by Lancisi in 1716, and subsequent 
appreciation of its association with the disease by 
Meckel in 1847 and Afanasiev in 1879, provided the 
foundation for Laveran's observation of the parasite 
in the blood (Gamham, 1966). Much of the proof of 
parasite growth and development within the insect is 
however due to Sir Ronald Ross, who first demonstrated
24
the presence of peculiar pigmented bodies in the gut 
wall of mosquitoes fed previously on malarious patients. 
Subsequently, Bignami and Grass! (1897-1900) demonstrated 
the whole life cycle in the mosquito (Garnham, 1966).
Following the important discoveries of the aetiologic 
agent and its mode of transmission, later researchers 
elucidated the life cycles of virtually all of the 
avian and many of the primate parasites. The knowledge 
gained from these studies led to the setting up of 
various programmes for both the rational treatment of 
malaria and the eradication of the disease.
Fig I. Illustrative points of attack in the Malaria transmission cycle
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Adapted from HOWARD (1972)
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2 REVIEW
2.1 HISTORICAL ACCOUNT OF CHEMOTHERAPY OF MALARIA
The complex development cycle of plasmodia indicated 
that control of malaria could be approached from the 
standpoint of curing the disease in man ( or other 
mammalian host) or in the mosquito, or in eradicating 
the mosquito vector. Fig. I illustrates points of 
possible attack in the malaria transmission cycle.
Chemotherapy of malaria in man was initially aimed 
at treatment of florid infection but later prophylaxis 
against invasion of the body by plasmodia was also 
utilised. Treatment of malaria by clearing the 
bloodstream of plasmodia had long been known through 
administration of folk remedies such as quinine and 
febrifugine. However, the discovery of anti-malarial 
drugs resulted from the application to malaria 
parasites of the methods which had been used with 
trypanosomes (Schnitzer, 1963) Applying this method, 
the Bayer workers investigated methylene blue, went on 
to other ring systems until in 1924 they brought out 
the active compound Plasmoquine. It was however found 
to be toxic and inferior therapeutically to quinine 
so that by 1930, it had passed out of general use. 
Later, during the 1939-1945 war, it was reinvestigated 
in regard to its remarkable power of preventing 
relapses and became the starting point from which 
primaquine and similar compounds were derived.
In 1933, Mauss and Mietzch by attaching the active 
side chain of plasmoquine to another heterocyclic 
nucleus produced Atebrin (mepacrine, quinacrine) This 
antimalarial was neglected until 1942, when the 
Japanese captured Java and cut off supplies of quinine. 
With the loss of quinine, Atebrin proved an invaluable 
antimalarial in protecting troops; however, soon after
the war, it was supplanted by chloroquine which did not 
stain the skin yellow as mepacrine did.
Chloroquine which is now probably the most used drug 
for the suppression and treatment of human malaria also 
had a chequered history. This antimalarial drug and 
the 3-methyl derivative (sontoquine) were prepared 
about 1938 by the Bayer workers (Andersag et al ;
1939). A small trial was made on a few general 
paralytic patients therapeutically inoculated with 
malaria, but the results suggested that its anti- 
malarial action was not sufficiently superior to that 
of Atebrin to encourage its commercial development. 
Lateij in 1941, limited amounts of chloroquine and 
sontoquine were sent to Professor Sergent of the 
Institute Pasteur, Tunis, then under German domination. 
When the Anglo-American forces occupied Tunis in 1943, 
these drugs together with relevant information were 
handed over to the American Commander who then sent 
them to America for investigation. Chloroquine, after 
thorough laboratory and clinical trials was shown to 
be superior to mepacrine and has since then, become the 
mainstay of antimalarial chemotherapy.
Proguanil (Paludrine) was introduced by Curd et al in 
1945 and pyrimethamine (Daraprim) by Hitchings et al 
in 1952. These compounds were selected by the new 
techniques of screening substances on Plasmodium 
gallinaceum in chicks and Plasmodium berghei in 
rodents. Since the introduction of these drugs, most 
other drugs used in antimalarial chemotherapy were 
generally not superior to those already discussed and 
also generally fell within the same classes. These 
classes will be discussed in detail later. Only 
recently did a new antimalarial drug which showed 
promise more than available drugs reach the stage of
28
clinical trials. This drug — mefloquine is being 
awaited with keen anticipation; and notes of caution 
arising from past experience. When pyrimethamine was 
introduced it was hailed as 'tbe greatest therapeutic 
triumph in malaria since the discovery of paludrine ....* 
(Fairley, 1952) This analogy was unfortunate since 
pyrimethamine was to suffer the same fate as its 
predecessor. This fate - development of resistance 
to antimalarial drug^ continues to be a thorn in the 
flesh of malariologists and will continue to spur on 
more research to keep the malaria chemotherapy arsenal 
ahead of the development of resistance to "old" 
antimalarials.
1.2.2. VECTOR CONTROL AND MALARIA ERADICATION
Attempts at eradication of the mosquito vector 
followed the development of malaria chemotherapy.
These attempts focused mainly on the drainage of the 
breeding grounds, use of insecticides and improvement 
in the ecological framework.
From 1936, the insecticide Pyrethrin was used in mass 
eradication of adult mosquitoes only to be displaced 
by a series of synthetic insecticides. Firstly by 
D.D.T. (dichlorodiphenyltrichloroethane) in 1939 and 
Gammexane in 1943. Since then, the use of these 
insecticides have presented problems, partly because of 
toxicity to humans and other animals and partly 
because the vector mosquitoes proved more adaptible 
than previously supposed.
It might be pertinent at this juncture to recall that 
painstaking research has led to the development of the 
fundamental understanding of the bases of the disease, 
establishment of the life cycles of the several 
plasmodia responsible for malaria. This has made
28
clinical trials. This drug - mefloquine is being 
awaited with keen anticipation; and notes of caution 
arising from past experience. When pyrimethamine was 
introduced it was hailed as 'the greatest therapeutic 
triumph in malaria since the discovery of paludrine....* 
(Fairley, 1952) This analogy was unfortunate since 
pyrimethamine was to suffer the same fate as its 
predecessor. This fate - development of resistance 
to antimalarial drug^ continues to be a thorn in the 
flesh of malariologists and will continue to spur on 
more research to keep the malaria chemotherapy arsenal 
ahead of the development of resistance to "old" 
antimalarials.
1.2.2. VECTOR CONTROL AND MALARIA ERADICATION
Attempts at eradication of the mosquito vector 
followed the development of malaria chemotherapy.
These attempts focused mainly on the drainage of the 
breeding grounds, use of insecticides and improvement 
in the ecological framework.
From 1936, the insecticide Pyrethrin was used in mass 
eradication of adult mosquitoes only to be displaced 
by a series of synthetic insecticides. Firstly by 
D.D.T. (dichlorodiphenyltrichloroethane) in 1939 and 
Gammexane in 1943. Since then, the use of these 
insecticides have presented problems, partly because of 
toxicity to humans and other animals and partly 
because the vector mosquitoes proved more adaptible 
than previously supposed.
It might be pertinent at this juncture to recall that 
painstaking research has led to the development of the 
fundamental understanding of the bases of the disease, 
establishment of the life cycles of the several 
plasmodia responsible for malaria. This has made
29
possible definition of the problems involved in 
malaria, provision of protocol for tackling them; 
and not the least, raised the hope that some day, 
malaria will be a disease of the past. Such was 
this hope, that the World Health Organisation 
considered malaria eradication rather than control 
to be a realistic goal. Unfortunately, it did not 
fully reckon with the considerable range of biological 
adaptability which was to be so brazenly exhibited 
by both plasmodia-in developing resistance to anti- 
malarial drugs and by mosquitoes - in developing 
resistance to insecticides. The dulling of response 
of plasmodia to drugs became evident early in 
laboratory work with chlorguanide (Bishop and Birkett, 
1947; Williamson and Lourie, 1947) and was soon 
followed by discouraging reports from widespread 
sections of the globe (Schnitzer, 1966), Indeed 
since 1961, there has been a rather uncomfortable 
realization that the battle for malaria might have 
taken a turn for the worse.
1.3. LIFE CYCLE OF MALARIA PARASITES AND DRUG INTERACTION 
Malaria is caused by multiplication of haemosporidian 
protozoa of the family Plasmodiidae in the blood and 
other tissues of the host. More than 100 plasmodial 
species have been described, causing malaria in a wide 
range of vertebrates and exhibiting narrowly defined 
host specificity (Garnham 1966; Coatney, Collins, 
Warren and Contacos 1971). Infection is primarily 
initiated by the bite of a female anopheline mosquito 
which inoculates saliva containing sporozoites (a).
The sporozoites are motile 11-12 pm long organisms 
and usually disappear from the circulation within 1 
hour and initiate the tissue stage of primary exo- 
erythrocytic development (b-e). The exo-erythrocytic 
development occurs in liver parenchymal cells in
30
ANTIRELAPSE
Fig. 2
Diagramatic representation of malaria parasite l i f e  cycle 
and drug interaction.
Adapted from Zaman, (1979) and Peters, (1970)
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mammalian malarias but is considered to occur in mononu-wW'vte.clear^cells close to the site of injection in avian 
malarias. Exoerythrocytic forms become multinucleate and 
within about 10 days they rupture the host cell to liberate 
between 100 to 30,000 exoerythrocytic merozoites (e), 
after repeated division by schizogony. The number of 
merozoites liberated depends on the species present and 
other factors. In avian malaria, these merozoites reinvade 
mesodermal tissues to initiate secondary exo-erythrocytic 
schizogony (z) the progeny of which invade either 
erythrocytes or further mesodermal tissues. In the majority 
of mammalian malarias on the other hand, primary exo­
erythrocytic schizogony is followed exclusively by
-throcytic infection. Previously it was thought that 
Plasmodium vivax merozoites liberated from exoerythrocytic 
schizonts re-invaded fresh liver cells producing secondary 
exoerythrocytic stages and that entry of merozoites into 
the blood from secondary exoerythrocytic stages was the 
cause of relapses. It now appears that relapses are due 
to different rates of development of preerythrocytic 
schizonts resulting in 'early' and 'late' forms. The time 
of maturation of the primary exoerythrocytic stage 
apparently is determined by the genetic make up of the 
individual sporozoites which initiate their formation 
(Coatney, 1976, Krotoski et al 1980)
1.3.1 DRUGS EFFECTIVE AGAINST EXO-ERYTHROCYTIC FORMS.
Two major groups of antimalarial drugs are 
effective against the exo-erythrocytic stages.
These ares (1) Causal Prophylactic drugs consisting 
of proguanil, pyrimethamine. (8 - 
aminoquinolines, e.g. primaquine
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and pamaquine are also effective here but are
not used because of toxicity)
(ii) Antirelapse drugs consisting of primaquine,
quinocide and other 8 - aminoquinolines.
These drugs are useful in the radical cure of malaria.
They are useful in prevention of mosquito infection by
sterilising the gametocytes. However, pamaquine and
primaquine are too toxic for prolonged use as causal
prophylactics and are thus not used in practice for this
purpose, but are generally reserved for use against
persistent preerythrocvtic forms of Plasmodium vivax and-----
P.ovale.
-j.ood infection is initiated by merozoite invasion of 
red cells. This involves a sequence of random adherence 
to the erythrocyte, attachment of the apical prominence 
of the merozoite to a specific cell receptor and induction 
of endocytosis by the red cell (f-g) (Bannister et al 
1975). Intracellular growth proceeds through stages of 
ring, trophozoite and schizont (h-j)
and terminates with rupture of infected cells at 24-72h 
intervals, liberating 10-30 merozoites (k) which initiate 
a further cycle of development (1). The clinical signs 
and symptoms of malaria are associated in mammals 
exclusively with cyclical blood stage schizogony, but in 
birds exoerythrocytic schizogony causes significant 
additional pathology.
1.3.2. DRUGS EFFECTIVE AGAINST ERYTHROCYTIC FORMS
The main class of antimalarial drugs effective 
against erythrocytic forms is the schizontocides 
and can be classified into (a) Quick and potent
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acting, consisting of quinine, mepacrine, chloroquine 
and amodiaquine. ("Blood schizonticides" - act only 
on blood stages) (b) Slower acting drugs consisting of 
proguanil, pyrimethamine, sulphonamides and sulphones.
These also act on tissue forms. These drugs are 
effective against the growing intraerythrocytic stages 
of plasmodia. Another class of drugs, 8 - aminoquinolines 
such as primaquine and pamaquine are referred to as 
gametocytocides and are effective against blood gametocytes 
^causing destruction and sterilisation of gametocytes.
After a period of asexual multiplication of erythrocytic 
parasites, a proportion of newly invaded merozoites 
differentiate into male and female gametocytes (m & n), 
micro and macro gametocytes respectively. These mature 
without further cell division over a period of about 10 
days. When ingested into the mosquito stomach, the 
microgamétocyte under goes exflagellation (P) liberating 
8 microgametes and fertilization occurs (q) The zygote 
(r) differentiates in the wall of the mosquito gut (s-v) 
and sporozoites finally accumulate in the insect's 
salivary glands (x) to complete the sexual cycle of 
development.
1.3.3. DRUGS EFFECTIVE AGAINST GAMETOCYTES AND OOCYTS 
IN THE MOSQUITO
These drugs are referred to as sporontocides and 
consist of proguanil, pyrimethamine, pamaquine 
and primaquine. They will prevent development of 
the sexual stages and the zygotes in the mosquito 
gut (Fig. 2 shows the interaction of groups of 
antimalarial drugs with the life cycle of malaria 
parasites. Letters in parenthesis in the text 
refer to letters in fig 2. Fig 3 is the summary
FIGURE 3. SCHEMATIC REPRESENTATION C” INTERACTION OF ANTIMALARIAL DRUGS WITH BLOOD, 
TISSUE & MOSQUITO FORMS OF MALARIA PARASITES.
1--------------1 On Asexual On tissue Schizont J On Gametocytes
forms in Blood . Tissue Schizontoci, es In Mosquito ! 
Sporonto- i 
cides (3)
MAIN USESDRUG Blood Schizontocides Preerythrocytic Secondary gametocytoeides
P,falciparum Other
Species
P.
falciparum
Other
sp f.
Exoery-
throcytic P.
falciparum
Other
Species
:
Chloroquine 
[ Amodiqquine 
Mepacrine 
Quinine
+ + + +
•
+ (2) .(2) Treatment of acute 
attack: radical cure 
Of falciparum malaria. 
V All except quinine 
are useful suppress- 
< ives by action on 
blood schizonts
Proguanil
Pyrimethamine
+ + ♦ + + + 'Causal prophylaxis 
infalciparum malaria. 
'’ Suppression against 
other spp. Prevention 
of mosquito infection 
(. by sterilising 
; gametocytes.
Primaquine
Pamaquine
•f + (3) + (3) + + + +
r
Radical cure of vivax 
and other relapsing 
malaria. Destruction 
and sterilisation of 
gametocytes.
(1) Sporontocides prevent development of the gametocyte after its ingestion by the mosquito.
(2) Although gametocytes of P.vivax and other species are removed from the blood rapidly, their development 
in the mosquito is not affected.
(3) Too toxic for prolonged use as causal prophylactics.
+ * active ” - not active.
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of the drug interaction represented schematically). Insec­
ticides interrupt the transmission cycle by killing the 
mosquito host.
1.4. PHYSIOLOGICAL ADAPTATION OF THE MALARIA PARASITE 
In the mammalian host, malaria parasites generally elect 
to inhabit two types of cells.
(i) The exoerythrocytic schizonts inhabit the parenchymal 
cells of the liver.
(ii) The erythrocytic stages inhabit red blood cell or its 
precursors. Some species show a preference for younger 
cells e.g. P.vivax,others for older cells or cells
of any age.
Previously, it was thought that P. falciparum preferred 
old cells but recent evidence suggests that P.falciparum 
also prefers younger cells in vivo and in vitro (Pasvol, 
et al 1980). Many strains of P.berghei preferentially 
invade immature cells,both polychromatophils and 
reticulocytes.
A third site of election unique to P.elongatum, a species 
of avian malaria parasites is the cells of the lymphoid- 
macrophage system with secondary exoerythrocytic schizogony 
occuring in erythrocyte stem cells of the haematopoietic 
tissues of bone marrow. This site of habitation is indeed a 
paradox of intraphagocytic parasitism (Peters, 1970), 
since the cells of the lymphoid-macrophage system are 
concerned with removal of parasites in defence of the host. 
Another analogous situation is the complete lack of 
cellular response to the exoerythrocytic parasites of 
mammalian malarias, up to the moment when they mature and 
erupt releasing their cryptozoites (merozoites) into the 
portal sinuses (Bray, 1957).
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By virtue of its intracellular habitat, the malaria 
parasite has evolved a very complex interelation with 
its host cell. This interesting situation may possibly 
convey some degree of protection from extraneous toxic 
compounds (e.g. antimalarial drugs or antibodies) which 
must first penetrate the host cell membranes and contents 
before coming into contact with the parasite itself. On 
the contrary, the long and intimate interaction with the 
host has resulted, in some instances, in the parasite 
becoming more vulnerable because of its crucial dependence 
on the host for certain basic metabolites or possibly 
enzymes with which to utilize the metabolites. As a 
result of this dependence, the parasite has developed 
various metabolic déficiences. It has been suggested 
(Peters, 1970aj) that the u ! • might have lost its
rigid inner cell membrane inorder to gain better access 
to its host cell's contents, apart from being able to 
adopt amoeboid movements. Thus the parasite is able to 
take in portions of the host substance by phagotrophy 
as well as other more soluble substances by active 
membrane transport or free diffusion (Danforth, 1967,
Jahn and Bovee, 1967).
One important feature of the erythrocytic stage of 
infection of malaria is the specialisation of the type 
of red blood cell infected by the various Plasmodium 
species. Plasmodium vinckei and P. chabaudi preferen­
tially invade mature red cells whereas P.berghel and 
P.yoelii prefer reticulocytes. The human malaria,
P.vivax infects predominately reticulocytes while 
P.malariae, P.ovale and P.falciparum appear to favour
mature red cells (but see Pasvol et al 1980)
The significance of the type of red cell infected lies 
in the difference in metabolic status'of young and mature 
red cells since there are variations in levels of 
metabolites and various ions in both types of red blood 
ooll, as shown in Fig. 4. However, in the erythrocyte, 
the importance of haemoglobin as a substrate cannot be 
overemphasised, but the position is less clear in the 
tissue phases. The parenchyma cells of the liver are 
rich in metabolites, and contain large quantities of 
glycogen, purines and B12 vitamins, as well as being a 
store for various substances transported by the blood 
and a factory for making nucleoproteins from amino acids 
and nucleotides.
As has been mentioned earlier, the intracellular habitat 
of the malaria parasite is a double-edged sword, protect- 
.»■’■'ir the parasite to some degree from toxic substances by 
obliging the toxic materials to first penetrate host red 
cell or liver cell membranes and contents before reaching 
the parasite itself, but rendering the parasite vulnerable 
because of its increasing dependence upon the host for 
certain basic nutrients or the enzymes with which to 
utilize them. Fig.5 shows some of the nutrients supplied 
to the parasite by the host cell and further underlines the 
crucial nature of the physiological dependence of the 
parasite on the host cell. It is pertinent at this point 
to mention the principal reactions which occur in plas- 
modial metabolism, all of which depend at one stage or 
other on the host cell.
1.4.1 UTILISATION OF GLUCOSE
Phosphorylation of glucose eventually provides energy 
required for the parasite's metabolism. The utilisation 
°f glucose is predominantly via the glycolytic pathway
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Fig 4 - Metabolic Characteristics of Red blood cells at 
2 stages of development.
*
Metabolic changes Reticulocyte Adult Cell
Glycolysis + + + + +
Oxygen Utilisation + + +
Total - SH + + + + +
RNA present + 0
Haem synthesis + 0
Protein synthesis + 0
Cytochrome and Electron
transport system + 0
Krebs Cycle + 0
Electrolytes
Potassium + + + + +
Sodium + + + + + (a)
Sodium + + + (b)
Storage changes
Breakdown of ATP + + +
(a) Joyce, (1958)
(b) Bernstein, (1953)
^Symbols adapted from Harris J. W. (1963) 
+ + + > + + >  +, 0 means virtually absent.
PLASMA
ERYTHROCYTE
MILIEU
PARASITE
Amino Acids
Sugars
----------- > Dihydrofolate
I m P— >A M P ___>  ATP/ "" ^  NUCLEIC
----------- >
_ .. _ „ T 0 fif ACIDS
g m p _ ^ g t p ---------- -
Isoleucine 's
Methionine J ----------- > Protein
Other amino \ \
acids J
\
Haemoglobin - ----------- Amino acids'
O-glurnse glycolys:^ Lactate
s
Coenzyme A --------- ----------- > Krebs cycle ?
----------- > Glycerides
Cholesterol ----------- > Cholesterol
Fig. 5
Illustration of dependence of Parasite metabolism on supply of substrates from erythrocyte.
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and very little glucose is utilised through the pentose 
phosphate pathway (Bowman et al 1961). Usually lactate 
is the end product of glycolysis in Plasmodium, and 
Fulton and Spooner (1956) have shown that the small 
amount of succinate found was probably produced by host 
cells. In general, all plasmodia break down glucose 
anaerobically through the classical Embden-Meyerhof 
pathway but the fate of the end product differs because 
of the lack of a Krebs cycle in many of them. Avian 
parasites can synthesise glutamate, aspartate and alanine 
through the Krebs cycle, but rodent parasites which lack 
the cycle (Howells 1970; Theakston, Fletcher and Maegraith, 
1970) are more dependent upon CO2- fixation for such 
synthesis. Free parasites of avian malaria can also form 
large amounts of acetate which is not further metabolised 
and it has been suggested that the basis for this shift 
in carbohydrate metabolism is probably due to the 
plasmodial requirement for preformed Coenzyme A from its 
host. (Sherman et al 1969).
1.4.2 UTILISATION OF HAEMOGLOBIN
Enzymatic break down of the globin portion of haemoglobin 
into amino acids and peptides, which are built up into 
parasite protein: It is apparent that malaria parasites 
hydrolyse globin, although an isolated plasmodial system 
capable of cleaving haemoglobin into haematin and 
globin is still to be demonstrated. In general, the 
amino acids produced in the highest concentration by 
parasitized erythrocytes are those found to be the most 
abundant in host haemoglobin but the parasite apparently 
produces many more amino acids than it can actually use 
(Cenedella, Rosen, Angel and Saxe, 1968) It is worth 
noting that other sources of amino acids obtainable by
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malaria parasites include:
(a) Biosynthesis from other carbon sources; by fixing 
C02. The amino acids synthesised via this route 
include aspartic, glutamic acids and alanine 
(Sherman, 1977).
(b) Amino acid transport from host plasma across the 
surface of the host cell and the parasite,
1.4.3 SYNTHESIS OF LIPIDS
Growth of the malarial parasite, results in a marked 
rise in the lipid content of the infected erythrocyte, 
particularly in the phospholipid fraction. Notable 
increases occur particularly in phospholipids associated 
with the malaria parasite - phosphatidylinositol and 
polyglycerol phosphatides (Lawrence and Cenedella, 1969) 
Plasmodium is incapable of denovo biosynthesis of fatty 
acids and chol esterol and has to synthesize its 
glycerides and phosphoglycerides from host supplied fatty 
acids, nitrogenous bases, alcohols and coenzyme A. 
Cholesterol is similarly obtained from the host. Lipid 
metabolism of the parasite results in alterations in 
octadecenoic fatty acids and cholesterol composition of 
the erythrocyte membrane and leads to changes in 
permeability and increased fragility of the erythrocyte 
(Holz, 1977).
1.4.4. SYNTHESIS OF NUCLEIC ACIDS
Tetrahydrofolate - containing cofactors are required by 
both mammalian host cells and plasmodia for the synthesis 
of essential metabolites such as thymine. Folate 
metabolism in plasmodia differs from that of the host in 
starting from para aminobenzoic acid (PABA) and the 
parasite is unable to utilise exogenous preformed vitamins
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folic and folinic acids, which man, for example can 
obtain from his diet.
It is now known, that malaria parasites make their own 
pyrimidines denovo, but the synthesis of purines is not 
performed denovo but they are obtained via metabolic 
salvage pathways. The salvage of preformed purines from 
the host can occur through the following pathways:
(1) Utilisation of adenine and adenosine to form 
adenosine monophosphate (AMP).
(2) Utilisation of inosine and hypoxanthine to form 
inosine monophosphate (IMP)
(3) Conversion of adenosine to adenine.
Fig 6 summarises the possible nucleotide pathways for 
the synthesis of nucleic acids in malarial parasites and 
emphasises that the salvage synthesis of purine nucleotide 
provides the precursor molecules for the biosynthesis 
of nucleic acids and the nucleotide coenzymes e.g. 
Guanosine 5' - triphosphate (GTP) which is the initial 
compound of the plasmodia - specific synthesis of 
dihydrofolate (Konigk, 1977)
The intraerythrocytic stages of plasmodia possess high 
rates of nucleic acid synthesis and protein synthesis 
and they require a vast supply of precursor molecules 
in amounts that will allow the successful growth and 
multiplication of the parasite within the cell. While 
the synthesis of dihydrofolate is an example of a 
parasite - specific sequence of reactions, the transfor­
mation of energy and the synthesis of nucleotides in the 
malaria parasite occur via metabolic routes very 
similar to those of their host cells. However, minor
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Fig. 6 Summary of possible nucleotide pathways for synthesis of nucleic acids in malaria parasites. 
Adapted after Van Dyke, (1977)
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differences may exist in the sequence and regulation of 
some reactions:- e.g. the synthesis of AMP from IMP 
has not been reported from human erythrocytes because 
of an apparent lack of adenylosuccinate synthetase and 
lyase, enzymes that have been observed in rabbit 
reticulocytes and in preparations of P.chabaudi (Konigk, 
1977). Further differences between malaria parasites 
and host cells in the manner in which purines and 
pyrimidines are utilised have been reported (Van Dyke £t_ 
fil 1977).
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1.5. CLASSES OF ANTI MALARIAL DRUGS AND THEIR MECHANISM 
OF ACTION.
Antimalarial drugs can be classified under three broad 
headings as follows:
(i) Blood schizontocides consisting of chloroquine, 
quinine, mepacrine, amodiaquine etc .
(ii) 8 - aminoquinolines, consisting mainly of primaquine
and quinocide
(iii) Antimetabolites consisting of pyrimethamine, 
proguanil, sulphonamides and sulphones.
As will be seen later, the classes especially (i) and 
(iii) are not completely mutually exclusive, since for 
example, the antimetabolites proguanil, pyrimethamine 
and sulphonamides are also schizontocidal drugs though of 
limited action, (but they are not restricted to the blood 
stage).
1.5. BLOOD SCHIZONTOCIDES
The blood schizontocides chloroquine, quinine, and 
amodiaquine are quinoline derivatives; while mepacrine 
(also a blood schizontocide) is specifically an acridine 
derivative. These drugs are quick acting and are used 
therapeutically. They are effective on the growing 
intraerythrocytic stages of plasmodia,having a variable 
effect on developing gametocytes.
The selective toxicity of the blood schizontocides is 
based on the enormous concentrative ability of the 
intraerythrocytic malaria parasite for the drugs. This 
concentrative ability has been demonstrated for quinine 
and mepacrine (Bock, and Oesterlin Warhurst 1980) 
and also more thoroughly for chloroquine (Macomber 
Si 1966, Polet and Barr 1969, Fitch 1969, 1970, 1973)
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With a medium chloroquine concentration of 10 nmol/litre, 
infected erythrocytes can accumulate 600 times this 
concentration of radioloabelled drug. The uptake 
mechanism is saturable and has an apparent Km of 
10 nmol/litre (Fitch, 1969) The uptake of chloroquine 
into P.berghei is dependent on a supply of D-glucose and 
is inhibited by metabolic inhibitors (Fitch, et al 1974), 
similarly, uptake of chloroquine in P.falciparum is 
glucose dependent. However, uptake of amodiaquine was 
less glucose dependent, though glucose stimulated uptake 
of drug in the chloroquine resistant strain (Fitch et al 
1974) The variation in the uptake of drug by resistant 
strains will be discussed later. It is Fitch's view 
that infected erythrocytes possess high affinity receptors 
for those drugs and that those receptors are absent in normal 
erythrocytes and reduced or absent in erythrocytes 
infected with drug resistant parasites. He further 
proposed that energy was required to make the receptors 
accessible to chloroquine and this accounts for the glucose 
requirement and explains the anomalous behaviour of 
amodiaquine which he proposes to be more accessible to 
receptors than chloroquine. An alternative explanation 
for the energy requirement has been suggested
(Warhurst and Thomas 1978). A two stage mechanism was 
suggested, the first stage of chloroquine uptake being 
binding to the high affinity site (non-energy dependent), 
the second stage was translocation of drug together with 
a proton into the parasite, under the influence of a 
proton gradient (energy dependent) •
The lysosome has also been postulated as a possible 
vehicle for the uptake of basic drugs in malaria
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(Homewood et al 1972) The mechanism was initially 
proposed by Rollo, ( 1968) following partition
profile studies indicating that the accumulation of 
basic antimalarials within the red cell was dependent 
upon differences between the pH of the plasma and the 
pH within the red cell. Rollo suggested that lactic 
acid production within the erythrocytic parasite led to 
a high hydrogen ion concentration enabling basic 
antimalarials to be concentrated. (This suggestion was 
based on the ionization characteristics of chloroquine.
The ionization constants of chloroquine (pka^ 10.2, 
pka2 8.1 - Irvin and Irvin 1947) indicate that at 
physiological pH, 18% of the drug is in the monoprotonated 
form which is soluble in lipid and hence capable of 
passing into the cell membrane. The drug would pass 
out readily from the membrane phase into a more acid 
cytoplasm with production of the doubly protonated form 
insoluble in lipid and incapable of passing back into 
the membrane. Chloroquine would thus cross the membrane 
into the cell provided that the pH inside the cell 
remained lower than that of the plasma).
Following the demonstration (Allison and Young 1964) 
that chloroquine concentrated in mammalian lysosomes, 
Homewood et al 1972, extended these observations to 
propose a physico-chemical basis for the accumulation of 
chloroquine within parasitised erythrocytes. These 
workers considered that a low pH within the parasite 
lysosomes would be effective in inducing accumulation 
of the drug within these organelles. The accumulation 
of chloroquine was followed by autophagic vacuole forma­
tion (Clumping) - enclosing the digestive 
vacuoles and their contents of haemozoin and 
haemoglobin. (Warhurst and Hockley, 1967)
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The digestive vacuoles of malarial parasites (and 
other protozoa (Kudo 1966) are considered to be analogous 
to mammalian secondary lysosomes and to be at acid pH - 
an assumption supported by the localization of acid 
phosphatase within the pigment vesicle of P.berghei 
(Aikawa and Thompson 1971) and the presence of acid 
protease with a pH optimum of 4.0 in the parasite 
(Cook et al 1961). Warhurst (1980) has also observed 
the concentration of the basic dye neutral red from 
medium concentrations of 200 pmols/litre into digestive 
vacuoles, proving the acidic nature of these vacuoles. 
Concentration of the drug, it was argued would cause 
a rise in the pH of lysosome contents and this change 
might cause the clumping of the pigment vesicles.
Evidence to support this concept was presented by the in 
vitro incubation of parasites in media made slightly 
alkaline with bicarbonate (HCO” ) It was observed that 
raising the extracellular pH of the parasites corres­
pondingly increased the amount of clumping of the 
pigment. Also the protonation of chloroquine within 
the digestive vacuoles would deplete them of hydrogen 
ions and uptake of drug would then cease, unless more 
acid were secreted into the vacuoles or new acid 
containing vacuoles were formed, either case would 
require energy thus explaining the second energy 
dependent phase of chloroquine uptake described by 
Polet and Barr ^ I t  is interesting to note that 
malaria infected rat erythrocytes have been reported 
to maintain a slightly higher average pH than the 
surrounding medium (Williams and Fanimo 1975), this 
observation would probably render Rollo's mechanism
unlikely though not necessarily disproving the proposal 7 0911).of Homewood et al Indeed in mammalian cells the 
majority of evidence tends to support the intralysosomal
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concentration of chloroquine and similar drugs (De Duve 
et al 1974).
This mechanism for the intraparasitic concentration of 
chloroquine is also probably suggestive of one of the 
mechanisms of action of this group of antimalarial drugs. 
Depleting the food vacuole of acid would change its 
internal pH from that required for the most efficient 
action of digestive enzymes, digestion of haemoglobin 
would be considerably impaired, and the supply of 
amino acids to the parasite dramatically reduced.
Because the mature mammalian erythrocyte is virtually 
impermeable to some amino acids (Winter and Christensen 
1964) the normal rapid growth of the parasite would be 
halted. Hence chloroquine would act initially by 
raising the pH of malarial food vacuoles, thereby 
reducing the digestion of haemoglobin by the parasite 
and preventing its growth. Further support for this view 
arises from the observation that chloroquine in high 
concentrations inhibits certain mammalian proteolytic 
enzymes (Cowey and Whitehouse, 1966). However, Wibo 
and Poole, (1974)have observed that in mammalian cell 
free preparations, the proteolytic enzyme cathepsin B 
was 50% inhibited by 5 mmol/litre chloroquine, but 
cathepsins D, A and C, of which D would be most important 
in digestion of haemoglobin, were not affected. Despite 
these observations, the evidence is strong that lysosomal 
systems in malaria parasites are affected by blood 
schizontocides. The evidence includes chloroquine 
induced autophagic vacuole formation (pigment clumping) 
and the effect of prolonged quinine and mefloquine
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treatment which causes cessation of haemozoin production 
and apparent dissolution of pigment (Peters, et al 1977)
Chloroquine at low concentrations (10^M) stabilizes 
erythrocyte membranes but at high concentration ( 10 M) 
labilizes them (Inglot and Wolma, 1968) Although the 
concentration in plasma does not rise above 10^M 
(Berliner et al 1948) and the red cell membrane is 
therefore unaffected, it is quite possible that the 
concentration of ctiloroquine in malarial food vacuoles 
could rise sufficiently to labilize its membranes 
(Allison, 1968). Thus the formation of autophagic 
vacuoles could then be regarded as a defensive attempt 
Dy the cell to segregate the hydrolytic enzymes released 
into its cytoplasm. However, Warhurst and Williamson 
(1970), have shown that clumping appears before break­
down of RNA can be detected suggesting that lysis of 
cellular constituents follows rather than precedes 
autophagic vacuole formation. Moreover in the experiments 
of Homewood et al raising the pH to 8.0 did not cause 
haemolysis of the red cells although clumping occured.
Several groups of workers have demonstrated that
chloroquine and quinine will, given several hours to
become concentrated within the parasite; inhibit
macromolecular synthesis such as that of DNA, RNA and
protein. O'Brien and Hahn have offered a model to
account for the antimalarial activity of chloroquine
and its congeners (O'Brien and Hahn 1965) Some workers
have also supported this model by showing that a high
level of structure-activity correlation can be obtained
with this model by comparing goodness of fit of regression
2lines obtained from calculated statistical quantities R ,
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F (overall) and explained variance (Bass et al 1971) 
However, there is no evidence that therapeutic levels 
of chloroquine affect macromolecular synthesis over the 
first hour (Homewood et al 1971, Warhurst, 1969), 
although this is the period during which the chloroquine 
induced autophagic vacuole is formed. The binding
constant for chloroquine and DNA under physiological
.. . . . 4 5conditions of ionic strength is between 10 - 10
l/mole and this is too low to explain concentrative
uptake of the drug by the parasite. Moreover, the
observation that mefloquine (WR 142, 490) which avidly
binds to the high affinity uptake site (Fitch, 1972)
will not interact with DNA in vitro (Davidson et al 1975,
Peters, et al 1977) strongly negates the contention
(Hahn, 1974) that DNA is the high affinity uptake site.
Moreover chloroquine binds equally well to both mammalian
and plasmodial DNA (Gutteridge et al 1972) Quinine and
mepacrine like chloroquine intercalate into DNA
(Hahn et al, 1966) and inhibit DNA and RNA synthesis.
Mepacrine is a planar molecule with dimensions similar
to those of the normal base pairs. It causes a local
spreading of the distance between adjacent base pairs
and a localised unwinding of the helix to accomodate
this distortion. Given that high concentrations of
these drugs are achieved in the parasite, their anti-
DNA template activity must be highly important.
Chloroquine has also been reported to inhibit coenzymes 
(ubiquinones) Q8 and Q9 linked NADH -oxidase systems of 
P. lophurae at 0.1 mmol/litre (Skelton et al 1968) 
Ubiquinone production by P.knowlesi, P.cynomolgi,
P. falciparum and P.loplaurae has been demonstrated 
(Skelton et al. 1970),
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Evidence has also been presented for a CC>2 - fixing 
pathway in P.berghei (Siu, 1967) and it was demonstrated 
that chloroquine at a concentration of 0.2 mmol/1 inhibited 
the action of parasite phosphoenolpyruvic carboxykinase 
by 507o. Other enzymes which have been shown to be 
inhibited by chloroquine (or other schizontocides ) 
include deoxyribo-nuclease (Kurnick and Radcliff 1957), 
adenosine triphosphatase (Bagnall, 1957) cocarboxylase 
(Silverman, 1949)& diaphorase (Guggenheim and Shamir- 
Zernik 1953) The multiplicity of this enzyme inhibition 
probably indicates non-specific action which is difficult 
to correlate with the selective antimalarial effect of 
schizontocides. Hence, the relevance of the inhibition 
of these enzymes to the mode of action of the schizonto­
cides in vivo is uncertain.
Chloroquine has been found to inhibit pinocytosis in 
cultured mouse macrophages. (Fedorko, et al, 1968) this 
observation could indicate effects on the feeding of 
plasmodia. Electron microscopic evidence (Rudzinska,
1960) showed that plasmodia feed on erythrocyte contents 
by pinocytosis.engulfing droplets of host cytoplasm 
into food vacuoles and thus producing extensive changes 
(shown up as Maurer's clefts in P.falciparum) The 
inhibition of pinocytosis coupled with the disruption of 
the digestive process, could lead to nutrient deprivation 
and parasite starvation.
1.5.2. 8 - AMINOQUINOLINES
The antimalarial action of 8 - aminoquinolines (prima­
quine .other 8 - aminoquinolines and napthoquinones) is 
predominantly on the exoerythrocytic schizonts with 
some effect on the gametocytes. Malaria parasites
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posses mitochondria-like structures and are able to 
synthesise ubiquinone 8. The structure and function 
of these organelles are disrupted by the exposure of 
tissue stages of mammalian and avian plasmodia to 
8 - aminoquinolines notably primaquine and to certain 
compounds of the napthoquinone series such as menoctone. 
The antimalarial effect of 8 - aminoquinolines is 
probably due to the quinoline 5, 6 diquinone active 
metabolites obtained by demethylation and oxidation 
(Tarlov et al 1962). The quinoline / quinone intermedia­
tes can act as intermediates in biological oxidation - 
reduction systems and are probably responsible for 
making erythrocytes susceptible to haemolysis especially 
in individuals with "G - 6 - PD" deficiency 
of the red blood cells. The quinoline / quinone 
intermediates, are active oxidants and may interfere 
v'ith the NADH linked reductive processes in the tissue 
cells containing the schizonts, resulting in a lack of 
necessary substrates essential to the rapid development 
of the parasites.
It has recently been suggested (Gutteridge, et al 1979), 
that a link between ubiquinone and pyrimidine synthesis 
is the basis for the mode of action of primaquine and 
napthoquinones. The enzyme dihydroorotate dehydrogenase 
which is important in pyrimidine synthesis, is linked 
to the oxidation and reduction of ubiquinone. Hence 
the presence of active primaquine intermediates which 
are similar to the naturally occuring ubiquinone might 
be expected to interfere severely with synthesis of 
pyrimidines which is a crucial function in plasmodia. 
However, much work is needed to elucidate further the 
mode of action of 8 - aminoquinolines and naphthoquinones.
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Unfortunately, primaquine is too toxic for use as 
a causal prophylactic (see fig 3) and its tendency to 
induce haemolysis in G6PD deficient individuals 
coupled with its low therapeutic index makes it an 
unsatisfactory drug.
1.5.3. THE ANTIMETABOLITES
An antimetabolite may be defined as a compound structurally 
related to a metabolite which prevents its further 
utilization by competing with it for an enzyme. The 
recognition that a compound, closely related to a 
metabolite, could prevent its participation in an 
essential biosynthetic pathway, arose from studies 
on the antibacterial effect of sulphanilamide and its 
reveisal by the structurally related p-aminobenzoic 
acid (PABA). In malaria chemotherapy, there are two 
main groups of antimetabolites - antagonists of 
dihydrofolate (the metabolic product of proguanil 
(cycloguanil) and pyrimethamine) and competitors for 
PABA (sulphonamides and sulphones), both groups thus 
act at two main steps of the folate pathway in plasmodia 
(see fig 8)
Plasmodia like bacteria depend on p-aminobenzoic acid 
(pABA) together with pteridine and glutamic acid for 
the production of dihydrofolate. The enzyme dihydro- 
pteroate synthase (EC 2.5.1.15) catalyses the condensation 
of pABA with 6 - aminohydroxymethyl dihydroxy pteridine 
to form dihydropteroic acid. This enzyme is the site 
of action of sulphonamides which inhibit it competitively; 
by competing with pABA. Dihydropteroate synthase has
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been found in P.chabaudi and P.berghei (FERONE, 1973) 
and has a Km for pABA of 0.21 to 2.8 pmol/litre.
Inhibition constants (Kj ) for sulphadiazine, sulphathiazole 
and sulphanilamide are comparable to those obtained with 
the enzyme from bacterial sources (Brown, 1971) and 
satisfactorily confirm an enzymatic basis for the 
sulphonamide - pABA interrelationship observed in 
malaria in vivo and in vitro.
Dihydrofolate synthetase (EC 6.3.2.12) catalyses the 
reaction of dihydropteroate +L-glutamic acid + ATP to 
form dihydrofolate which is the next reaction in the 
sequence for the formation of dihydrofolate by analogy 
to bacteria. This enzyme has not been demonstrated 
in any malarial system. It has been speculated that 
P.berghei might utilise pABG (paraamino benzoyl glutamate) 
as an alternative substrate to form dihydrofolate 
directly (Ferone, 1977) .
Tetrahydrofolate dehydrogenase (EC 1.5.1.3) is the key 
enzyme in folate metabolism and converts dihydrofolate to 
tetrahydrofolate by reduction of the pteridine ring to 
the tetrahydro reduction state required for the reactions 
in which folate cofactors are utilised. These reactions 
include formation of methionine from homocysteine by 
donation of the S-methyl group, conversion of glycine 
to serine, generation of inosinate from purine precursors 
and synthesis of thymidylate from deoxyuridylate. Pro- 
guanil and pyrimethamine prevent the reduction of 
dihydrofolate to tetrahydrofolate by inhibiting 
tetrahydrofolate dehydrogenase. Proguanil is first 
metabolised to the active metabolite cycloguanil. The
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affinity of these compounds (pyrimethamine and cycloguanil)
for the plasmodial enzyme is much higher than for the
mammalian enzyme and moreover these antagonists of dihydro- 
4 5folate bind 10 - 10 times more strongly than dihydrofolate
and so the inhibition is essentially an irreversible one 
(Bacq 1975).
The basis of the selective toxicity of sulphonamides to 
malaria parasites depends on the possession of a metabolic 
pathway to dihydrofolate distinct from the mammalian one, 
since mammals do not synthesise dihydrofolate via pABA 
but convert folic acid direct to dihydrofolate utilising 
folate reductase which is not present in plasmodia (Pratt, 
1973) Mammals and plasmodia, convert dihydrofolate to 
tetrahydrofolate using tetrahydrofdate dehydrogenase. The 
basis of the selective toxicity of pyrimethamine and cyclogua­
nil appears to be the much higher affinity of the plasmodial 
enzyme for these drugs (in the case of pyrimethamine up to 
1000 times higher).
However, it is important to note that the fact that the 
antifolates and the sulphonamides are so effective in 
inhibiting plasmodial growth even in the liver which is 
rich in folate cofactors indicates that host folate 
cofactors are not available or cannot be used by ithe 
parasite. This phenomenon might be indicative of the 
inability of the parasites to take up preformed folates, 
as most micro organisms that synthesise folates de novo, 
are impermeable to exogenous folates (Hitchings and 
Burchall, 1965) probably due to a lack of a permease 
system (Albert, 1973). Fig 7 summarises the grouping 
of major antimalarial drugs and their probable mechanisms
of action
56
affinity of these compounds (pyrimethamine and cycloguanil)
for the plasmodial enzyme is much higher than for the
mammalian enzyme and moreover these antagonists of dihydro- 
4 5folate bind 10 - 10 times more strongly than dihydrofolate
and so the inhibition is essentially an irreversible one 
(Bacq 1975) .
The basis of the selective toxicity of sulphonamides to 
malaria parasites depends on the possession of a metabolic 
pathway to dihydrofolate distinct from the mammalian one, 
since mammals do not synthesise dihydrofolate via pABA 
but convert folic acid direct to dihydrofolate utilising 
folate reductase which is not present in plasmodia (Pratt, 
1973) Mammals and plasmodia, convert dihydrofolate to 
tetrahydrofolate using tetrahydrofolate dehydrogenase. The 
basis of the selective toxicity of pyrimethamine and cyclogua­
nil appears to be the much higher affinity of the plasmodial 
enzyme for these drugs (in the case of pyrimethamine up to 
1000 times higher).
However, it is important to note that the fact that the 
antifolates and the sulphonamides are so effective in 
inhibiting plasmodial growth even in the liver which is 
rich in folate cofactors indicates that host folate 
cofactors are not available or cannot be used by (the 
parasite. This phenomenon might be indicative of the 
inability of the parasites to take up preformed folates, 
as most micro organisms that synthesise folates de novo, 
are impermeable to exogenous folates (Hitchings and 
Burchall, 1965) probably due to a lack of a permease 
system (Albert, 1973). Fig 7 summarises the grouping 
of major antimalarial drugs and their probable mechanisms
of action
EigURE GROUPING OF MAJOR ANTIMALARIAL DRUGS AND ROBABLE MECHANISMS OF ACTION
Group Chemical
class.
Drug * Synonym * Probable mechanisms of Action.
Schizontocides 
blood <
4-amino 
quinoline
Chloroquine
Si
Alvoclor
Nivaquine
Resochin Aralen etc.
After concentration
Inhibition of digestive processes.
Digestion of plasmodial cytoplasm due to 
cytolysosome formation.
Binding to nucleic acid & inhibition of protein 
synthesis; other Biochemical effects including 
enzyme inhibition.
Amodiaquine Camoquin 
Flavoquine etc.
9-amino
acridine
Mepacrine Atebrin 
Atabrine 
Quinacrine etc.
After concentration
Binding to DNA & RNA and inhibition of 
transcription, translation & protein synthesis.
quinoline
methanol Quinine Quininine
.. r 8-amino tissue .^  quinolines Primaquine Neo-Quipenyl Disruption of structure & function of malarial parasite mitochondrion-like 
organelles
Antiïetabolites Biguanide Proguanil Paludrine 
Chlorguanide etc
Inhibition of tetrahydrofolate dehydrogenase 
Competition with dihydrofolate.
Diaminopy-
rimidine
Pyrimethamine Daraprim
Malocide
Inhibition of tetrahydrofolate dehydrogenase 
Dihydrofolate antagonist.
Sulphona-
mides
Sulphadiazine
etc.
Adiazine 
Co diazine 
Eustral etc
Antagonism of pABA
Inhibition of dihydropteroate Synthetase
SuIphones Dapsone etc Avlosulfone 
Damitone 
Udolac etc.
Antagonism of pABA
Inhibition of dihydropteroate synthetase.
* International Nonproprietary Name
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l 2+ p-V ATP,. Mg ^ i  _ Dihydro
(  J
i  pteroic
acid
6 aminohydroxy 
methyl dihydro- 
Pteridine
A
DNA
t
t
d TMP dUMP
X
5,10-methylene-
t
5-formyl-F
F H
4
Fig. 8
Folate cofactor sythesis and u tilisa tion  in plasmodia.
Blocks show point of inhibition of sulphonamides and sulphones (1), 
pyrimethamine & cycloguanil (2).
Enzymes inhibited (1) Dihydropteroate 
(2) Tetrahydrofolate dehydrogenase 
(?) Dihydrofolate synthetase which catalyses 
this reaction has not been reported in malaria.
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1.6. RESISTANCE TO ANTIMALARIAL DRUGS 
Drug resistance in malaria has been defined as the 
'ability of a parasite strain to survive and/or to 
multiply despite the administration and absorption of 
a drug given in doses equal to or higher than those 
usually recommended but within the limits of tolerance 
of the patient' (W.H.O, 1965) This definition extends 
to all species of malarial parasite aid all useful 
dosages of blood or tissue schizontocides, gametocy toe ides 
and sporontocides. However, drug resistance although 
occuring has never proved to be a serious obstacle to 
chemotherapy or prophylaxis of any of the relapsing 
malarias, i.e. in those infections due to P.vivax and 
P.ovale or of P.malariae. Hence, in practise the 
definition of resistance to antimalarial drugs is most 
commonly applied to the resistance of P.falciparum. 
Resistance to all antimalarial drugs can however be 
induced in experimental animals and in human volunteers 
under laboratory conditions.
Resistance of P.falciparum to antimalarials, ranges 
from a loss of effect demonstrable only by occasional 
recrudescence to a level of resistance at which the 
drug apparently has no effect on severe infections.
The WHO Scientific Group on Chemotherapy of Malaria 
in 1967 proposed a grading system based on the response 
to normally recommended doses of chloroquine. The 
three grades of resistance RI, RII and RIII are as 
follows:
RI - Clearance of asexual parasitaemia as in 
sensitivity, followed by recrudescence.
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Sensivitity is typified by clearance of asexual 
parasitaemia within 7 days of initiation of 
treatment, without subsequent recrudescence.
RII - Marked reduction of asexual parasitaemia, but 
no clearance.
RIII - No marked reduction of asexual parasitaemia.
The problem of drug resistant P.falciparum has become 
acute in the last decade with increasing reports of 
chloroquine and multi-resistant parasites. Usually 
resistance to chloroquine conveys resistance to mepacrine 
and quinine, as well as to other 4 - aminoquinolines in 
experimental animals and often in P.falciparum infections 
in man. There is little cross resistance between the 
antifolics and the 4 - aminoquinolines (Schnitzer, 1966; 
Peters, 1967), but resistance to pyrimethamine usually 
carries with it cross resistance to other tetrahydrofdate 
dehydrogenase inhibitors.
Chloroquine resistance in P.falciparum was first 
reported in Venezuela in 1960 by Maberti; but it was not 
until 1961 that the potentially catastrophic development 
attracted attention (Moore and Lanier, 1961) Since then, 
chloroquine resistance has been reported, again in Colombia 
(Comer, et al 1968), Bolivia and Paraguay (daSilva 1966, 
Rieckmann and Lopez-Antunano 1971) in Guyana (Giglioli g_t 
al 1967,) and in other areas of South America.
Chloroquine resistance was suspected in Thailand in 1957 
but was only confirmed in 1962 (Harinasuta et al 1962).
A more recent study using Rieckmann's in vitro test 
demonstrates wide spread chloroquine resistance in central 
Thailand (Colwell et al 1972) and now probably extends
to Laos, Sumatra and the Philippines. Until recently,
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in sub-Sahara Africa, reports of P.falciparum resistant to 
chloroquine have remained open to challange, on the 
basis of W.H.O. criteria, of adequacy of chloroquine 
therapy or supervision of patient follow up (W.H.O. 1973) 
Bruce - Chwatt (1970) was unable to find convincing 
evidence of resistance to chloroquine in Africa upto 1970, 
since then additional reports (Dennis et al 1974, Omer, 1978, 
Fogh et al 1979, Moody 1979 and Eke 1979) have confirmed 
the existence of chloroquine resistant -falciparum malaria 
in Africa.
Proguanil and pyrimethamine - resistant strains were 
readily obtained in human volunteers with cross-resistance 
between the drugs as early as 1949 (Adams and Seaton 1949; 
Burgess and Young 1959) but it was felt that the sporonto- 
cidal action of the drugs would limit the possibility of 
resistance spreading under natural conditions. Unfortunately 
this assumption has not been borne out by subsequent events.
Foci of proguanil resistance in Asia have been reported 
from India, Taiwan, West Pakistan, Malaya, Thailand,
Cambodia, Vietnam and Java. Proguanil resistance also 
occurs in Africa with the foci in Senegal (Payet et al. 1966), 
Rhodesia (Lunn et al, 1964) Tanzania (Clyde 1967). It would 
appear that Proguanil resistance in P.falciparum often 
arises as a result of the parasite becoming insensitive 
to pyrimethamine though there is also considerable 
evidence that resistance also arises because of the 
use of the drug per se (WHO, 1965, Peters, 1970a)
Pyrimethamine resistance is now widespread in much of 
East and West Africa, in Malaya, South America and the 
Far East. However, part of the resistance to anti-
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metabolite drugs arises as part of a broader spec­
trum of drug resistance.
Sulphonamides and sulphones have been little used 
until recently for the prevention and treatment of 
malaria and even now, they tend to be used in com­
bination with other drugs. Sulphonamides and sul- 
phone drugs induce cross resistance to pyrimethamine 
in P. falciparum (Martin and Arnold 1968a, 1968b). 
Resistance to dapsone (a sulphone) develops rapidly, 
particularly in strains already resistant to pyrime­
thamine and this conveys cross resistance to sulphon­
amides (Verdrager et al 1969). Also, the possibility 
of induced resistance to sulphonamides and sulphones 
in various other pathogens exists, (Powell and Tigerrt 
1968) this has occurred in Chad, where an epidemic has 
occurred of cerebrospinal meningitis caused by strains 
of Neisseria meningitidis which might have become 
resistant to sulphonamides as a result of malaria 
prophylaxis. (Sirol et al 1969).
Though resistance to antimalarial drugs by P. falci­
parum parasites, remains the most important type of 
resistance to antimalarials, it must be pointed out 
that, other strains of plasmodia may show relative 
insusceptibility. P.vivax is known to respond less
quickly than P. falciparum
63
to equivalent doses of quinine, while sulphonamides 
and sulphones have little if any action on P. yivax 
(WHO, 1973), Strains of P. vivax resistant to proguanil 
have been noted in West Malaysia while P. malariae 
resistant to proguanil has been reported in Indonesia 
and Taiwan. Insusceptibility to pyrimethamine has 
been shown by P . vivax in Kenya, Pakistan, and Venezuela 
(W.H.O, 1973) ,
1.6.1 MECHANISM OF RESISTANCE TO CHLOROQUINE
(AND RELATED DRUGS)
One of the early attempts to rationalise 
chloroquine resistance was that resistant plasmodia 
might have an abnormally high rate of production of 
ferrihaemic acicf* (haemin) an intermediate in the synthesis 
of the malaria pigment (haemozoin). Chloroquine and quinine 
form complexes with haemin in vitro (Cohen et al, 1964, 
Schueler and Cantrell, 1964, Phifer et al 1966). This 
complex is less effective than the drugs per se when 
injected into mice infected with P. berghei. It was 
therefore suggested that the chloroquine - resistant 
plasmodia would more extensively complex with and 
inactivate the antimalarial by virtue of their excessive 
accumulation of haemin Though it has been suggested 
that strains of P. berghei resistant to chloroquine form 
less pigment probably because of excessive liberation of 
the soluble intermediate porphyrin - haemin (Peters,
1964, Peters et al 1965) resistant strains of P. falciparum 
contain normal levels of haemozoin. (McNamara et al 
1967, Kellett et al 1968 and it is now clear that 
haemozoin formation ....
*ferriprotoporphyrin IX
64
in P .berghei is also related to the age of the red 
cell. Thus reduced pigment levels in chloroquine 
resistant P.berghei are associated with its presence 
in immature red cells and not necessarily to drug 
resistance as such (Howells et al; 1968a, b) Moreover 
it has also been demonstrated that one of the most 
virulent strains of P.berghei (NS line) which shows 
an innate resistance to chloroquine produces abundant 
haemozoin in mature erythrocytes. Hence reduced pigment 
formation does not appear to be causally associated 
with chloroquine resistance (Ladda and Sprinz, 1969), 
Similarly, these points appear to argue against the 
contention that interference with the formation of 
pigment from haemoglobin during digestion in the 
parasite was the basis of resistance (Peters et al,
1965) especially, since certain very virulent strains 
of P.berghei produce large amounts of haemozoin and 
presumably the intermediate haemin but are still 
resistant to chloroquine (Peters, 1970b)
It has also been postulated that a general impairment 
of the parasitised erythrocyte's concentrating 
mechanism for chloroquine could lead to the development 
of resistance (Macomber et al 1966) and that this 
impairment accounts for the cross resistance to mepacrine 
and quinine which have been shown like chloroquine to 
be concentrated in lysosomes (Allison and Young, 1964). 
Indirect evidence for a role of parasite lysosomes in 
the antimalarial action of chloroquine and related 
drugs was provided by experiments that demonstrated 
synergism between cortisone (Cantrell and Kendrick,
1963) or promethazine (Warhurst, 1965a) and chloroquine.
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Both cortisone and promethazine like chloroquine have 
been shown to stabilise lysosome membranes (Weissman,
1965). (However, although several attempts have been 
made to demonstrate lysosomes in malaria parasites 
by classical methods other than cytochemistry, (Aikawa 
and Thompson 1971) no success has yet resulted) Rollo 
(1968) has also suggested that some unspecified change in 
the general metabolism of the resistant parasite might 
raise their overall pH and that this could lead to a 
reduced accumulation of chloroquine. This suggestion 
has been further elaborated by Homewood.
Chloroquine resistant erythrocytic parasites do concen­
trate less chloroquine than sensitive ones (Macomber 
et al. 1966, Fitch, 1969, 1970) and some apparently degrade 
less haemoglobin. These observations have been thought 
of (Homewood et al 1972) as being due to a reduction 
of the acidity of food vacuoles of resistant parasites.
Lack of acid would reduce the uptake of chloroquine 
and also prevent effective haemoglobin digestion by 
enzymes requiring acid pH for maximum activity. The 
inability of the resistant parasite to digest sufficient 
haemoglobin would necessitate an alternative source of 
amino acids possibly by transamination of citric acid 
cycle intermediates (Howells, et al 1970) Howells had 
earlier proposed that a switch to the breakdown of glucose 
via the citric acid cycle in the resistant parasite would 
confer resistance by enabling the parasites to synthesise 
amino acids by the transamination of citric cycle 
intermediates. The presence of a demonstrable succinic 
dehydrogenase activity in the parasite using the blue
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tétrazolium technique at the light microscope level 
presented preliminary evidence to support this theory. 
Unfortunately, there has been no further evidence to 
support the presence of a citric acid cycle in chloroquine 
resistant P. berghei-, and there have been doubts raised 
regarding the specificity of localisation of tétrazolium 
salts following staining (Pearse and Hess, 1961) and 
attempts made at both electrophoretic separation and 
the fine structural localisation of succinic dehydrogenase 
were unsuccessful (Howells et al, 1972). It is 
important to mention that avian malarias utilize the 
citric acid cycle, synthesise amino acids by transamina­
tion, produce haemozoin and are sensitive to chloroquine!
Evidence from uptake studies in erythrocytes suggest 
that chloroquine and quinine are selectively 
toxic to plasmodia because of their preferential 
accumulation in parasitised erythrocytes (Macomber et 
al, 1966;Polet & Barr, 1968) Thus mouse erythrocytes 
infected with chloroquine sensitive P.berghei showed 
over a 600: 1 (cells : medium) concentration gradient 
when exposed to 10 ^moles/1 chloroquine at 22°C and 
physiological pH; while similar cells infected with 
chloroquine resistant strains showed only 100 : 1
gradients, controls containing no parasites had gradients 
of only 14 ; 1 (Fitch, 1969). The erythrocytes contain­
ing chloroquine sensitive P.berghei had high-affinity 
receptors for the drug which were absent in normal 
erythrocytes and reduced in number or absent in erythrocytes 
infected with chloroquine resistant parasites. In 
subsequent work, Fitch showed that a similar drug 
concentrating mechanism with a of 67 nmol/1 was 
present in owl monkey erythrocytes infected with a 
relatively chloroquine sensitive P,falciparum
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(Camp) and deficient in a chloroquine - resistant 
(Monterey) strain (Fitch, 1970) Uptake of chloroquine 
into P. berghei depends on a supply of glucose and is 
prevented by metabolic inhibitors (Fitch, et al;
1974a); similarly in P. falciparum uptake of chloroquine 
is glucose dependent but in the chloroquine resistant 
strain glucose does not stimulate uptake. From these 
and other experiments - (Fitch, et al ; 1974b),
Fitch has concluded that chloroquine resistance is 
specifically associated with a reduction in the 
number or efficiency of the high affinity binding sites. 
The high affinity binding site has been suggested to 
identical to haemin (ferriprotoporphyrin IX; Chou, 
et al. 1980)
The very diversity of actions of chloroquine and 
related drugs upon plasmodial metabolism makes it 
likely that the parasite must have to adopt more than 
one method to protect itself from chloroquine attack. 
Episomal transfer of resistance (which has so far been 
excluded in plasmodia - Peters, 1980) usually 
expresses itself in a reduction in permeability of the 
organism to drugs (Watanabe, 1963) and deficiencies 
in the binding of chloroquine, be it to iron - porphyrin 
or to other substrates may indeed be only one of the 
possible changes to be implicated in the development 
of chloroquine resistance.
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1.6.2. MECHANISM OF RESISTANCE TO PRIMAQUINE 
Primaquine resistance in P.berghei may involve the 
ability of the parasite to increase its respiratory 
capacity by biogenesis of mitochondria, in the same 
way that the erythrocytic forms of sensitive malaria 
parasites resist the oxidative actions of primaquine 
as compared with the tissue forms (Howells et al, 1968b, 
1970) It has been speculated that resistance to 
chloroquine may also express itself in a similar way, 
because erythrocytes infected with chloroquine 
resistant P.berghei take up twice as much oxygen 
as do normal parasites(Paleœk et al 1967, Cho and 
Aviado, 1968) While this may simply reflect on 
increase in the oxygen carrying capacity of the host 
haemoglobin, it is possible that it is associated 
with the marked increases in mitochondrial cytochrome 
oxidase activity observed in chloroquine-and quinacrine- 
resistant strains of parasite (Howells et al, 1969) 
Though the poor activity of 8 - aminoquinolines like 
primaquine if used alone against erythrocytic forms of 
plasmodia is a clear incentive to emergence of 
resistant strains, they are unlikely to appear in the 
field because the drugs are usually administered 
together with a quick acting schizontocide and also 
because of their pronounced gametocytocidal effects 
which prohibit transmission to the mosquito.
69
1.6.3 MECHANISM OF RESISTANCE TO ANTIMETABOLITES 
Metabolic adaptation plays an important role in the 
development of drug resistance in protozoa just as 
it does in bacteria. The enzymes involved in this 
adaptation may be quite new or simply derepressed. 
Pyrimethamine, cycloguanil and other inhibitors of 
tetrahydrofolate dehydrogenase interact with the 
parasite enzyme in vitro in a highly selective, 
stoichiometric manner. This specific binding is 
the basis of their antimalarial action (Ferone, et al
1969) Rodent parasites such as P. berghei (Diggens, 
et al 1970; Ferone, 1970) and P.vinckei (Ferone, et al
1970) and P. knowlesi (Gutteridge and Trigg, 1971) 
produce a mutant tetrahydrofolate dehydrogenase that 
is different from the normal parasite enzyme. The 
mutant enzyme has a larger specific activity than the 
normal enzyme (17.4 nmole/min/mg protein as compared 
tp A .8 for normal P.vinckei tetrahydrofolate dehydro­
genase (Pinder, 1973)) This increase in specific 
activity is due to the increased number of catalytic 
sites on the protein chain effectively increasing the 
enzyme levels of the parasite. Also, there is a 
corresponding decrease in the affinity of the mutant 
enzyme for both dihydrofolate and the drugs. The two 
factors combine to increase the parasite's ability to 
synthesise tetrahydrofolate even in the presence of 
previously inhibiting concentrations of pyrimethamine and 
cycloguanil. The decrease in affinity for dihydrofolate 
accounts for the observation that a pyrimethamine 
resistant strain of P.berghei had an increased 
requirement for pABA (Jacobs, 1964; Vary, 1970)
Resistance to pyrimethamine does not confer a similar 
resistance to sulphonamides and sulphones and there may 
be a certain degree of hypersensitivity to sulpha^drugs
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due to the reduction of affinity of the enzyme for 
dihydrofolate.
Sulphonamide resistance has been speculated to arise 
from the ability of the parasite to commence folate 
synthesis at a stage beyond pABA or utilisation of 
pABG (paraaminobenzoylglutamic acid) in place of pABA.
It is clear that there are various possible mechanisms 
for the emergence of drug resistant strains in plasmodia. 
These include the selection of resistant mutant strains, 
superinfection by environmental strains of a resistant 
nature, the transfer of genetic information from 
resistant to sensitive strains and the ability to 
induce adaptive enzymes. A unique mechanism for the 
transfer of pyrimethamine resistance in rodent malaria 
has been proposed by Yoeli et al (1969). The mechanism 
was termed "Synpholia" and involved 'nonsexual' transfer 
of pyrimethamine resistance from pyrimethamine 
resistant P.vinckei to P.berghei while the two parasites 
lived together in the same host. Peters, (1970a) has 
critised the experimental procedure in the original 
experiment and has been unable to repeat the original 
experiments in his laboratory. However, Ferone et al 
(1970) have shown that the dihydrofolate reductase of 
pyrimethamine resistant P. berghei produced by 
"synpholia" in the experiment reported by Yoeli et al, 
(1969) had characteristics intermediate between the 
dihydrofolate reductase of sensitive P. berghei and of 
the pyrimethamine resistant P. vinckei.
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1.7. MECHANISMS OF UPTAKE OF DRUGS ACROSS MEMBRANES
There are fundamentally two broad mechanisms whereby 
drug pass across biological membranes. These are
(1) Passive transfer consisting of
(a) Simple diffusion
(b) Filtration (hydrodynamic flow)
(2) Specialised transport consisting of
(a) Carrier mediated transport with components of
- Active transport 
Facilitated diffusion
- Exchange diffusion
(b) Facilitated diffusion not associated with 
membrane carriers.
(c) Pinocytosis
In simple diffusion, the rate of transfer of drug is 
directly proportional to the concentration gradient 
across the membrane. The speed of penetration of drug 
is also determined by the lipid to water partition 
coefficient. The cardiac glycosides afford clinically 
interesting examples of the effect of partition 
coefficients on permeability. Digitoxin, the most 
readily accumulated glycoside in clinical use, is the 
most lipophilic.
Partly ionised drugs may distribute unequally because of 
a Donnan type of ionic distribution or because of 
differences in hydrogen ion concentration on the two 
sides of the membrane. Donnan distribution occurs 
whenever the solution on one side contains some ions 
that cannot cross to the other side. A difference in pH
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on the two sides of membrane affects the distribution 
of a partly ionised drug because of preferential 
permeability of membranes to the lipidsoluble unionised 
forms of compounds. Accordingly, the concentration of 
the solute (ionised plus unionised) on each side of 
the membrane is a function of the pH of the two fluids 
and the dissociation constant of the solute. According 
to the Henderson - Hasselbach equation;
pH = pk + log[base] 
[acid]
log [base] = pH 
[acid]
by approximation 
log Cm
PK
(1)
(2)
pK„ - pH for acids (3)
log C
pK - pH for bases
Cm
(4)
where Cm = total drug concentration
C^ = concentration of drug in ionized state 
pKa = negative logarithm of the acidic dissociation 
constant of the acid or base.
Similarly, for a weak acid
Ct 1 + 10(PHr P Ka>
2 1 + 10^pH2-pKa^
and for a weak base
(5)
i ♦ ic/PVeV
1 + 10<pKa-pH2) (6)
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where and C2 are the concentrations of drug in the 
two fluids. (Schanker, 1962)
Equations (2) - (6) emphasize once again the importance 
of pH in the distribution of the concentration of 
certain drugs in different fluid compartments of an 
organism.
Filtration occurs as a result of hydrostatic or 
osmotic pressure difference across a membrane, the 
flow of the water and its solutes is passive in nature. 
For example, water that filters across the glomerular 
membrane is accompanied by all of the solutes of 
plasma except the large protein molecules.
Carrier transport offers a tentative explanation of 
the peculiar permeability of cell membranes to certain 
lipid insoluble solutes. Active transport has the 
following characteristics:
(a) Drugs move across the membrane against a 
concentration gradient or against an electrochemical 
gradient if an ion.
(b) The transport mechanism becomes saturated 
when the concentration of drug is raised high enough.
(c) The process shows specificity for a particular 
type of chemical structure.
(d) If two substances are transported by the same 
mechanism, one will competitively inhibit the transport 
of the other.
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(e) The transport mechanism is inhibited non-competitively 
by substances which interfere with cell metabolism.
Facilitated diffusion describes carrier transport in which 
the substrate does not move against a concentration 
gradient. For example D-glucose readily penetrates the 
human red cell attaining the same concentration inside 
the cell as that on the outside by a process that shows 
specificity, saturability and sensitivity to certain 
metabolic inhibitors (Lefevre, 1961)
Facilitated diffusion not associated with membrane 
carriers has been proposed to explain the accelerated 
diffusion of certain lipid-insoluble substances across 
membranes. Stein and Danielli proposed that penetration 
might occur through hydrogen bonding structures (polar pores) 
extending through the thickness of the lipid membrane.
Polar substances would penetrate rapidly if their stereoche­
mical characteristics corresponded closely to those of the 
hydrogen-bonding pore. In addition there would be competition 
for transfer through the pores and the pores would be satu­
rable (Stein and Danielli, 1956).
During exchange diffusion, a carrier is thought to transport 
the substrate from one surface of the membrane to the 
opposite surface where it releases the substrate, picks 
up another molecule of substrate and transports it to the 
original surface. Exchange diffusion may occur in any 
carrier - mediated transport system that is near saturation». 
(Wilbrant and Rosenberg, 1961).
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Cells growing in tissue culture take up small droplets 
of the external medium by an engulfing or sucking in 
process known as pinocytosis. There is electronmicroscopic 
evidence suggesting that pinocytosis occurs in certain 
mammalian cells (Holter, 1959). Very little is known 
about the physiological significance of pinocytosis, 
but the process is too slow to account for the rapid 
cellular uptake of natural substances and some drugs, 
though it could account for uptake of small amounts 
of proteins and other macromolecules. (Christensen 
et al, 1958).
Tt must be pointed out that the mechanisms whereby a 
drug secures passage across membranes may not necessarily 
belong to one class only. There might be cases of 
interaction of two or more mechanisms further 
complicating the picture. Moreover, the way in which 
energy is coupled to drug transport is poorly understood, 
progress being hindered both by the present lack of 
information about its molecular basis and by the 
complexity of plausible kinetic models of energy 
coupling in transport.
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1.8. RODENT MALARIA AS A MODEL FOR STUDY OF
HUMAN MALARIA..
The most important single factor for the massive 
utilisation of P.berghei in malaria research since 
1964 was the development of resistance to chloroquine 
by human malaria parasites. Experimental chloroquine 
resistance in P.berghei was produced by Ramakrishnan 
et al, (1957), Hawking and Gammage (1962), Peters,
(1964). Since then, there has been a massive search 
for antimalarials active against chloroquine resistant 
strains using the P.berghei - mouse model. There is 
no doubt that it would not have been possible to 
îaunch the search for antimalarials without this 
model being available (Peters, 1980) and in almost 
all instances, a drug effective in the human malaria 
has been proved also effective in rodent malaria. After 
the discovery of Plasmodium berghei by Vincke and Lips 
in 1948 in the blood of the tree rat (Grammomys surdaster) 
in the Belgian Congo, and its successful passage into 
laboratory mice, resistance to virtually all antimalarial 
drugs has been induced and laboratory investigations 
have allowed examination of the factors governing emergence 
of resistance and of the fundamental biochemical 
mechanisms underlying the problem.
Recently it has been pointed out that the moderately 
chloroquine - resistant NS line of P .berghei in 
secondary screening of antimalarials was a good model 
for chloroquine resistant P.falciparum, while the highly 
resistant R C strain of P.berghei is valuable for its 
predictive value as to whether or not a parasite that 
is already chloroquine - resistant can become resistant
77
to another drug (Peters, 1980) For example mefloquine 
the new antimalarial drug presently undergoing clinical 
trials is effective against P.berghei NS and multiple - 
resistant P .falciparum, but has less activity against 
P.berghei RC, thus proving that it could be relatively 
easy to develop strains resistant to mefloquine from 
P.berghei NS and also forecasting the probability of 
further development of resistance of P. falciparum to 
this drug.
It is significant that a rough estimation of potency index 
based on activity of antimalarial drugs against 
P.berghei is valid for human forms of malaria (Aviado,
1969) except for a few anomalies like menoctone which 
was a complete failure in man probably because of inadequate 
absorption from the human intestinal tract; and also 
RC12 which could not " fulfil" in man its promise as 
a tissue schizont*cide (Peters, 1980) Evidence from 
14C - chloroquine uptake studies shows that a similar 
mechanism of uptake, and resistance to chloroquine 
might be operating in P.berghei and P,falciparum (Fitch 
1969, 1970) Both models have shown similar kinetic 
parameters and substrate utilisation (Fitch, 1970, Fitch _et 
al. 1974a, b) Moreover, the tetrahydrofolate dehydrogenase 
inhibitors (pyrimethamine, cycloguanil) that have proved 
to be causally prophylactic in mouse are also active 
in man. Indeed, the mechanism of resistance to these 
antimetabolites was largely worked out in rodent 
malaria (Ferone, 1970).
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1.9 AIMS OF THE RESEARCH PROJECT
Plasmodium falciparum malaria resistant to chloroquine 
and in some cases to quinine is now prevalent in South 
America, and South East Asia and constitutes a renewed 
major threat to world health. In Africa, though the 
situation is still confusing, there is no doubt that 
the continent might be the next citadel to fall! In 
approaching the subject of development of drug resistance 
by plasmodia, a fundamental area of investigation must 
lie in assessing the biochemical mechanisms which give 
rise to the phenomenon. Though many advances have 
been made in the study of morphological changes (Peters 
1964, 1965a,b,c; Jacobs and Warren; 1967) and pathological 
changes (Sadavongvivad and Aviado, 1969) much is yet to 
be done from the biochemical standpoint if the basis of 
resistance is to be understood and overtaken.
The present work was undertaken in order to obtain a 
better understanding of the biochemical mechanisms 
governing the accumulation of chloroquine. In order to 
attack chloroquine resistant malaria, it is important 
to understand the basis of selective toxicity, mechanism 
of resistance and mode of action of drugs such as 
mefloquine which are capable of treating the resistant 
strains. In this way, it should be possible to design 
new approaches to rational therapy (for example see 
Warhurst and Thomas, 1975) and to counteract both 
resistance to chloroquine and to its replacements 
should it arise.
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CHAPTER 2
2. MATERIALS AND METHODS
2.1. CHEMICALS AND DRUGS
Chloroquine (Ring - 3 - ^4C ) diphosphate (specific 
activity 30.0 mCi/mmol) was obtained from New England 
Nuclear, Boston, Mass. USA.
Inulin (14C) carboxylic acid (CFA 399) (Specific 
activity 12.6 mCi/mmol), L - (1-^4C) glucose (Specific 
activity 61.4 mCi/mmol), n-(l-^4C) hexadecane (specific 
activity 0.526 mCi/mg) were obtained from the Radioche­
mical Centre, Limited, Amersham, England.
The ionophores - monensin sodium and nigericin sodium 
were obtained from Eli Lilly and Co. Indianapolis, USA.
Chloroquine (7-chloro - 4 (4-diethylamino-l-methyl- 
butylamino) quinoline) diphosphate salt, ouabain 
( Strophanthin G) , 5 - hydroxytryptamine (5HT), L-epinephrine, 
2 - deoxy - D - glucose, Valinomycin, N-ethyl maleimide, 
Reserpine (R.0875) (3,4,5-trimethoxybenzoyl methyl 
reserpate), were obtained from Sigma Chemical Co.
Foetal Calf Serum was supplied by Wellcome Reagents 
Limited, Beckenham, England.
4 - chloromecuribenzoic acid and other reagents were 
obtained from Hopkin and Williams, Chadwell, Heath,
Essex, England.
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2.2 INCUBATION MEDIA
Malaria usually alters erythrocyte cation transport in 
all erythrocytes (Dunn, 1969b) Red blood cell sodium 
concentration is usually elevated and cellular 
potassium decreased in proportion to the elevation of 
sodium. To assess the probable effects of the altered 
cation metabolism, the cation content of the media used 
in experiments was varied. The following systems were 
tested:
(i) Standard medium I (SBI) consisting of NaCl - 
60 mmol/litre, Mg S04 - 2.0 mmol/litre, KC1 - 5.0 
mmol/litre, Na„HP04 - 50 mmol/litre, NaH2 P0^ -
5.0 mmol/litre, D-glucose - 5.0 mmol/litre.
(ii) Standard medium II (SB2) consisting of Nad 
25 mmol/litre, Mg S0^ 1.2 mmol/litre, Na^ HP04
50 mmol/litre. This medium was modified from that 
used by Fitch (1969) by reducing the glucose concentra­
tion from 86 mmol/litre, (later reported to be inhibitory, 
Fitch, 1975) to 5.0 mmol/litre.
(iii) High Potassium buffer (HKB) consisting of 
KC1 - 65 mmol/litre, Mg S04 2.0 mmol/litre K2HP04 - 
50 mmol/litre, NaH^ P04#2H20 - 5.0 mmol/litre,
D-glucose - 5.0 mmol/litre.
Incubation media SBI and HKB were adjusted to pH 7.4 
with 0.IN HC1 and average osmolarity was 286 mOsm/kg 
when measured at room temperature in a Digimatic Osmometer, 
Model 3D II (Advanced Instruments inc. Mass. USA)”.
Standard medium II (SB2) after adjustment to pH 7.4 
with 0.INHC1 had an osmolarity of 185 mOsm/Kg.
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2.3 PARASITE LINE
2.3.1. Plasmodium berghei berghei NK 65. The N.K 65 
strain was orginally isolated by Professor M. Yoeli 
in January 1964 in the forest gallery of the River 
Kisanga near Lumbumbashi (Yoeli and Most, 1965) and 
was maintained by cyclical transmission in his 
laboratory. This strain was later sent to Dr.D. C.
Warhurst at the National Institute for Medical Research 
from where it was sent to Dr. D. Walliker at the 
Institute of Animal Genetics and designated Edinburgh 
stabilate No. 277. The strain was passaged into mice 
and sent to London School of Hygiene and Tropical 
Medicine, Winches farm station, where blood from the 
infected mice was cryopreserved in liquid nitrogen 
and this strain was now designated LUMP 1150. This strain 
has now been passaged continously in mice for about three 
years, without intervening mosquito passage.
2.3.2 PLASMODIUM BERGHEI BERGHEI RC STRAIN 
This RC strain was obtained from the Department of 
Medical Parasitology of the Liverpool School of Tropical 
Medicine and is a line of a strain originally developed 
by Professor W. Peters. Strain N(K173) isolated from 
the same area as NK 65 but in 1948 (Vincke and Lips 1948) 
was made resistant to chloroquine by treating mice infected 
with Plasmodium berghei Vincke and Lips 1948, with 
increasing doses of chloroquine parenterally. The 
resistance of this RC strain is unstable in the absence 
of drug pressure. On receipt from the University of 
Liverpool, the stabilate was passaged into T.O mice 
and after one subpassage was tested for chloroquine
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sensitivity (5.0mg/kg base, i.p. x 5 days) Thereafter, 
the strain was kept under drug pressure to ensure the 
retention of resistance. Drug pressure was maintained 
by intraperitoneal administration of chloroquine at 
a dose of 10 mg/kg wt. of mice twice weekly (I.P). 
However before utilisation of infected T. 0. mouse 
red cells for experiments, the infection was passaged 
at least once without concomitant drug pressure.
2.4. ROUTINE PASSAGE TECHNIQUES
2.4.1. Blood Passage
Parasite strains were maintained in 18 - 22g male 
Theiler's Original (T.O.) albino mice, which were free 
from infection with Eperythrozoon coccoides. The 
mice were kept at about 25°C, fed on Dixon's diet - 86, 
(Dixon and Sons Limited, Crane Mead, Mills) and supplied 
with water ad libitum.
The parasitaemia (percentage of erythrocytes infected) 
of mice was assesed by examination of their blood 
films. Prior to a blood passage, the tips of the tails 
of donor mice were snipped with a pair of sterilised 
scissors, a drop of blood was removed and thin blood 
smears were prepared. The smears were labelled, fixed 
in absolute methanol and stained for 45 minutes in a 10% 
solution of Giemsa's stain (10ml Giemsa's stain (B.D.H); 
diluted with 90 ml phosphate buffered water pH 7.’2 - 
The phosphate buffered water was prepared by dissolving 
in 1 litre distilled water 3.0g of anhydrous Na_ HP04
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and 1.2g of anhydrous P04, the concentration of
phosphate in the medium was thus 0.03 mol/litre) . At the 
end of the staining, the excess stain was washed off 
carefully in running water and the slides air dried.
Stained blood smears were examined under the 100 x oil 
immersion objective and 10 x eyepiece of a Zeiss 
standard microscope and the percentage of parasitised 
cells estimated by examination of 500 erythrocytes.
Random fields from appropriate parts of the blood films 
were examined.
The donor mouse at a suitable parasitaemia was anaesthe­
tised with chloroform or CO^ and blood collected by 
cardiac puncture using a heparinised syringe (approximately 
10 units of heparin per 0.5 ml blood). To pass on the 
infection, normal mice were each given an intraperitoneal 
injection of 0.2 ml of parasitised blood; suitably 
diluted in ice cold foetal calf serum/sterile saline 
(1:1) Occasionally, the intravenous route of injection 
was utilised via the tail veins which were previously 
enlarged by warming the mice under an infra-red heater 
for 10 minutes. The degree of dilution utilised in 
passaging was based on the following rationale:
Assuming there are 8 million (8.0 x 10 ) red blood cells9per mm^ in healthy mouse, then there are about 8.0*10 red9cells in 1.0ml and therefore 1.6*10 in a standard 
inoculum of 0.2ml.
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Hence the formula:
X „ _ 9x 1.6 x 10 ; gives the total number of 
parasitised cells in 0.2ml blood obtained from a donor 
mouse with parasitaemia of X%. For example, if the 
mice had a parasitaemia of 10%, 0 .2ml of its blood will 
have:
X 9---- X 1.6 x 10 parasites
100
g= 1.6 x 10 parasites.
The above rationale is based on the assumptions that3the number of red blood cells/mm is the same in each 
mouse and. that each infected red blood cell contains 
one parasite. These assumptions are not always correct 
since multiple infection of red blood cells can occur 
with P.berghei (Garnham, 1966) Hence the calculated 
number of parasites is only an approximation.
2.4.2 INDUCTION OF RETICULOCYTOSIS IN MOUSE INVIVO. 
Phenylhydrazine - HC1 (PH), a haemolysis inducing drug 
was used to induce reticulocytosis in T. 0. mice. This 
drug was dissolved in deionised water just before use 
and injected subcutaneously into the experimental mouse 
in doses of 60mg/kg for three days. The rise in 
reticulocytes was followed by light microscope examination 
of New Methylene blue-stained slides of blood from 
phenylhydrazine HC1 treated donor mice. Equal volumes of 
blood and New methylene blue stain (l.Og/lOOml 3% citrate
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saline) were drawn into a haematocrit tube, mixed and 
placed in an incubator at 37°C for 15 min. and then 
smears made without fixing. Reticulocytosis was expressed 
as percent of total red blood cell population examined 
which stained with new methylene blue.
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2.5. PURIFICATION OF INFECTED RED BLOOD CELLS.
Red blood cells from groups of 5 mice were pooled and 
"purified" as follows:
The pooled heparinised blood (4-6ml) was added to an 
equal volume of standard medium 1, supplemented with 
heparin and kept in ice. The blood cells were collected 
by centrifugation at 700g for 5 mins. Subsequently, 
the blood cells were washed twice with 5 volumes of 
standard medium 1. After washing the cells the white 
blood cells were removed, using an adaptation of the 
cellulose powder CF 11 procedure (Williams and Richards, 
1973, Baggaley and Atkinson, 1972).
1.0 ml of packed blood cells previously washed and 
kept in ice was made up to 6ml with standard medium.
The suspension of red blood cells was carefully layered 
on an plastic column of dry CF 11 cellulose powder 
(Whatman Limited, Maidstone, Kent). The plastic column 
was made from a 20 ml plastic syringe, with a piece 
of cotton wool covering the needle end. The column was 
packed to a depth of 6 cm with 6-7g Whatman CF11. The 
red blood cells were then eluted with 10ml of ice cold 
standard medium 1 applied under slight pressure from a 
20ml syringe, the needle of which was inserted through a 
tightly fitting rubber bung at the top of the column.
The eluted red blood cell suspension (not more than 10ml) 
was then centrifuged at 700g for 5 min. and the resultant 
pellet suspended in standard medium 1 to a ratio of 1:14 
(V:V) and kept in ice.
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PROTOCOL FOR CHLOROQUINE UPTAKE STUDIES IN MOUSE ERYTHROCYTES 
INFECTED WITH PLASMODIUM BERGHEI .
Hepar inised blood from donor mice in equal volume of ice cold 
standard medium. I.
centrifuge 700g x 5 min.
supernatant Ç-
packed rbcs
suspend in 5 vols medium and wash twice
suspend washed packed rbcs in 5 vol standard medium and pass 
through dry cfll Cellulose column, eluting with more medium.
rbcs, free from wbcs and platelets
wash and suspend pellet in standard medium 1:14.
I
1 ml rbc suspension mixed with 2ml medium containing 
radioactive chloroquine and 1 ml medium containing otheroadditions if needed, incubated at 37 C for varying periods 
of time in weighed steriliflplastic centrifuge tubes and then 
centrifuged to separate the cells from the medium.
PELLET
contains unabsorbed chloroquine]
I
3ml added to 0,3mg cold chloroquine 
in 1ml water - 1 ml 5N NaOH added ; 
extraction for 20 min into 2.5 ml 
heptane, 1ml extract read in 10 ml 
toluene scintillator.
iCalculation of 14C chloroquine 
concentration in supernatant.
chloroquine in parasite-erythrocyte
complex and in water space 
(inulin space)
pellet lysed after weighing.
(lml distilled water added) 
and 0,1 mg cold chloroquine.
Then lml 2N NaOH, and extract into 
2.5 ml heptane. 1 ml extract 
read in 10 ml toluene scintillator.
Calculation of 14C chloroquine 
concentration in pellet.
Efficiency of counting measured by 
channels ratio method. Using the inulin space, concentration of 
14C chloroquine per Kg rbc calculated
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2.6. DETERMINATION OF PACKED CELL VOLUME OF MOUSE
BLOOD
The sample of whole mouse blood was thoroughly mixed 
and sucked into a heparinised capillary pipette to within 
2.0 cm of the top by means of a teat and adapter. The 
top end of the capillary pipette was sealed in a 
microbumer and allowed to cool. The capillary pipette 
was then centrifuged at 10,000 r.p.m. in a Hawksley 
micro haematocrit centrifuge for 15 min. (in 
preliminary experiments, the packed cells were measured 
at intervals until a constant volume of packed cells 
had been obtained, the average time required to obtain 
a constant packed volume was found to be 15 min.)
The height of the blood column (A) and that of the
packed cells (B) was measured. The packed cell volume (PCV)
was calculated as the fraction of packed cells, B .
A
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2*1' ANALYSIS OF SIZE DISTRIBUTION OF BLOOD CELLS
Blood samples to be analysed were suitably diluted, 
usually utilising the "two step dilution" method.
40pl of whole blood was mixed with 20 ml of standard 
buffer 1 giving a dilution of 1:500. Then 200pl of 
the above suspension was added to an additional 20ml 
of standard medium kept at room temperature to 
minimize changes in red blood cell size. The resistivity 
of the standard medium was usually between 10-20 
kilo ohms across the aperture used giving an acceptable 
signal to noise ratio (Brechner 1962). The
standard medium was previously cleaned by passing it 
through a millipore filter (size 0.22 pm), and light 
microscope examination did not detect any swelling or 
shrinkage of the cells by standard medium 1. The final 
diluted suspensions (1:50,000) were then analysed on 
a coulter counter (Model B) with an automatic particle 
size distribution analyser (Model J). The Coulter 
counter was set at the matching switch of L64H with an 
aperture opening of 100 microns. However amplitude and 
aperture current gain settings were adjusted to yield 
'normal' particle pulses on the oscilloscope. The 
settings were calibrated by use of latex P.V.P. particle 
standards of mean diameter 15.0 pm. The mean volume of 
the major cell component was determined and a normal 
curve, obtained, from the histogram produced by the 
plotter, by joining the midpoints of the peak of each 
histogram plot. Any changes in plotter settings are 
indicated in the appropriate graphs.
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2.8. ASSESMENT OF HAEMOLYSIS OF INCUBATED ERYTHROCYTES
In order to avoid errors introduced by binding of 
chloroquine to exogenous haemoglobin, the extent of 
haemolysis in the incubated erythrocytes was evaluated 
routinely as follows:
A "100%" haemolysed solution of erythrocytes 
was prepared by lysing 0.1ml of packed purified red 
blood cells in 50pl of distilled water and made up to 
4.0ml with isotonic saline (154 mmol/litre). "0%"
haemolysed solution was prepared by diluting 0.1ml 
of packed purified red blood cells to 4.0 ml with isotonic 
saline. Both solutions were then centrifuged at 700g 
for 5 min. and the optical density of the supernatants 
obtained were found by measuring at 600 nm in a UNICAM SP 
600 spectrophotometer.
By using varying quantities of the supernatants from 
the 100% and 0% haemolysed solutions, optical density 
readings were obtained for 20%, 40%, 60% and 807» haemolysis 
and a calibration curve for the instrument prepared (Fig 
10) The degree of haemolysis (if any) after each experi­
ment was then checked by comparing the optical density 
reading of the supernatant, with the calibration curve 
at the same wavelength. During experiments, plasticware 
and siliconised glassware only were used to minimise 
haemolysis. The same precaution was adopted during 
collection and purification of blood.
90
2.8. ASSESMENT OF HAEMOLYSIS OF INCUBATED ERYTHROCYTES
In order to avoid errors introduced by binding of 
chloroquine to exogenous haemoglobin, the extent of 
haemolysis in the incubated erythrocytes was evaluated 
routinely as follows:
A ”l007o" haemolysed solution of erythrocytes 
was prepared by lysing 0.1ml of packed purified red 
blood cells in 50jj1 of distilled water and made up to 
4.0ml with isotonic saline (154 mmol/litre). "0%" 
haemolysed solution was prepared by diluting 0.1ml 
of packed purified red blood cells to 4.0 ml with isotonic 
saline. Both solutions were then centrifuged at 700g 
for 5 min. and the optical density of the supernatants 
obtained were found by measuring at 600 nm in a UNICAM SP 
600 spectrophotometer.
By using varying quantities of the supernatants from 
the 1007o and 0% haemolysed solutions, optical density 
readings were obtained for 20%, 407o, 60% and 80% haemolysis 
and a calibration curve for the instrument prepared (Fig 
10) The degree of haemolysis (if any) after each experi­
ment was then checked by comparing the optical density 
reading of the supernatant, with the calibration curve 
at the same wavelength. During experiments, plasticware 
and siliconised glassware only were used to minimise 
haemolysis. The same precaution was adopted during 
collection and purification of blood.
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Fig. 10
Haemolysis calibration curve.
This curve was u tilise d  to check degree of haemolysis 
( if  any) after each experiment. Haemolysis below 2 x OS 
haemolysis was accepted as insignificant, flesu^ts obtained  ^
from experiments with haemolysis above 2 x OS haemolysis 
are indicated in relevant tables.
#
2 x c o n t r o l ( 0 %  h a e m o l y s i s )
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2.9 DETECTION AND MEASUREMENT OF RADIOACTIVITY
A Packard TriCarb Liquid Scintillation Spectrometer 
(Model 3003 - Packard Instruments Limited, Caversham, 
Berkshire) was used for the detection and measurement 
of radioactivity in the radiolabelled drugs and 
substrates utilised in various experiments in the project. 
The selected window settings of the scintillation 
spectrometer are shown in Fig 11.
In order to correct for optical, colour and chemical 
quenching, the counting efficiency of the scintillation 
spectrometer was determined using the sample channels 
ratio method. The method involved the preparation of 
a quench correction curve. The procedure adopted was 
essentially as follows:
A sample was prepared in heptane containing a known
amount of standard carbon-14 labelled hexadecane
(P disintegrations per min) and was counted in toluene
scintillator (Packard) in two channels (Q counts per
14min in the green (medium energy C) channel (2) and
3R counts per min. in the red (low energy H channel (1)
The counting efficiency in channel 2 was then calculated 
(Q/P x 100%). The sample channels ratio is the ratio 
of counts recorded in channel 2 and channel 1 (i.e. R/Q). 
Increasing amounts (0.1 ml increments) of chloroform 
(quenching agent) were then added to the sample and 
counting repeated. This procedure was repeated four 
times and the counting efficiency in channel 2, and the
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channels ratio were calculated after each increment of 
the quenching agent. A Calibration curve (Fig 11) was 
then prepared which was used when determining the 
counting efficiency of the scintillation spectrometer 
with various experimental samples. The channels ratio 
for each sample was determined and the counting efficiency 
calculated using the slope and intercept values for the 
regression of % of efficiency of counting against 
channels ratio. The calibration curve applied to all 
samples containing the same isotope.
It was found that counting efficiency for samples 
extracted into n-heptane and counted in toluene scinti­
llator was generally high. (75 - 857o). Percentage 
recovery of radioactivity was also generally high and 
averaged over 90%. Recovery of radioactivity was 
evaluated by comparing radioactivity added (from 
specific activity converted to dpm) to radioactivity 
obtained by summation of total dpm obtained in pellet 
and dpm left in supernatant.
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0.1 0.2 0.3 0.4 0.5 0.6 0.7
CHANNELS RATIO (RED/GREEN)
Fig. 11
14 \Channels ratio quench correction curve using n - (1- C) 
Hexadecane standard.
The slope of the regression line (correlation coefficient 
0.98) and the interception on the y axis were utilised  in 
the programme for calculating total disintegrations 
per min /g erythrocytes (Appendix 1).
The liqu id  sc in t illa t io n  spectrometer settings are as follows:
CHANNELS 1 2 3
BACKGROUND
SUBTRACTION NIL NIL
NIL
GAIN 5 ,1 5,0 1,0
(1 0 0 « ) ( 10« ) (100« )
WINDOW A-B c -  oo E- OO
A-B C-D E-F
0-10 0-10 0-10
50-2 50-0 50-0
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2.9.1 ESTIMATION OF TRAPPED FLUID VOLUME (INULIN SPACE) 
Washed and "purified" T. 0. mouse red blood cells 
(1.0ml) were suspended in 3.0 ml of SB2, pH 7.4 containing 
Inulin (14C) carboxylic acid (which does not enter 
erythrocytes) at 100,000 d.p.m/ml. After incubation for 
45 min at 37 C, red cells were separated by centrifugation 
at 700g for 5 min, the supernatant was aspirated, and 
the wet pellet weighed. The amount of radioactivity in 
the trapped fluid volume of the red blood cells was 
measured as follows:
After weighing the pellet, 2.0ml of 5% (W/V) 
trichloroacetic acid (TCA) was added to the pellet and 
left overnight. After stirring and centrifugation at 
700g for 5 min, the radioactivity in the TCA extract 
was determined by adding 1.0ml of the TCA extract to 
10ml of Xylene based Emusifier scintillator (Special 
Ml-96) and counting radioactivity as described earlier.
The proportion of wet red blood cell weight contributed 
by water in the "inulin space" was determined by 
measuring the total radioactivity (dpm) of the extract 
and calculating what this represented in terms of the 
volume of extracellular water (100,000 dpm/ml). This 
was expressed as a proportion of the weight of the 
pellet and was then used to correct both the "wet weight" 
of red blood cell pellets and the total radioactivity 
taken up by the red blood cells (see appendix 1). The 
mean value was found to be 0.T5 (inulin space = 15%).
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2.9.2. DETERMINATION OF (^C) CHLOROQUINE UPTAKE
BY INFECTED AND UNINFECTED T..O. MOUSE
ERYTHROCYTES
1.0ml of a 1:14 (packed red cell: incubation medium, v/v) 
dilution of purified red blood cells was added to 2.0ml 
of radioactive chloroquine in buffer equilibrated to 
37°C. To bring the incubation medium to a total volume 
of 4.0ml, 1.0 ml of standard medium pH 7.4, was also 
added. (Usually, the same buffer system, SBI or SB2 or 
HKB was used in preparing the dilution of the red blood 
cells and during incubation,) On various occasions, the 
1.0 ml of standard medium also contained compounds under 
study.
The incubation mixtures in Sterilin plastic centrifuge tubes, 
were left at 37°C on a roller tube apparatus. Red 
blood cells were separated after 45 mins by centrifuga­
tion at 700g for 5 min. at room temperature. In other 
instances, incubation time was varied.
Immediately after centrifugation, the supernatant 
medium was aspirated from the pellet and the wet pellet 
weighed. All calculations of the amounts of radioactive 
chloroquine taken up by erythrocytes are based on wet 
weight corrected for inulin space. In order to determine 
chloroquine uptake, the amounts of radioactivity in the super­
natant medium and red blood cell pellets were 
measured according to the following method based on 
Fitch, 1969:
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Approximately 0.10g pellet was lysed with 1.0ml water 
containing O.lOmg non-radioactive chloroquine. To the 
lysate was then added 1.0ml of 2M NaOH. 2.5ml of 
n-heptane containing 1.57» (V/V) isoamyl alcohol was 
added and the mixture shaken vigorously on a "Whirlimixer" 
for 1 minute. 1.0 ml of the heptane extract was added 
to 10ml of Packard toluene scintillator (containing 
0.1g POPOP (1,4-bis (2-(5-phenyloxazolyl) benzene and 
5.0g PPO (2,5-diphenyloxazole) per litre) and the 
radioactivity read.
After addition of 1.0ml water containing 0.3mg non- 
radioactive chloroquine to 3.0ml of supernatant medium, 
the mixture was made alkaline by addition of 1.0ml of 
5M NaOH. The mixture was extracted into 2.5ml heptane 
containing 1.5% isoamyl alcohol as before and radioactivity 
similarly read. The absolute concentration (^imol/kg wet 
weight erythrocytes) of the radioactive chloroquine in 
pellet and in the supernatant medium (pmol/litre) was 
computed using the programmes in Appendices I, II and 
III using a Texas TI Programmable 57, calculator. (See 
also Fig. 9)
In prelimary experiments, it was observed that n-heptane 
containing 1.5% isoamyl alcohol could extract over 95% 
of radioactive chloroquine present in the incubation 
medium. Binding of radioactive chloroquine to the walls 
of the sterilin plastic centrifuge tubes and glass 
tubes used during the experiments was negligible.
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2.10 EFFECTS OF SUBSTRATES AND DRUGS ON UPTAKE OF
(14C) CHLOROQUINE
2.10.1 PREPARATION OF CHEMICALS
D-glucose and glucose analogues (2- deoxy- D-glucose,
3 - 0 - methyl - D - glucose) were prepared directly in 
the appropriate buffers and serial dilutions made when 
required. All stock solutions of D-glucose and analogues 
were prepared fresh. Concentrations of all substrates 
used are indicated in appropriate places in the text.
Ionophores (Monensin, Nigericin, Valinomycin) and 
ouabain were dissolved first in a very small volume of 
absolute ethanol, usually less than 0.5 ml and stored 
refrigerated at - 20°C. Working concentrations were 
made up immediately before use with appropriate buffer.
< > ' ‘‘y, the final concentration of ethanol in the
incubation medium was less than 1% (V/V). This concentra­
tion of ethanol was shown (see results) to have no 
effect on (*4c) chloroquine uptake.
Sulphydryl reactive agents, N-ethyl-maleimide (NEM) and 
parachloromercuribenzoic acid (pCMB) were dissolved in 
SB1. In the case of p-chloromercuribenzoic acid, a few 
drops of 5N NaOH was added to the stock solution to aid 
dissolution. Any variation from pH 7.4 was adjusted 
accordingly with 0.1M acid or alkali. N-ethyl maleimide 
was always prepared fresh to avoid slow hydrolysis to 
N-ethylmaleamate.
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Reserpine, 5-hydroxytryptamine and L-epinephrine were 
first dissolved in a small volume of glacial acetic acid 
(less than 0.1ml) and then made up to correct concentra­
tion by dilution with appropriate buffer. 1.0M NaOH 
was utilised to correct variations in pH to 7.4.
1 0 0
2.10.2 DOSE RESPONSE
1.0ml of a suitably diluted suspension of infected or 
uninfected erythrocytes were incubated for 45 minutes 
at 37°C in 3.0ml of medium containing (*^C) chloroquine 
at a concentration*of 50 nmol/litre and a range of 
concentrations of the compounds under investigation.
The dose range was usually 0.125 - 40 mmol/litre for 
D-glucose and analogues and 1.0 x 10 ^  - 2.0 x 10_  ^
mol/litre for the ionophores - nigericin and monensin. 
The incubations were usually in duplicate and controls 
which did not contain either D-glucose and analogues or 
ionophores were included. At the end of the incubation 
period, the tubes were centrifuged at 700g for 5min 
and the supernatant and pellet assayed for radioactivity 
as indicated previously. From the results of the 
experiments, log dose response curves were prepared.
* final
1 0 1
2.10.3 TIME COURSE OF EFFECT OF IONOPHORES
The time course of action of the ionophores was also
investigated as follows:
After purifying the erythrocytes, 1.0ml of a suitably 
diluted suspension was preincubated with 3.0 ml of medium 
containing 0.5pmol/litre*of appropriate ionophore at 
room temperature. For experiments with valinomycin and 
nigericin, the medium (SBI) also contained an additional 
40 mmol/litre KC1. After the preincubation for varying 
periods of time (5 min - 60 min), the tubes were 
centrifuged at 700g for 2 min and the pellet was 
washed once in SBI and resuspended in the incubation 
medium. The resuspended erythrocytes were then incubated 
as usual (in an incubation medium containing (^C) 
chloroquine at a concentration of 50 nmol/litre) for 
45 min at 37°C. At the end of this time, the red 
blood cells were separated and drug uptake determined 
radiochemically as previously described. The time 
course of the effect of the ionophores was determined 
by plotting drug uptake against time of preincubation.
*final concentration
1 0 2
2.11 KINETICS OF (14C) CHLOROQUINE UPTAKE BY
UNINFECTED AND INFECTED T.O. MOUSE ERYTHROCYTES 
2.11.1 TIME COURSE OF DRUG UPTAKE
14The time course of ( C) chloroquine uptake was 
investigated over concentration ranges where the uptake 
of drug varied linearly with drug concentration in the 
medium, giving a first order kinetics. Using a (^C) 
chloroquine concentration within this range, the time 
course of drug uptake was determined as follows:
1.0 ml of "purified" erythrocyte suspension was added 
to 12 siliconised stoppered glass test tubes containing 
3 Dull of incubation medium (SBI) with 50nmol/litre* (^C) 
chloroquine. These tubes were then incubated at 37°C 
in a roller tube apparatus for varying periods of time 
ranging from 5 minutes to 60 minutes. At the end of 
each incubation period, the tubes (in duplicate) were 
centrifuged at 700g for 5 min. The supernatant was 
aspirated and the pellet was weighed. The amount of 
radioactive drug in the pellet and supernatant was 
then determined as previously stated. This experiment 
was performed for P.berghei - infected and uninfected 
T.O mouse erythrocytes.
* final concentration
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2.11.2 AFFINITY OF UPTAKE SYSTEM FOR CHLOROQUINE.
Purified T.O. mouse erythrocyte suspensions infected
with P.berghei NK65, RC strain, and uninfected, were
divided into 1.0ml aliquots and incubated with a series
of concentrations of (* C) chloroquine (2.5xl0~7-9.75xl0_1
mol/litre) After 45 mins incubation at 37°C in a roller
tube apparatus, the erythrocytes were collected by
centrifugation at 700 x g for 5 min and the amount of 
/14 v( C ) chloroquine concentration in the pellet and 
supernatant were determined.
Double reciprocal graphs of these data were used to 
determine the dissociation constants of the chloroquine 
drug 'receptor* complex. In another series of similar 
experiments, the purified erythrocytes were incubated with 
the same series of concentrations of (^C) chloroquine 
with the addition of a constant concentration of 
nonradioactive inhibitor test drug. The inhibitor test 
drugs examined were quinine, Monensin and L-epinephrine. 
Double reciprocal graphs of the data obtained from 
these experiments were also used to evaluate the type of 
inhibition caused by the drugs and to estimate the 
inhibition constant (K^) for the drug if the inhibition 
was competitive.
r v
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2.11.3 SPECIFICITY OF UPTAKE OF (14C) CHLOROQUINE 
The erythrocyte - parasite system is a very complex 
system containing various components and "barrier" 
systems. One result of this complexity, is that there 
could be nonspecific uptake components in the system which 
would be non-saturable at therapeutic chloroquine concen­
trations and might be distinguishable from the saturable 
"specific" uptake sites of high affinity. Experiments 
were therefore devised to distinguish between "specific" 
and "non specific" uptake.
This distinction has been made by parallel incubations
over the same range of radioactive drug (5.0x10  ^ - 3.9x10
mol/litre) in the presence and absence of an excess of
nonradioactive drug (1.25x10  ^mol/litre). This excess
only minimally occupies the "nonspecific" uptake system
»
and therefore does not block "nonspecific uptake". On 
the otherhand, the specific uptake system is overwhel­
mingly filled by the excess nonradioactive drug and a 
reduced amount of radioactive drug is taken up via this 
system. When the nonspecific uptake is subtracted from 
the total uptake, a specific uptake value is found.
Hence, by parallel incubations of (^C) chloroquine 
alone (Total uptake) and in the presence of excess non 
radioactive chloroquine (nonspecific uptake) variations 
or similarities in the "specificity" of uptake of (*^C) 
chloroquine into uninfected T. 0. mouse erythrocytes, 
P.berghei NK 65 and P.berghei RC strain were compared.
2.12 MEASUREMENT OF PERMEABILITY OF ERYTHROCYTES TO 
(14C) L-GLUCOSE
1.0 ml of a 1:14 dilution (packed purified red blood cells 
SBl) of red blood cells was added to 2.0 ml of L - (l-^C) 
glucose in standard medium 1 at pH 7.4. The incubating 
medium was made up to 4.0 ml by addition of an extra
1.0 ml of medium with or without a test compound.
After incubation at 37°C for 45 min and centrifuging 
at 700 x g for 5 min. the supernatant was removed and the 
pellet weighed. Any L-(l-^C) glucose taken up into the 
pellet was extracted into 5% (W/V) trichloroacetic acid. 
The radioactivity was determined by adding 1.0 ml of the 
T.C.A extract to 10.0ml of xylene based emulsifier 
scintillator (special Ml-96) and radioactivity was 
counted.
The amount of L - (l-^C) glucose left in the supernatant 
was similarly determined. Absolute concentrations of the 
radioactive L-glucose were then computed using the 
programmes in Appendices 1, 11 and 111.
This experiment was done using various concentrations 
of (14C) L-glucose (5.0x10"7-3.9x10-1° mol/litre) for 
both uninfected and P.berghei infected T. 0. mouse 
erythrocytes.
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2.13 MEASUREMENT OF D-GLUCOSE UTILISATION AND L( + )
LACTATE PRODUCTION.
1.0ml of a 1 in 10 dilution of purified P.berghei 
infected T. 0 mouse erythrocytes was incubated at 37°C 
in 4.0ml of standard medium (SBI) containing a range of 
concentrations of D-glucose (0.5-5.0 mmol/1) 1.0 ml of 
sample was removed from the incubation medium at room 
temperature at time zero and therefter 1.0 ml of sample 
was revoved at 15 minutes intervals until thirty minutes 
had elapsed. Immediately after removal of aliquots 
from the incubation medium, they were deproteinised with 
0.1 ml of 6 M perchloric acid and kept chilled in ice. 
After spinning the chilled aliquot in a centrifuge at 
4°C for 10 min at 700g„ 0.5 ml of each supernatant was 
transferred to a clean sterilin tube and neutralised with
O. 091 ml of KHCO^ (3 mol/1). This neutralised sample 
was used for assay for both D-glucose and L(+) lactate 
in the sample. This experiment was done for both
P. berghei NK 65 - and RC strain - infected T. O. mouse 
erythrocytes. The effect of the ionophore Monensin on 
utilisation of D-glucose and production of L(+) lactate 
was investigated by running parallel experiments 
containing the ionophore.
2.13.1 ASSAY OF D - GLUCOSE
The method used for the assay of D-glucose is a modifi­
cation of the method of Bergmeyer (1974). The
principle is based on the formation of NADPH as measured 
by the change in extinction at 340nm, the NADPH formed 
is proportional to the amount of glucose present as shown 
in equations below:
D-glucose + ATP Hexokinase G-6-P+ATP.
+ -----------w +G-6-P+ NADP G6P-DH 6-Phosphogluconate + NADPH +H
0.1ml of standards and neutralised deproteinised samples 
were made up in 1.0 ml cuvettes containing 0.82ml of 
0.3M triethanolamine (TEA) with 3 mmol/1 MgSO^ (5.6g TEA 
and 740mg MgSO^^H^O dissolved in 7.0ml H^O, and adjusted 
to pH 7.5 with 1M NaOH, then made up to 100 ml) and 
0.06 ml of ATP/NADP (455mg ATP.Na2 .3H20 and 50mg NADP+. 
Na^ made up in 5.0ml of TEA buffer). After measuring the 
absorbance of this mixture at 340nm in an SP600 
spectrophotometer, 0.02 ml of a mixture of G6P-DH and 
hexokinase (lmg/ml in 3.2 mol/1 (NH^)^ S0^) was added 
to the 1.0 ml cuvettes containing the mixtures and the 
increase in absqj>ance followed at 340nm to completion 
(5-15 min) The increase in absorbance was calculated.
The amount of D-glucose present was calculated with 
reference to a calibration run with a D-glucose standard.
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2.13.2 ASSAY OF L(+) - LACTATE
L-(+)-Lactate was assayed using a modification of the
method of Gutman and Wanefield (Bergmeyer 1974). The 
assay is based on the production of NADH by the oxidation
The formation of NADH was measured in an SP 600 
spectrophotometer by the increase in extinction at 340nm. 
The equilibrium of the reaction lies in favour of lactate 
and NAD. However pyruvate is trapped by reaction 
with hydrazine as the hydrazone while the protons are 
removed by an alkaline reaction medium to yield:
0.8ml of neutralised deproteinised samples were added 
to 3.0ml cuvettes containing 2.0 ml hydrazine/glycine 
buffer (0.4 mol/1 hydrazine; 0.5 mol/1 glycine pH 9.0)
absorbance of this mixture at 340nm, 0.02 ml of 5mg/ml 
LDH was added to the reaction mixture and stirred. The 
reaction was allowed to go to completion in a water bath
340nm was measured, and the change in optical density 
used to calculate the amount of L-(+)-lactate in the 
sample; according to the method of Bergmeyer (1974).
of L-(+) - lactate to pyruvate by NAD in the enzymatic 
reaction catalysed by lactate dehydrogenase (LDH)
L( + ) Lactate + NAD+
LDH
^  Pyruvate + NADH + H+
LDH
Pyruvate
PH 9.0
hydrazone + NADH + H+
and 0.2ml NAD+ (40 mmol/1) After measuring the
at 37°C. After 30 min. the increase in extinction at
109
2.14 DETERMINATION OF H+ EFFLUX INDUCED BY IONOPHORES.
The measurement of pH changes induced by the ionophores 
Monensin and Nigericin was carried out in a cylindrical 
Sterilin plastic cell of 5.0ml capacity with a combination 
glass micro electrode containing a silver-silver 
chloride reference cell (W.G Pye Limited, Cambridge) The 
cylindrical cell was mounted on an electrically driven 
horizontal turntable with a constant speed of 24 rev. per 
min. The pH meter (model 290) was connected to a 
potentiometric flatbed recorder (RE 541.20 - Smith 
Industries Limited, London) via its external outlet which 
had a variable resistor inserted. The potentiometric 
flatbed recorder was calibrated to give a sensitivity 
of 1 mm per 0.01 pH change between the pH range of 6.0 
to 8.0. At this amplification, the background noise 
level corresponded to less than 2mm on the chart. Control 
experiments with various solutions used, indicated a 
constant response time by the flatbed recorder, over the 
whole recording width. The medium used in the experiments 
had a constant volume of 4.0ml. Generally, the procedure 
was as follows:
4.0ml of the medium (sterile saline 154 mM, or 
KC1 154 mM or K+ supplemented isotonic saline, details 
in relevant result text) was pipetted into the cylindrical 
cell and allowed to equilibrate. The pH meter was then 
turned on to "read" and the variation in the meter response 
followed over a duration of 10 min. 1.0 ml of the medium 
was gradually pipetted off and 1.0 ml of "purified" red 
blood cells in the same medium was added and the resultant 
change in pH followed over the next 10 minutes. To test 
the effect of various compounds, 10 pi of a solution of the
1 1 0
compound was added and the pH change induced followed 
over 10 min with constant stirring by the horizontal 
mixer. At the end of each experiment, the glass micro 
electrode was wiped clean with paper tissue soaked in 
deionised water and the micro electrode temporarily 
stored in a concentrated solution of KCL (3 mol/1). The 
linearity of the calibrated scale on the flatbed recorder 
was checked in between experiments by measuring the pH 
and corresponding pen positions on the scale when the 
microelectrode was transferred into solutions of pH 
standards 6.0, 7.0 and 8.0 respectively.
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2.15 MEASUREMENT OF INTERNAL pH (pHi) OF RED BLOOD CELLS 
A modification of the method of Deane and Smith (1957) 
was used in measuring the intracellular pH of red blood 
cells :
Blood from groups of 10 T. 0. mice was collected in 
5ml glass haematology bottles pretreated with heparin and 
stored in ice. Prior to collecting blood, the mice were 
anesthetised with chloroform only. After thoroughly 
mixing the blood in the haematology bottles, the pH of 
the whole blood at room temperature (25°C) was recorded 
and the blood centrifuged at 700g for 3 min.
The plasma obtained after centrifugation was allowed to 
to attain room temperature (25°C) and the pH measured.
The buffy coat on top of the packed red blood cells was 
carefully removed and the top half of the packed cells 
was transferred to another glass haematology bottle.
For P.berghei - infected mice the top fraction removed 
was usually about one third the volume of packed red 
blood cells containing parasites in various developmental 
stages. Aliquots of the top fractions were then pooled 
to provide a sizable portion. 0.3ml of Verislube 
silicone oil was carefully layered on top of the sample 
and then gradually mixed with the packed red blood cells.
The mixture was then centrifuged at 700g for 3 min after 
which, the Verislube silicone oil layer together with the 
trapped plasma was gently aspirated off. The packed 
cells were then frozen rapidly in liquid nitrogen and then 
thawed. The cycle of freezing and thawing was repeated 
twice. When the lysed red blood cells had attained 
room temperature, the pH of the resulting liquid was then
1 1 2
measured using the micro glass electrode. The pH value 
thus obtained is the average intracellular pH (pHi) of 
the red blood cells.
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CHAPTER 3 
3. RESULTS
3.1 VARIATION OF JACKED CELL VOLUME.
The packed cell volume (PCV) of normal (uninfected)
T.O. mouse red blood cells having 2.5 - 5.5 % 
reticulocytes was found to be 0.30 + 0.03. For
phenylhydrazine treated T.O. mice, reticulocytes in­
creased to 65% + 5.0 and the packed cell volume was
O. 201 ± 0.001. From Coulter counter readings, the
average concentration of red blood cells in normal
mice was 5.54 x 1 0 ^  per litre whole blood while that
12of reticulocyte enhanced blood was 3.28 x 10 per 
litre whole blood. Packed cell volume varied with the 
degree of parasitaemia for both P. berghei NK 65 and 
RC strain infected erythrocytes.
At about 50% parasitaemia, the packed cell volume of
P. berghei NK 65 infected erythrocytes was 0.23 +
0.09 with reticulocytosis of 16% i 4.0, while P. berghei 
RC strain infected blood at a parasitaemia of 30% had 
a packed cell volume of 0.172 + 0.04 and reticulocy­
tosis of 55% + 5.0. The concentration of purified 
red blood cells in infected T.O. mouse blood was 
1.05 x 101:lper litre (at the dilution (1:14) of the 
standard erythrocyte suspension used in experiments) 
for NK 65 and 8.0 x 1010 per litre for RC strain.
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3.2 SIZE DISTRIBUTION OF RED BLOOD CELLS.
Results obtained from the automatic particle size 
distribution analyser, show that P. berghei NK 65 
and RC strains infect different populations of red 
cells. After calibration of the analyser with P.D.V.B 
latex particles, the mean cell volume and volume 
distribution of uninfected erythrocytes was obtained. 
The mean cell volume of uninfected T.O. mouse erythro­
cytes was 46.0 and that of reticulocyte enhanced
blood was 65.0 pm^.
After infection with P. berghei, there was a slight 
reduction in the mean cell volume, and at about 50% 
parasitaemia, the mean volume of T.O. mouse red cells 
was 40.0 p m  . However with P. berghei RC, there was
O ,a marked increase in the mean cell volume to 63.0pmJ> 
towards peak parasitaemia. Figs 12 and 13 are the 
coulter counter calibration curve and size distri­
bution graphs respectively. The mean cell volume of 
erythrocytes infected with P. berghei RC was evident­
ly the same as the mean cell volume obtained for 
reticulocyte-enhanced mouse red blood.
TABLE 1 VARIATION OF HAEMATOLC^ICAL DATA OF T.O. MOUSE BLOOD
Strain and 
Stage of Infection
Population 
(xlO *2/Litre) % RETS.
Mean Cell 
Volume (mmJ) PCV
Normal ^ 5.54 t 0.01 4 t  1.5 46.0 0.30 t 0.03
Normal +PH^a^ 3.28 t  0.06 65 t 5.0 65.0 0.201 - 0.001
NK 65 ^  
50% 0.105 - 0.001 16 t 4.0 40 0.23 t 0.01
RC strain ^  
30% 0.08 - 0.002 55 i 5.0 63.0
0.172 - 0.04
(a) Population determined for whole blood.
(b) Population determined for purified blood, (i.e. 1:14 dilution) 
Results given as mean - S.D for 3 experiments.
PH is phenylhydrazine hydrochloride.
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Fig. 12
Coulter counter calibration curve
a __^  P.D.V.B. Latex calibration standard at Coulter counter
aperture current of 2.0 and amplification of 0.06. Mean 
volume of PDVB latex particles is  1767 pm 3 ; with a spread 
of 358.22 - 3140.0 pm3.
© --- ©  Size distribution of unifected T.0. mouse erythrocytes at
coulter counter aperture current setting of 2.0 and 
amplification of 2.0 . 1 unit volume is  equivalent to 7.0 
cubic microns and mean volume of unifected T.0. mouse 
erythrocytes is approximately 46.0 urn3' 8'.
(a) The unit volume can be obtained from the P.D.V.B. latex calibration 
standard curve only after correction for any differences in aperture 
current and amplification. Th is ’borrection" together with any 
variations in the venier scale of automatic particle size 
distribution analyser generates the calibration factor which was 
used to derive the unit volume of the red blood ce ll from that of 
the P.D.V.B. latex standard.
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F ig .13
Size distribution graph.
0  P.berghei NK 63 infected T.O. mouse red ce lls  
A  P.berqhei RC strain infected T.O. mouse red ce lls
One unit volume of red ce ll is  equivalent to 7.0 cubic microns. 
Mean c e ll volume for P.berghei NK 65 infected red ce lls  is  
approximately 40 cubic microns and for P.berghei RC strain  
infected red ce lls  is  63.0 cubic microns.
?o parasitaemia is  about 40SS for both strains.
Coulter Counter aperture current setting =2.0 
Amplification setting = 2.0
3.3 DEVELOPMENT OF MALARIA INFECTION IN MICE
INFECTED WITH P. BERGHEI.
After inoculation of 10^ parasitised red cells intra- 
peritoneally, the P. berghei NK 65 infection developed 
more rapidly than P. berghei RC. Fig 14 shows the 
course of parasitaemia for both strains. Linear 
regression analysis of the curves show that the pre- 
2% period (Warhurst and Folwell, 1968) for P. berghei 
NK 65 was 2.4 days while that of P. berghei RC 
strain was 5.4 days. The maximum parasitaemia obtain­
able was 80.1% + 5.0 for P. berghei NK 65 by the 
7th day after infection, and 37% - 2.5 for RC strain 
by the 14th day. This yields a growth index of 
11.4 for NK 65 strain and 2.6 for RC strain (Growth 
index is obtained here by dividing maximum parasit­
aemia by time in days required to attain it.)
While P. berghei NK 65 did not show any preference 
for polychromatophiles, P. berghei RC strain, 
invaded mainly immature polychromatophilic cells.
P. berghei NK 65 infection usually kills the mice by 
the 7th day while RC strain usually took 14 days or
more.
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F ig .14
Profile of infection of P.berghei NK 65 0  and
P.berqhei RC strain , in t.O . mice.
Inoculum containing 1.0 x 10  ^ infected red ce lls  from 
donor mouse was inoculated intraperitoneally on day 0 . 
Average weight of mice is  17.5g.
Points are mean ± S.D. of four experiments, with 5 mice 
per experiment. Asterisks indicate usual time of death 
of infected mice.
3.4 TIME COURSE OF (14C) CHLOROQU1NE UPTAKE.
The curve obtained for the time course of the up­
take of chloroquine by P. berghei NK 65 infected 
erythrocytes is a rectangular hyperbola (Fig 15) 
and suggests that the uptake is of first order 
kinetics. The initial rate of uptake was rapid 
and could not be determined accurately. However, 
uptake of drug appeared to attain a steady state at 
40 - 45 minutes.
Since the uptake was first order, it can be described 
by the equation :
d(x) \^  = k (a-x)
where a is the initial concentration of drug. The 
characteristics of this system is that for each time 
interval (within the linear uptake period) a constant 
fraction x is taken up (Voicu and Olinescu, 1977).
From the slopes of the linear portion of the graphs, 
the infected erythrocytes accumulated drug at a 
rate 10 times the uninfected. K' is rate constant and 
t is time elapsed.
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4.0 _
Fig. 15
Time course of uptake 
erythrocytes.
of (^C)chloroquine by T.0.mouse
O  T.O. mouse infected with P.berghei NK 65 
A  Uninfected T.O. mouse erythrocytes.
Washed erythrocytes were incubated in 50 nmol/litre 
chloroquine in SB II at 37°C for varying periods of time 
the in it ia l pH o f incubating medium was 7.4. Points on 
curve are mean o f three experiments. Five minutes was the 
earliest possible time a determination could be made using 
this technique.
1 2 2
3.5 RELATIONSHIP OF PARASITAEMIA TO DRUG UPTAKE.
The degree of parasitaemia was found to be directly 
proportional to drug uptake in both P. berghei NK 
65 and RC strain infected T.O. mouse erythrocytes.
Fig 16 shows the correlation of (*^C) chloroquine 
uptake with parasitaemia in P. berghei NK 65 
infected T.O. mouse erythrocytes. Uptake of (*^C) 
chloroquine by P. berghei RC strain infected T.O. 
mouse erythrocytes was also found to fit into lin­
ear regression line drawn for P. berghei NK 65 at 
the appropriate parasitaemia.
The trend equation for the regression line was: 
y = (0.06x + 1.1) which is in the form of the 
straight line equation y = mx + c, where x is the 
percentage parasitaemia and y is drug uptake in 
pmol/kg. The initial ( 1Z*C) chloroquine concentration 
in the medium was 5.0 x 10~® mol/litre. When the 
data obtained for ( *^C) chloroquine uptake at 
different parasitaemias of P. berghei RC infected 
erythrocytes was included with those of P. berghei 
NK 65, the points were found to fit a line with a 
correlation coefficient of 0.998 (with P <  0.001)
The trend line equation was y = (0.06 + 1.2) Fig 17 
shows the regression for P. berghei NK and RC 
strains.
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It is interesting to observe that the intercept 
on the y-axis (0% parasitaemia) corresponds, to the 
uptake of ( ^ c) chloroquine by uninfected erythro­
cytes in SBI. (see Table 2).
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Fig. 16
Correlation of (*^ C) chloroquine uptake (in P.berghei NK 65) 
with parasitaemia.
Numbers in parenthsis are no. of experiments.
Dashed line is  regression line with P<0.001.
A ll experimentswere carried out in SB1 containing 
5.0 x 10“8 mol/1 (14C) chloroquine at 37 °C.
The trund line equation is  : y = 0.06*+ 1.1
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10 . 0-
F ig .17
Correlation of (^C) chloroquine uptake in  
P.berghei NK 65 © , and P.berghei RC Q  , with
parasltaemia.
Numbers in parenthesis are no. of experiments. 
Dashed line is regression line  with P¿0.001.
The trend line equation is  y = £ 0.06x + 1.2^ 
Correlation coefficient of points is 0.998.
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3.6 EFFECTS OF VARIATION OF IONIC COMPOSITION OF 
INCUBATION MEDIUM ON UPTAKE OF ( 14C)
CHLOROQUINE
3.6.1 UNINFECTED ERYTHROCYTES
High K"*” buffer (HKB) at pH 7.4 depressed uptake of
drug by uninfected erythrocytes. After incubation
for 45 minutes at 37°C, the uptake of drug was
0.62 Î 0.01 pmol/kg from a medium concentration of 
-8 145.0 x 10 mol/litre, ( C) chloroquine. This is 
an inhibition of 48.3%, when compared to an uptake 
of 1.2 Î 0.05 ¿imol/kg using standard medium (SBI)
The decrease in drug uptake in high K+ medium was 
statistically significant (p <  0.05, student t test).
There was also a similar reduction in drug uptake 
ratio. Here, the drug uptake ratio is the ratio of 
the distribution of drug between the erythrocyte and 
the medium at equilibrium. The concentration of 
drug taken up by the erythrocyte (Vg) = F g(Se), 
where Fg represents uptake ratio and Se is the 
equilibrium extra cellular drug concentration in 
the medium (in pmol/litre). v B is in pmol/kg.
The equation Vg = Fg (Se) is adapted from Whitfield 
and Schworer (1978) who used Fg to represent the 
"carrier" coefficient for uptake of D-glucose into 
avian erythrocytes. Applying the above equation,
we obtain an uptake ratio of 13.2 when the incuba­
tion medium is high K+ buffer (HKB) and 27.9, when 
standard medium 1 (SBI) is the incubation medium. 
There is thus a two fold variation in the activity 
of the uptake system as indicated by the uptake 
ratio (Fs) (see Tables 2-3).
128
3.6.2 P. BERGHEI NK 65 INFECTED ERYTHROCYTES
High K+ buffer did not cause any marked inhibition 14of ( C) chloroquine uptake by erythrocytes infected 
with P. berghei NK 65. Uptake of (^C) chloroquine 
from higji K+ incubation medium containing 5.0 x 10~® 
mol/litre ( ^ C )  chloroquine was 3.91 t 0.04 pmol/kg, 
while the uptake in standard medium 1 was 3.99 t 
0.06 ;jmol/kg. The drug uptake ratio was 5171.9 in 
the presence of high K+ medium and 5377.4 in stan­
dard medium 1; indicating that the uptake system 
was not adversely affected by high K+ in the incu­
bating medium. (see also Tables 2 - 3).
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3.6.3 P. BERGHEI RC STRAIN INFECTED ERYTHROCYTES.
High K+ buffer (HKB) inhibited the uptake of ( ^ C)
chloroquine by P. berghei RC infected erythrocytes.14 _i_Uptake of ( C) chloroquine was 3.09 _ 0.10 pmol/kg
in high K+ medium compared to 3.89 - 0.10 pmol/kg obtained
in standard medium 1. This represents an inhibition of 20.6%.
The uptake ratio also decreased from 1088.8 in the 
presence of standard medium to 543.1 in the high 
K+ medium. This is a two fold decrease.
It is interesting to note that though RC strain 
infected erythrocytes accumulated almost as much 
drug as P. berghei NK 65 infected erythrocytes 
(especially in SBI, see Table 2a) the comparative 
drug uptake ratios (ie uptake ratio in HKB divided 
by uptake ratio in SBI) was similar for both 
uninfected and RC strain infected erythrocytes 
(see Table 3).
TABLE 2a ; COMPARISON OF (14C) CHLOROQUINE 
UPTAKE IN 2 MEDIA.
STRAIN
High K+ 
medium
High Na+ 
medium
H KB SBI
URBC 0.62 t 0.01 1.2 t 0.05
P. berghei 
NK 65 3.91 t 0.04 3.99 - 0.06
P. berghei RC 3.09 t 0.02 3.80 t 0.1
URBC = uninfected erythrocytes.
Results (in umol/kg) are given as mean i S.D 
(3 experiments)
Parasitaemia of P. berghei NK 65 approximately 50% 
P. berghei RC, 40%.
TABLE 2b; MEDIUM CONCENTRATION 0F ( C) CHLORO­
QUINE AFTER 45 MINS. INCUBATION AT 37UC.
STRAIN
Medium concentration of 
chloroquine (jomol/litre)
High K+ 
medium
High Na+ 
medium
URBC 4.69 x 10"2 4.3 x 10"2
P.berghei NK 65 7.56 x 10"4 7.42 x 10"4
P.berghei RC 5.69 x 10'3 3.49 x 10-3
I
1 3 1
TABLE 3; VARIATION IN DRUG UPTAKE RATIOS.
STRAIN FsHKB ^ s SB I
Fc= Fs in HKB
F in SB Is
URBC 13.2 27.9 0.47
P.berghei NK 65 5171.9 5377.4 0.96
P.berghei RC 543.1 1088.8 0.50
1 3 2
3.7 EFFECT OF D-GLUCOSE ON UPTAKE OF ( C) 
CHLOROQUINE
3.7.1 UNINFECTED ERYTHROCYTES
Between the concentration range 0.1 - 400 mmol/litre,
D-glucose showed little effect on the uptake of
(^C) chloroquine by uninfected erythrocytes. At 
14a ( C) chloroquine concentration of 5.0 x 10“8
mol/litre, in SBI, the uptake of (^C) chloroquine
by uninfected T.O. mouse erythrocytes was 1.05 Ï
0.162 jjmol/kg (n = 7 ). In the absence of D-glucose
in the incubating medium, T.O. mouse erythrocytes
14could take up 0.90 ymol/kg, ( C) chloroquine. The 
drug uptake ratio (erythrocytes : medium) remained 
virtually unchanged in the presence or absence of 
D-glucose. In the incubating medium (SBI) alone, 
the uptake ratio was 32.53 - 4.1, while in the 
presence of D-glucose in the medium, the uptake ratio 
was 38.50 Î 4.1. (see Table 4)
1 4
3.7.2 P. BERGHEI NK 65 INFECTED ERYTHROCYTES.
In the absence of D-glucose, P. berghei NK 65 
infected erythrocytes can accumulate chloroquine up 
to 2.37 i 0.3 pmol/kg at an initial medium (*^C) 
chloroquine concentration of 5.0 x 10“® mol/litre.
With D-glucose in the medium (SBI), there is stim- 14ulation of ( C) chloroquine uptake. This activat­
ion of drug uptake is linear with the D-glucose 
concentration range of 0.125 - 2.0 mmol/litre. The 
increased uptake plateaus between 2.0 - 20 mmol/ 
litre and then declines steadily at D-glucose con­
centrations greater than 40 mmol/litre. Fig 18a 
shows the log-dose relationship of D-glucose and (^C) 
chloroquine uptake. At maximum stimulation, an 
activation of up to 65.82 % over the total uptake in 
the absence of D-glucose in the incubating medium 
(SBI) is obtained. The peak uptake (3.93 t 0.3 
pmol/kg) represents an uptake ratio of 801.7 ^ 37.7 
compared to an uptake ratio of 56.30 _ 5.2 obtained 
in the absence of D-glucose. (see table 5)
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3.7.3 P. BERGHEI RC STRAIN INFECTED ERYTHROCYTES.
Presence of D-glucose in the incubating medium (SBI) 
showed a small but consistent effect on the uptake 
of (14C) chloroquine into P. berghei RC infected 
erythrocytes. In the absence of D-glucose in the 
incubating medium, uptake of radiolabelled drug 
amounted to 2.92 * 0.13 pmol/kg. With 5.0 mmol/litre 
D-glucose in the medium, uptake amounted to 3.48 i 
0.28 pmol/kg. However, the uptake ratios showed 
a wide variation of 165.90 * 24.9 for uptake in the 
absence of D-glucose and 749.87 i 65.96 for uptake 
in the presence of 5.0 mmol/litre D-glucose. The 
maximal effect of D-glucose (5.0 mmol/litre) 
produced an activation of uptake of (^C) chloroquine 
of 19.2 % (see Table 6).
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3.8 EFFECT OF 2-DEOXY-D-GLUCOSE ON UPTAKE OF714“ ----------------------------------------------------------------------------------------------( C) CHLOROQUINE.
3.8.1 UNINFECTED T.O. MOUSE ERYTHROCYTES.
2-deoxy-D-glucose showed virtually no inhibition of 
( C) chloroquine uptake in this model. The uptake 
in the presence of 5.0 mmol/litre 2-deoxy-D-glucose 
amounted to 0.88 * 0.05 pmol/kg compared to 1.05 Î 
0.162 pmol/kg total uptake with 5.0 mmol/litre 
D-glucose alone in SBI. Also there was little change 
in the drug uptake ratios. An uptake ratio of 
38.30 Î 4.1 was obtained in the presence of 5.0 mmol/ 
litre D-glucose alone in the medium and 32.62 - 4.0 
in the presence of 5.0 mmol/litre D-glucose and 5.0 
mmol/litre, 2-deoxy-D-glucose. Table 4 summarises 
the effect of D-glucose and 2-deoxy-D-glucose on 
uptake of radiolabelled chloroquine by uninfected 
erythrocytes.


LEGEND.
(a) Concentration of (1^C) chloroquine after 45 
minutes incubation at 37°C in standard buffer.
(b) Uptake ratio is ratio of (1^C) chloroquine 
concentration in cells (umol/kg) to free (14C) 
chloroquine (pmol/1) left in incubating medium 
after 45 min. incubation at 37°C.
(c) % Parasitaemia of P. berghei NK infected 
erythrocytes is 46.4 Î 10.0.
(d) % Parasitaemia of P. berghei RC infected 
erythrocytes is 30.96 * 7.5
TABLES 4,5, AND 6.
Results given as mean _ S.D. of 4 experiments.
TABLE 4 . THE EFFECT OF D-GLUCOSE AND 2-DEOXY-
le after 45 
Indard buffer. 
|loroquine 
|to free (14C) 
bating medium
nf ected
nfected î
experiments.
D-GLUCOSE ON THE UPTAKE OF (14C) 
CHLOROQUINE BY UNINFECTED ERYTHROCYTES.
Additions Uptake
pmol/kg
Uptake . . 
Ratio (b'
Incubation medium (SBI) only 0.90 Î 0.06 
+ 5.0M D-glucose 1.05 t 0.162
t n ' V ?  °-eluc“se.+ Ï 0.88 Î 0.05 5.0 mM 2-Deoxy-D-glucose )
32.53 t 4.0 
38.30 + 4.1
32.62 t 4.0
TABLE 5. P. BERGHEI NK 65 ( c ) INFECTED ERYTHROCYTES.
Additions Uptake
pmol/kg
Uptake
Ratio
Incubation medium only 2.37 * 0.3 56.30 t 5.21
+ 5.0 mM D-glucose 3.93 Î 0.3 801.7 t 37.7
+ 5.0 mM D-glucose + 3 i / -> + „ „„ 6 3 1.47 - 0.02 33.78 t 4.3
5.0 mM 2-deoxy-D-glucose )
1 3 8
TABLE 7 - LEGEND
(e) Total drug uptake in the presence of 5.0 mmol/1 
D-glucose in incubating medium (SBI)
(f) Uptake ratio for (*^C) chloroquine uptake in 
incubating medium alone regarded as having an 
index of 1.0.
Results calculated from "means" only.
URBC is uninfected T.O. mouse red blood cells.
. TABLE 6 P. BERGHEI RC INFECTED ERYTHROCYTES(d)
Additions Uptake
pmo1/kg
Uptake
Ratio
Incubation medium only 2.92 * 0.13 
+ 5.0 mM D-glucose 3.48 t 0.28 
+ 5.0 mM D-glucose + ) 3.04 + 0<05 
5.0 mM 2-deoxy-D-glucose }
165.90 Î 24.9 
749.87 t 65.96
366.5 t 25.7
TABLE 7 . SUMMARY OF INHIBITION PROFILE AND VARIATION 
OF UPTAKE RATIO OF (I4C) CHLOROQUINE BY 
T.O. MOUSE ERYTHROCYTES.
Percentile Inhibition 
of mean of maximal 
drug uptake'■e '
Change in uptake 
Index (f)
STRAIN
+ 5.0 mmol/1
2-Deoxy-D-
glucose
Incubation
medium
only
+ 5.0 mmol/1 
D-glucose
+ 5.0mmol/l
2-Deoxy-
D-glucose
URBC 16.2 14.29 1.17 1.002
NK 65 62.60 39.7 14.24 0.6
RC strain 12.64 16.9 4.52 2.2
3.8.2 P. BERGHEI NK 65 INFECTED T.O. MOUSE
ERYTHROCYTES.
The activation of (*^C) chloroquine uptake induced 
by D-glucose (2.0 - 20 mmol/litre) was consistently 
inhibited by 2-deoxy-D-glucose. Within the 2-deoxy- 
D-glucose concentration range of 2.0 - 20 mmol/litre, 
the inhibition of ( ^C) chloroquine uptake was 
62.75 % Î 2.33. However, when compared to the 
uptake in the absence of D-glucose, the resultant 
inhibition was 39.57% t 3.78.
The drug uptake ratio was also reduced significantly, 
from 801.7 *37.7 in the presence of D-glucose 
(5.0 mmol/1) to 33.78 Î 4.3 in the presence of 
5 mmol/1, 2-deoxy-D-glucose and 5 mmol/1, D-glucose. 
Fig 18b shows the inhibitory effect of deoxy-D- 
glucose on uptake of radiolabelled chloroquine by 
P. berghei NK 65 - infected erythrocytes. Table 5 
also shows the effect of D-glucose and 2-deoxy-D- 
glucose on uptake of (^^C) chloroquine by this model.
1 4 1
3.8.3 P. BERGHEI RC STRAIN INFECTED T.O. MOUSE 
ERYTHROCYTES.
Between 2.0 - 20 mmol/1, 2-deoxy-D-glucose, there 
was fairly uniform inhibition of (*^C) chloroquine 
uptake of 18.8% + 4.15, in the pre sence of 5.0 
mmol/1, D-glucose in the incubating medium. When 
compared to uptake of (^C) chloroquine in the absence 
of D-glucose in the incubating medium (SBI), the 
inhibition amounted to only 1.2% t 0.20. However, 
very high concentrations (100 - 200 mmol/1) of 
2-deoxy-D-glucose, showed inhibition of 27.0 - 32.8% 
at incubating medium (SBI) D-glucose concentration 
of 5 mmol/1.
At 2-deoxy-D-glucose concentration of 5.0 mmol/1, 
the total uptake of (*^C) chloroquine was 3.04 t 
0.05 jamol/kg and corresponded to an uptake ratio of 366.6- 
25.7, compared to an uptake ratio of 165.90 _ 24.9 
for uptake of radiolabelled drug in the absence of 
D-glucose and 749.87 * 65.96 for uptake in the presence 
of 5.0 mmol/1 D-glucose alone, in the incubating medium. 
Table 6, shows the effect of D-glucose and 2-deoxy- 
D-glucose on uptake of (14C) chloroquine by P. berghei 
RC strain infected T.O. mouse erythrocytes.
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Fig. 18a
Effect of D-glucose on chloroquine uptake□  Uptake into P.berqhei NK 65 infected T.O.mouse erythrocytes. Average parasitaemia = 45%
/7\ Uptake into P.berqhei RC strain infected T.O. 
mouse erythrocytes. Average parasitaemia = 38%
^Uptake into uninfected T.O. mouse erythrocytes
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Fig. 18b
Effect of 2-Deoxy-D-glucose on uptake of 
(l^C) chloroquine.■  Uptake into P.berqhei NK 65 infected T.O. mouse erythrocytes. % parasitaemia = 45• Uptake into P.berghei RC strain infected T.O. mouse erythrocytes. % parasitaemia = 38
A  Uptake into uninfected T.O. mouse erythrocytes.
Incubating medium in addition to various concentrations 
of 2-Deoxy-D-glucose contained 5.0 mmol/1 D-glucose.
Points on y axis at zero Deoxy-D-glucose concentrations 
represent uptake in the absence of D-glucose.
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F ig .  18b
E f f e c t  o f  2-Deoxy-D-glucose on uptake o f  
(l^C) ch lo roq u in e .
■  Uptake in to  P .b e rqhe i NK 65 in fe c te d  T.O. mouse e ry th ro cy te s . % p a ra s ita em ia  = 45
• Uptake in to  P .b e rghe i RC s t r a in  in fe c te d  T.O. mouse e ry th ro cy te s . % p a ra s ita em ia  = 38
A  Uptake in to  u n in fe c ted  T .O . mouse e ry th ro cy te s .
In cu ba t in g  medium in  a d d it io n  t o  va r io u s  con cen tra t io n s  
o f  2-Deoxy-D-glucose con ta ined  5 .0  mmol/1 D -g lucose.
P o in t s  on y a x is  a t zero  Deoxy-D-g lucose con cen tra t io n s  
rep re sen t uptake in  the absence o f  D -g lucose.
3.9 EFFECT OF 3-0-METHYL-D-GLUCOSE ON UPTAKE OF
,14 . ' -----------( C) CHLOROQUINE.
This analogue of D-glucose was tested within the 
concentration range of 2.5 - 400 mxnol/1. There was 
no significant effect on uptake of (^C) chloroquine 
by P. berghei NK 65, P. berghei RC and uninfected 
erythrocytes; in the absence of and in the presence 
of 5 mmol/1 D-glucose.
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3.10 EFFECT OF L-GLUCOSE ON UPTAKE OF (14C )
CHLOROQUINE.
Between the concentration range of 2.5 - 400 mmol/1, 
L-glucose did not show any significant effect on 
the uptake of (*^C) chloroquine by P. berghei NK 65,
P. berghei RC and uninfected T.O. mouse erythrocytes; 
both in the presence and absence of D-glucose (5 mmol/1).
3.11 EFFECT OF IONOPHORES ON (14C) CHLOROQUINE 
UPTAKE.
3.11.1 MONENSIN AND NIGERICIN
These carboxylic polyether antibiotics (structures 
in appendix) exchange protons across membranes for 
Na+ and K"1- respectively (Pressman. 1976). These 
"ionophores" showed significant inhibition of (^C) 
chloroquine uptake by both infected and uninfected 
T.O. mouse erythrocytes. The inhibition was both 
dose and time dependent.
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3.11.2 DOSE RESPONSE ANALYSIS
Between the concentration range of 1.0 x 1 0 " -
2.0 x 10~6 mol/1, both Monensin and Nigericin showed 
graded and dose dependent inhibition of drug uptake 
into P . berghei - infected and uninfected erythrocytes.
In the high Na+ incubation medium (SBI) the ID^q 
(concentration causing 50% inhibition of maximal 
chloroquine uptake) for monensin was 2.5 - 5.0 x 10~7mol/l 
This ID^q was increased to 1.0 x 10“^ mol/1 when the 
incubation medium was SB2 and contained a lower Na+ 
concentration. In the presence of high K+ (eg In HKB)
5.0 x 10“  ^mol/1 monensin, caused only 25.41% t 4.6 
inhibition of ( ^ C )  chloroquine uptake by erythrocytes 
infected with P. berghei NK 65.
In the presence of high K+ concentration in the 
incubation medium (HKB or SB2 supplemented with 40 
mmol/1 KC1) Nigericin caused significant inhibition of 
drug uptake into both P. berghei infected and uninfected 
T.O. mouse erythrocytes. The ID50 for Nigericin was
1.0 - 2.0 x 10”7 mol/1 for P. berghei NK 65 infected 
erythrocytes and 0.6 - 2.0 x 10”  ^mol/1 for uninfected 
erythrocytes. In high Na"*" incubating medium alone,
2.0 x 10“  ^mol/1 Nigericin could only elicit 12% i 2.6 
inhibition of drug uptake by erythrocytes infected 
with P. berghei NK 65.
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However, at concentrations greater than 3.0 x 10-6 mol/1 
both Monensin and Nigericin caused partial lysis of 
the incubated T.O. mouse erythrocytes and all such 
results were discarded. Figs 19 and 20 are log dose 
response curves for Monensin, while Figs 21 and 22 
are log dose response curves for Nigericin. Fig 33 
shows the effect of Monensin on (*^C) chloroquine 
uptake at varying medium (*^C) chloroquine concentration.
The inhibition of drug uptake by Monensin was also 
found to be noncompetitive. Fig 23 shows the 
inhibition of chloroquine uptake by monensin in 
erythrocytes infected with P. ber^hei NK 65. The 
inhibition is noncompetitive since Umax (maximum up­
take at infinite medium chloroquine concentration) 
is changed from 50 to 7.46 pmol/kg.
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3.0^P
2 . 0 -
1 .0 -
o
A
A.
0-1— //-0 — r- 9 I-8 -7 — I--  6 --1- 5
LOG MONENSIN CONC. (mol/1)
Fig. 19
Log - Dose response curve o f Monensin
/'T'v Uptake of (* C^) 
infected T.O.
chloroquine by P.berghei NK 65 
mouse erythrocytes.
Uptake of (* C^) chloroquine by uninfected T.O. 
mouse erythrocytes.
Infected and uninfected T.O. mouse erythrocytes were 
incubated in SB II medium (reduced Na"*; at 37°C for 45min. 
In it ia l concentration of radio labelled chloroquine in 
medium was 5.0 x 10“® mol/1 and in it ia l  pH of incubating 
medium was 7.4 .
Points on the curves are means of three experiments . 
Points on ordinate indicate value of drug uptake 
in absence of monensin.
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Fig. 20
Log - Dose response curve of Monensin
o Percentage of maximum uptake of (*^ C) chloroquine by P.berghei NK 65 infected T.O. mouse erythrocytes.
^  Percentage of maximum uptake of (14 C) chloroquine 
by uninfected T.O. mouse erythrocytes.
Arrow indicates I.D50 and is approximately 1.0 x 10~6mol/J 
for both uninfected mouse erythrocytes and P.berghei 
NK 65 infected T.O. mouse erythrocytes.
Incubating medium is  SBII. (reduced Na+)
I D 5Q o f Monensin for P.berghei NK 65 infected T.Q.mouse 
erythrocytes in SB 1 (high Nat j is  2.5 - 5.0 x 10“ ' mol/1.
I D 50 in  regarded as concentration of ionophone required 
to in h ib it  uptake of radiolabelled drug by 50SJ
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3.0o
2.0  -
1 . 0 -
A
A. O
"A.
A " A
o-L/A — r
-9
— [“
-7
— r
-6
-- I
_ 5
LOG NIGERICIN CONC. (mol/1)
F ig .21
Log - Dose response curve of Nigericin
(7 ) Uptake of (^C) chloroquine by P.berghei NK 65 
infected T.O. mouse erythrocytes.
^  Uptake of (1 4 C) chloroquine by uninfected T.O. 
mouse erythrocytes.
Incubation medium was SBII supplemented with 40 mmol/l.KCl 
Points on the curves are means of three experiments. 
(Total K+ cope'. = 45 mmol/1).
Points on ordinate indicate value o f drug uptake in 
absence of n igericin .
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100_
o -H  / ----------- r
-9
I------- 1------- 1------- 1
- 8  -7  - 6  -5
LOG NIGFRICIN CONC. (mol/1)
Fig. 22
Log -  Dose response curve of Nigericin
o Percentage of maximum uptake of (* C) chloroquine by P.berghei NK 65 infected T.O.mouse 
erythrocytes.
A Percentage o f maximum uptake of (^C) chloroquine by uninfected T.O. mouse erythrocytes.
Arrow indicates ID50 and is  1.0 x 10"  ^mol/1 for P.berqhei 
NK 65 infected T.O. mouse erthyrocytes.
Incubating medium is  SBII supplemented with 40mmol/l KC1. 
(Total K+ concentration = 45 mmol/1).
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RECIPROCAL OF MEDIUM CHLOROQUINE 
( Vpmol/1 )
F ig. 23
Double reciprocal plot of uptake of radioactive 
chloroquine by P.berghei NK 63 infected T.O. mouse 
erythrocytes in the presence of monensin.
© Control, No Monensin in incubation medium.
• 5.0 x 10- 8  mol/1 Monensin in incubation medium. 
® 2.5 x 10" 7 mol/1 Monensin in incubation medium.
Incubation was for 45 min at 37°C in  SBII 
Lines are calculated regression lines.
Ab4jissa is reciprocal of medium chloroquine at 
equilibrium.
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3.12 TIME COURSE OF INHIBITION OF (14C) CHLOROQUINE 
UPTAKE BY IONOPHORES.
3.12.1 MONENSIN AND NIGERICIN
Inhibition of (l^C) chloroquine uptake by monensin 
and nigericin is proportional to the time of pre­
incubation of T.O. mouse erythrocytes in the ionophore. 
The relationship of inhibition to time pre-incubated 
in 5.0 x IQ"7 mol/1 Monensin is relatively linear for 
the first 15 min. of preincubation and attains 
equilibrium by 45 minutes.
Fig 24 illustrates the effect of preincubation of 
P. berghei NK 65 infected mouse erythrocytes over 60 
minutes in 5.0 x 10"7 mol/1 Monensin in SB2. Nigericin 
in K+ supplemented buffer showed a similar profile.
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5.0 5
TIME Or PREINCUBATION (min.) in 5.0 x 10" 7 mol/1 
MONENSIN
Fig, 24
Effect of preincubation of mouse erythrocytes in 5 x 10 7mol/l 
Monensin.
@ Uptake of (^C) chloroquine by P.berghei NK 65 
infected T.O. mouse erythrocytes.
14
+ ( C) chloroquine concentration le f t  in incubation
medium at the end of 45 mins incubation at 37 °C . 
In it ia l concentration o f (l^C) chloroquine in incubation 
medium was 5.0 x 10~®mol/1.
Inhibition o f (*^ C) chloroquine uptake into 
P.berqhei RC infected and uninfected T.O. mouse 
erythrocytes showed the same p ro file . A similar result 
was obtained for N igericin in the appropriate buffer.
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3.12.2 VALINOMYCIN
This cyclic dodecadepsipeptide antibiotic 
catalyses electrogenic transfer of K"4" across mem­
branes (Pressman, 1976). Over the concentration 
range of 1.0 x 10”^  - 1.0 x 10“  ^mol/1, valinomycin
in high Na+ medium (SB2) showed no effect on uptake 
of (^C) chloroquine. In the presence of SB1 
supplemented with 40 mmol/1 KC1, valinomycin (2.0 
xlO-'7 mol/1) showed only 8% inhibition of uptake of 
(1AC) chloroquine by both infected and uninfected 
T.O. mouse erythrocytes.
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The Na+/K+ ATPase inhibitor ouabain was tested for 
its effects on uptake of drug. In the concentration 
range of 5.0 x 10“^ - 5.0 x 10“5 mol/1, Ouabain 
inhibited uptake of radiolabelled chloroquine in 
uninfected, P. berghei NK 65 and RC strain infected 
T.O. mouse erythrocytes. Maximum inhibition of drug 
uptake was obtained at ouabain concentrations of 
1.0 x 10“^ mol/1 and above. This inhibition for 
uninfected T.O. mouse erythrocytes was 0.27 i 0.04 
pmol/kg and represented a percentage inhibition of 
25.48 i 3.51. For P. berghei NK 65 infected erythro­
cytes, inhibition was 0.75 t 0.1 pmol/kg equivalent 
to 23.3 - 5.0%,and 1.01 - 0.19 pimol/kg • equivalent to 
28.25 - 5.5% for P.berghei RC infected T.O. mouse 
erythrocytes (see tables 8, 9 and 10).
It is thus evident that the percentage inhibition of14
( C) chloroquine uptake caused by ouabain (1.0 x 10 
mol/1) was similar in all three models, though the 
absolute reduction in drug uptake was in the order 
RC >  NK 65 >  URBC. Ethanol at concentrations up to 
1% did not show any significant inhibition of drug 
uptake.
On combination of 1.0 x 10"4 mol/1 ouabain with 2.0 x 
10"7 mol/1 Monensin, ouabain partially alleviated the
3.13.1 EFFECT OF OUABAIN ON UPTAKE OF (14C)
CHLOROQUINE.
inhibitory effect of Monensin in SB1 incubating 
medium. For uninfected T.O. mouse erythrocytes, 
inhibition caused by 2.0 x 10-7 mol/1 Monensin was 
reduced from 0.51 ± 0.06 pmol/kg to 0.30 ± 0.03 
^imol/kg; a reduction of 19.4%. This percentage 
reduction was statistically significant P <  0.05, 
t-test. There was also similar reduction of " 
inhibition of ( C) chloroquine uptake caused by 
Monensin in P. berghei NK 65, but a lesser and more 
variable effect in RC strain infected erythrocytes.
For P. berghei NK 65, the reduction was from 1.74 t 
0.06 jamol/kg to 1.1 ^ 0.14 pmol/kg; a reduction of 
18.2% which was statistically significant, P = 0.05, 
t-test. For P. berghei RC strain infected erythro­
cytes, there was a slight reduction in the inhibitory 
effect of Monensin by ouabain, from 1.47 - 0.3 pmol/kg 
to 1.19 i 0.03 umol/kg. However, this reduction was 
not statistically significant (P > 0 . 0 5  student t 
test with DF = 6).
Ouabain (1.0 x 10"^ mol/1) had no alleviating effect 
on inhibition of (1ZfC) chloroquine uptake caused by 
Nigericin (2.0 x 10"7 mol/1) in all three systems.
For P. berghei NK 65 infected erythrocytes, there was 
an enhanced depression of uptake, indicating an 
additive effect, from 42.0 i 2.0 % inhibition to 
48.35 - 1.35 (see table 9). For RC strain infected 
cells and for uninfected erythrocytes there was very 
little difference from the effect of Nigericin alone 
(see table 8 and 10).
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L-epinephrine and 5-hydroxytryptamine (5HT, serotonin) 
were the biogenic amines tested. Both showed some 
inhibition of (^4C) chloroquine uptake in SB1 con-
™ 8 i /■taining 5.0 x 10 mol/1 ( C) chloroquine, in all 
three systems. At 2.0 x 10  ^mol/1, L-epinephrine 
inhibited drug uptake by 47.39 % - 3.46 (0.52 ^ 0.06 
jomol/kg) in uninfected mouse erythrocytes whilst 5HT 
(2.0 x 10 7 jnol/1) caused a similar inhibition of 
48.02% - 5.51 (0.53 - 0.06 nmol/kg). For P. berghei 
NK 65 infected T.O. mouse erythrocytes, the inhibition 
of drug uptake by L-epinephrine was 13.3% - 1.87 
(0.54 * 0.07 ¿omol/kg) whilst 5HT inhibited drug up­
take by 16.6% - 3.3 (0.63 - 0.05 nmol/kg).
For P. berghei RC strain infected erythrocytes, the 
inhibition for L-epinephrine and 5HT was 16.6 *
3.7 (0.60 - 0.13 pmol/kg) and 25.2% - 7.9 (0.91 - 0.3 nmol/ 
Kg ) respectively. It is thus evident that both 
L-epinephrine and 5HT each caused a similar percentage 
inhibition and about the same absolute amount of drug 
uptake was inhibited in all three models by L-epine­
phrine and 5HT.
(0.55 - 0.03 umol/kg inhibition by L-epinephrine, 
mean - S.D. for all three models).
0.69 * 0.16 ¿imol/kg inhibition by 5HT, mean - S.D. 
for all three models).
Tables 8, 9 and 10 also summarises the effect of 
L-epinephrine and 5HT on uptake of ( C) chloroquine 
by the three models.
3.13.2 EFFECT OF BIOGENIC AMINES ON UPTAKE OF
(14C) CHLOROQUINE.
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The inhibition of drug uptake by L-epinephrine was 
found to be competitive. Fig 25 is the double 
reciprocal plot of uptake of chloroquine by 
P. berghei NK 65 infected erythrocytes in the absence 
and presence of L-epinephrine. The inhibition is 
competitive since Umax (maximum uptake at infinite 
chloroquine concentration) is unchanged but the 
dissociation constant is raised The inhibition 
constant is calculated from Gaddum's equation:
DR-1 = (i)
Ki
where DR (Dose ratio) is
Km for chloroquine in presence of inhibitor 
Km  in absence of inhibitor, and (i) is the
molar concentration of inhibitor (Paton, 1970).
The inhibition constant for inhibition by
L-epinephrine was calculated to be 1.0 - 2.0 x 10 ^
mo1/1.
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F ig . 25
E ffect of non radioactive L-Epinephrine on uptake of 
(l^C) chloroquine by P.berghei NK 65 infected T.O. mouse 
erythrocytes. _
• 2 .0  x 1 0 - 7  mol/ 1 Epinephrine
El 5.0 x 10- 8  mol/1 Epinephrine
© Control (NK 65)
L-Epinephrine was dissolved in minimal amount of glacial 
acetic  acid and then diluted appropriately with high Na+ 
buffer (SB 1).
Incubation was in SB 1 at 37 °C for 45 min.
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The -SH blocking agents parachloromecuribenzoate 
(pCMB) and N-ethylmaleimide (NEM) were tested within
the concentration range 1.0 x 10"® mol/1 to 1.0 x 10“® 
mo 1/1 in SBI containing 5.0 x 10“® mol/1 (14C) chloro­
quine. Below 10"4 mol/1, both pCMB and NEM showed 
no effect on the uptake of radiolabelled drug. But 
at 10"®M, both compounds inhibited the uptake of 
(14C) chloroquine into uninfected and infected 
erythrocytes.
_ 3At 10 M, pCMB reduced uptake of radioactive chloro­
quine into P. berghei NK 65 infected erythrocytes 
by 38.75% t 3.05, however this reduction was accom­
panied by haemolysis far greater than twice the control. 
At the same concentration NEM caused a 67.2% Î 1.1 
reduction in uptake of radioactive chloroquine in this 
model. These percentage decreases correspond to 
decreases in drug concentrations of 1.60 t 0.13 and 
2.75 t 0.05 ¿imol/kg respectively.
For P. berghei RC strain infected erythrocytes, 
pCMB (10"® mol/1) caused an inhibition of 61.8% t 
6.0 (2.23 - 0.22 ¡umol/kg) while NEM caused an 
inhibition of 73.4% t 7.9 (2.65 t 0.29 *imol/kg).
3.13.3 EFFECTS OF SULPHYDRYL REACTIVE AGENTS ON
UPTAKE OF (14C) CHLOROQUINE.
There was lysis in both cases with pCMB showing 
greater lytic effect. This lysis not withstanding, 
there was similarity of inhibition by both pCMB 
and NEM in this model. (see tables, 8, 9 and 10).
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TABLE 8. EFFECTS OF VARIOUS AGENTS ON UPTAKE OF
, 1 4  .( C) CHLOROQUINE BY UNINFECTED ERYTHROCYTES.
Addition to 
medium
14C CQ 
uptake
JJtTlO 1/kg
Inhibition
pmol/kg^^
by agent
% (c)
Control O•o
+ 1<T>O _
Monensin
2.0 x 10“7mol/l 0.58 t 0.07 0.51 47.45 - 7.07
Nigericin
2,0 x 10“'mo1/1 0.52 t 0.06 0.57 49.66 t 8.62
Ouabain
\,0 x 10"4mol/l 0.82 t 0.03 0.27 25.48 * 3.51
L- Epinephrine
2.0 x 10“7mol/l 0.57 - 0.05 0.52 47.39 - 3.46
5HT
2.0 x 10~7mol/l 0.56 - 0.04 0.53 48.02 - 5.5
Ouabain/Monens in 0.79 - 0.07 0.30 28.01 t 3.5
Ouabain/Nigericin 0.56 * 0.02 0.53 48.6 t 6.9
Ethanol 1% v/v 1.03 - 0.03 0.06 5.5 - 0.21
Valinomycin 1.00 t 0.07 0.09 8.25 t 0.4
(a) 40.0 mM KC1 added to SB1.
Values are means - S.D of four experiments.
(b) Values given for comparison only.
(c) Actual % inhibition in individual experiments 
summed up to give mean - S.D.
A
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TABLE 9. EFFECT OF VARIOUS AGENTS ON UPTAKE OF (14C) 
CHLOROQUINE BY P. BERGHEI NK 65 INFECTED 
ERYTHROCYTES (dK
Addition to 
medium
14C CQ 
uptake 
pmol/kg
Inhibition
jomol/kg^k)
by Agent 
%<c>
Control 4.1 - 0.17 _ _
Monensin
2.0 x 10“7mol/l 2.36 ± 0.12 1.74 42.5 - 1.5
Nigericin
2.0 x 10“7mol/l 2.43 + 0.17 1.67 42.0 - 2.0
Ouabain
1.0 x 10_4mol/l 3.35 + 0.13 0.75 23.3 - 5.0
L- Epinephrine 
2.0 x 10-7mol/l 3.56 + 0.10 0.54 13.13 - 1.87
5 Hi'
2.0 x 10"7mol/l 3.47 + 0.11 0.63 16.6 - 1.4
Ouabain/Monensin 3.0 + 0.1 1.1 24.3 - 3.3
Ouabain/Nigericin 2.06 + 0.1 2.04 48.35 - 1.35
* PCMB 10“ 3 mol/1 2.50 + 0.18 1.63 38.75 - 3.05
* NEM 10"3 mol/1 1.35 + 0.04 2.75 67.2 Î 1.1
Reserpine 4.05 + 0.1 - -
Ethanol 1% 4.03 + 0.1 - -
Valinomycin^a ^ 4.10 + 0.2 “
(d) Average parasitaemia was 55%
* Haemolysis greater than 2x "control" haemolysis.
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TABLE 10. EFFECTS OF VARIOUS AGENTS ON UPTAKE OF (14C)
CHLOROQUINE BY P. BERGHEI RC- INFECTED
ERYTHROCYTE sle ^
Addition to 
medium
14C CQ 
uptake 
pmol/kg
Inhibition
pmol/kg^^
by Agent 
7o(c)
Control 3.61 - 0.23 - -
Monensin
2.0 x 10“7mol/l 2.14 - 0.40 1.47 40.97 - 10.4
Nigericin^3 ) -1 -2.0 x 10"7mol/l 2.01 - 0.25 1.61 44.6 - 6.8
Oubain
1.0 x 10“4mol/l 2.60 - 0.20 1.01 28.3 - 5.5
L-Epinephrine
2.0 x 10 'mol/1 3.01 - 0.20 0.60 16.6 - 3.7
5HT
2.0 x 10“7mol/l 2.7 - 0.30 0.91 25.2 - 7.9
Oubain/Monensin 2.42 - 0.40 1.19 32.7 - 9.2
Oubain/Nigericin 1.98 - 0.2 1.63 45.3 - 5.0
* PCMB 10”3mol/l 1.38 - 0.2 2.23 61.8 - 6.0
* NEM 10“3 mol/1 0.96 - 0.04 2.65 73.4 - 7.9
Reserpine 3.26 - 0.3 - -
f Q  \Valinomycinv ' 
l
3.52 - 0.1
(e) Parasitaemia was maximal after 14 days of inoculation 
* Haemolysis greater than 2 x "control" haemolysis.
167
3.14 KINETICS OF (14C) CHLOROQUINE UPTAKE
3.14.1 AFFINITY OF UPTAKE SYSTEM FOR CHLOROQUINE 
When reciprocals of the 45 min. (XHC) chloroquine uptake 
values were plotted against reciprocals of the equilibrium 
concentrations of radio labelled chloroquine in the incubating 
medium, straight lines were obtained for uninfected,
P.berghei NK 65 and RC strain infected T. 0. mouse erythro­
cytes. This suggests that the amount of radiolabelled 
chloroquine in the erythrocytes at equilibrium in the presence 
of increasing external concentrations of chloroquine follows 
the Langmuir absorption isotherm:
1 1 1
---  = K ----  + -----
C. C Uin ex max
C Cwhere ex is the external concentration of chloroquine, in
4he amount of drug taken up by the erythrocyte and Umax
is the maximal amount taken up by the erythrocyte or
erythrocyte/parasite complex at saturating concentrations
of chloroquine, (Capacity of the cells).
The dissociation constant K, was obtained from the interceptU _ g
on the abscissa and was found to be between 1.0 - 2.0x10
- 8tnol/l for P.berghei NK 65 and 2.7 x 10 mol/1 for P.berghei 
RC infected T. 0. mouse erythrocytes. The uptake maximum 
(Umax) was found to be the same for both P.berghei RC 
strain and uninfected T. 0. mouse erythrocytes - approxi­
mately 20 pmol/kg, while Umax for P.berghei NK 65 infected
T. 0. mouse erythrocytes was 53.5 ¿imol/kg.
The plot for uninfected T. 0. mouse erythrocytes almost
passed through the intersection of the ordinate and abscissa,
but the K. obtained from the linear regression was 1.33X10 d
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mol/1. Fig 26 shows the double reciprocal plots of uptake 
of ( C) chloroquine in the 3 cell systems used.
14Fig 27, illustrates the inhibition of ( C) chloroquine 
uptake by quinine and non radioloabelled chloroquine.
The capacity of the cells (Umax) remains unchanged in the 
presence of the inhibitors, unlike the effect of monensin 
(Fig. 23). The inhibition constant for inhibition 
by quinine was calculated to be 2.2 X 10 ^ mol/1 from Gaddum's 
equation. for "cold" chloroquine was calculated to
be 7.7 X  10  ^mol/1. The competitive inhibition showed 
that quinine probably shared the same uptake system as 
chloroquine.
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F ig . 26
Double reciprocal plots of uptake of radioactive 
chloroquine by T.O. mouse erythrocytes as a function 
of medium concentration of chloroquine at equilibrium.
© Uptake by P.berghei NK 65 infected T.O. mouse 
çrythrocytes.
B  Uptake by P.berghei RC strain infected T.O. mouse 
erythrocytes.
▲  Uptake by uninfected T.O. mouse erythrocytes.
A l l  incubation was in SBIIfor 45 min.at 37°C .
I n it ia l pH of incubating medium was 7.4.
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RECIPROCAL OF MEDIUM CHLOROQUINE 
( V>Jmol/l)
Fig.27
Effect of non radioactive quinine and chloroquine on 
uptake o f radio labelled chloroquine by P.berghei NK 65 
infected T.O. mouse erythrocytes.
q  Uptake by infected erythrocytes in absence of any 
other drug.
Uptake by infected erythrocytes in presence of 10- ^mol/l 
non radio labelled quinine.
0  Uptake by infected erythrocytes in presence of 10 ^mol/l 
non radio labelled chloroquine.
Incubation was inSBIIat 37 °C for 45 min
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3.14.2 SPECIFICITY OF UPTAKE OF (14Ç) CHLOROQUINE 
Over the same range of concentrations of radioactive chlo­
roquine (5.0 xlO 4.0 x 10 ^  mol/l)P.berghei NK 65 
infected T. O. mouse erythrocytes took up 55.82% - 2.3 
of the drug "specifically" as compared to 23.87 - 2.42 
for P.berghei RC strain. Uninfected T. 0. mouse 
erythrocytes showed a "specific uptake" of 40.24% * 6.18 
compared to 45.4%, + 3.0 for reticulocyte enhanced T. 0. 
mouse blood. Tables 11 & 12 show the variation in 
specific uptake of (^4C) chloroquine at varying initial 
drug concentrations in the medium (SBI).
Nonspecific uptake in chloroquine resistant P.berghei 
RC strain is almost twice that of chloroquine susceptible 
P.berghei NK 65. Figs 28, 29 and 30 are plots of uptake 
of drug against equilibrium free drug concentration (drug 
concentration left in medium, at the end of the experiment) 
for P.berghei NK 65, RC strain and uninfected erythrocytes 
respectively. Fig 31 shows specific uptake for the 
three models. Fig 32 is the "Scatchard" transformation 
(Scatchard, 1949) of specific uptake plots (Fig 31) 
from the slopes of the Scatchard plots, the dissociation 
constant (Kd) values for specific uptake are 1.0x10 mol/l 
for the NK 65 strain and 4.0x10 ^ mol/l for the RC strain. 
The intercept on the X axis shows that there is a sixfold 
difference in the total specific uptake of radiolabelled 
chloroquine, 3.4x10  ^mol/kg and 5.7 x 10 ^ mol/kg for 
P.berghei NK 65 and RC strains. This intercept 
(n) also represents the total receptor sites available 
for uptake. (Goldstein et al 1968, Klotz & Hunston, 1971).
TABLE 11. UPTAKE OF (14Ç) CHLOROQUINE BY RETICULOCYTE 
ENHANCED RED BLOOD CELLS.
Initial (14C) 
CQ concentra­
tion in 
medium 
(mol/1)
Uptake of
( 14c )
chloro­
quine
(pmol/kg)
Uptake
Ratio
Non-
Specific
uptake.
(¿imol/kg)
Specific
Uptake.
(umol/kg)
5.0 X 10~8 vOoo
+niH 43.2 0.71-0.09 0.59
Reticulocytosis was 60 %
Incubation was at 37°C for 45 min. in SBI 
with 5.0 mmol/1 D-glucose.
7o specific uptake = 45.4 - 3.0
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TABLE 12. VARIATION OF "SPECIFIC" UPTAKE OF (14C) 
CHLOROQUINE.
Initial (14C) CQ 
concentration in 
medium (mol/1)
"Specific" uptake (pmol/kg)
NK 65 RC Strain U R B C
1.25 x 10-7 6.62 + 0.15 2.89 - 0.12 0.70 - 0.05
6.25 x 10-8 3.23 - 0.15 1.88 - 0.33 0.56 - 0.10
3.125 x 10‘8 1.76 - 0.19 0.79 - 0.09 0.26 - 0.02
1.56 x 10"8 0.90 - 0.04 0.36 i 0.11 0.16 - 0.02
00 X O 1 vO 0.44 - 0.03 0.16 - 0.0 0.09 - 0.03
3.9 x 10-9
.
0.17 - 0.02 0.07 - 0.02 0.02 - 0.0
Values for specific uptake obtained by subtracting 
"non specific" uptake from total uptake.
% of specific uptake is 55.82 - 2.3 for NK 65, 23.87 - 
2.42 for RC strain and 40.24 + 6.18 for uninfected T.O. 
mouse erythrocytes (URBC).
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FIG .28 14Uptake of ( C) chloroquine over a range of free drug concentrations 
in P.berghei NK 65 infected T.O. mouse erythrocytes 
14
0  Total ( C) chloroquine uptake 
■  "non sp e c if ic "  (^C) chloroquine uptake
% Parasitaemia 59.25 t 14.46 (n = 8)
n = no. of mice/experiment ; points are mean of values from three 
experiments in  SB 1 .
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FIG.28
Uptake of (^C) chloroquine over a range o f free drug concentrations 
in P.berghei NK 65 in fected  T.O . mouse erythrocytes 
14
0 Total ( C) chloroquine uptake 
■  "non sp ecific"  (^4C) chloroquine uptake
X Parasitaemia 59.25 Î  14.46 (n = 8)
n = no. of mice/experiment ; points are mean of values from three 
experiments in SB 1 .
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FIG. 29
14Uptake of ( C) chloroquine over a range o f free drug concentrations 
in P.berghei RC stra in  infected T.O. mouse erythrocytes.
14
o Total ( C) chloroquine uptake 
• "non s p e c if ic "  (^ C) chloroquine uptake
Average % parasitaemia 31.5?0 . Points are mean of values from 
three experiments in SB1.
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FIG. 30 14
Uptake of ( C) chloroquine over a range of free drug concentrations 
in uninfected T.O. mouse erythrocytes.
A Total (^4C) chloroquine uptake 
A  "non sp e c ific"  (^4C) chloroquine uptake
Points are mean of values from three experiments in SB1
C)
 
CH
LO
RO
QU
IN
E 
"S
PE
CI
FI
C"
 
UP
TA
KE
 
(p
m
ol
/k
g)
177
EQUILIBRIUM FREE (14C) CHLOROQUINE (nmol/1)
FIG. 31
"Specific"uptake of ( 4^C) chloroquine over a range o f free drug 
concentrations in Plasmodium berghei NK 65 0  , RC stra in  o  and 
uninfected T.O. mouse erythrocytes A
"Specific"  uptake is  generated by subtracting non sp e c if ic  uptake 
from to ta l uptake
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FIG. 32
Transformation o f data shown in  F ig .31 to a "Scatchard" plot 
Intercept on Y axis = nk
Intercept on X axis = n, where k is  equivalent to a f f in i t y  constant
0  P.berghei NK 65 
© P.berghei RC stra in
Both lin e s  are Regression lin e s  with p^O.Ol .comparison of linear  
regression co e ffic ie n ts  by student t  test yielded no s ig n if ic a n t  
difference
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3.15 ENTRY OF (14C) - L - GLUCOSE INTO T. 0. MOUSE 
ERYTHROCYTES
Between the initial ( 4C) - L - glucose medium concentra-
-9 -7tion range of 4.0 x 10 - 5.0 x 10 mol/1, there
was no detectable uptake of L - glucose from the medium 
(SBI) into uninfected T. 0. mouse erythrocytes. There 
was however uptake of radiolobelled L-glucose into both 
P.berghei NK 65 and P.berghei RC strain infected 
erythrocytes. The cells: medium ratio was between 0.38 
and 0.9, hence there was no concentration of L-glucose 
by the erythrocyte parasite complex.
At an initial medium concentration of 5.0 x 10  ^mol/1
(14C) - L-glucose, only 0.181 ^imol/kg L-glucose was
-9 14taken up and at 4.0 x 10 mol/1 ( C) - L - glucose, only 
0.003 ¿imol/kg L-glucose was taken up by the infected 
T. 0. mouse erythrocytes. The ionophores Monensin,
Nigericin and Valinomycin did not affect uptake of 
L-glucose into infected T. 0. mouse erythrocytes. Similarly, 
ouabain (1.0x10 4mol/l), L-epinephrine and 5- hydroxytryp- 
tamine (2.0 x 10~^ mol/1) did not alter uptake of 
L-glucose.
Fig 33 is a semilog plot of the effect of Monensin on 
the uptake of chloroquine and L-glucose by P ,berghei 
NK 65 - infected erythrocytes.
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F ig.33
Effect of Monensin on the uptake of (^C) chloroquine and ( C) 
L-glucose by P.berghei NK 65 infected T.O. mouse erythrocytes.
A
A
Uptake of L-glucose in absence of Monensin
Uptake of L-glucose in the presence of 5.0 x 10  ^mol/1 
Monensin
© Uptake of (^C) chloroquine in absence of Monensin
m Uptake of (1 4 C) chloroquine in presence of 5.0 x 10 
Monensin
, - 7 3l/l
Average parasitaemia was 53?i
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3.16 UTILISATION OF D-GLUCOSE AND PRODUCTION OF L( + )
LACTATE BY T. 0. MOUSE ERYTHROCYTES.
Unfortunately the assay system used for determination 
of D-glucose was not sufficiently sensitive in the 
concentration range utilised for the experiments (0.5 - 
5.0 ¿imol/ml). Results obtained from experiments to 
determine glucose utilisation varied widely and the 
reason for the inconsistency could not be detected.
However, the lactate assay was sensitive and was thus 
used as an indirect measure of glucose utilisation.
Fig 34 shows the similarity of production of 
L-( + )-lactate in both P.berghei NK 65 and RC strain 
infected T. 0. mouse erythrocytes. L-(+)-lactate produc­
tion was linearly related to initial glucose concentration 
in both strains from 0.5 to 2.0 ^imol/ml. At low D-glucose 
concentration (0.5 jamol/ml), up to 85.7% of D.glucose 
utilised, could be accounted for by L-(+)lactate production 
while at high D-glucose concentration (5.0^unol/ml) only 
about 407o D-glucose utilised could be accounted for by 
L(+) lactate production. (2 molecules of lactate produc­
tion by glycolysis of 1 molecule of glucose - see 
Homewood, 1978). However, variations in these results 
were quite wide as mentioned above.
Monensin (2.0*10_7mol/i) had only a small effect on 
L(+) Lactate production. Thus for P.berghei NK65 infected 
erythrocytes, the maximum L(+) lactate produced after 
30 minutes incubation in the presence of 5.0 ^imol/ml D- 
glucose was 0.79 - 0.03 pmol/ml and for P.berghei RC 
strain infected T. 0. Mouse erythrocytes 0.81 - 0.04
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pmol/ml. In 
produced was 
P.berghei NK 
erythrocytes
the presence of Monensin, L-(+)-lactate 
0.76^0.02 and 0.67^0.04 pmol/ml for 
65 and RC strain infected T.0. mouse 
respectively.
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3.17 PROTON EFFLUX INDUCED BY IONOPHORES.
Results obtained showed that there was no detectable 
efflux of H+ from uninfected erythrocytes in the absence 
of D-glucose in the medium; on the otherhand, there was 
a steady but slow efflux of H+ from both P.berghei NK 65 
and RC strain infected erythrocytes. On addition of 
20 mmol/1 D-glucose (final concentration), both infected 
and uninfected erythrocytes showed a marked efflux of H+ . 
The glucose stimulated efflux of H+ was in the order 
P.berghei NK 65>RC strain>Uninfected T. 0. mouse 
erythrocytes. Computation of initial rates of H+ efflux 
showed that NK 65 strain had a relative H+ efflux of 
3.0 by the 1st minute of addition of 20 mmol/l D-glucose 
while RC strain had a relative H+ efflux of 2.0 in the 
1st minute and uninfected T. 0. mouse erythrocytes 1.0. 
(Relative H+ efflux here was computed by calculating 
the slope of the curve produced on the printout per 
minute, calculated and expressed as^pH x 50 per minute, 
since 100 mm on the printout was equivalent to 2 pH 
units i.e. 1 unit on the ordinate (relative H+ efflux) 
is equivalent to 0.02 pH units).
After about 5 minutes, the D-glucose induced H+ efflux 
levelled at 1.0 for both NK 65 and RC strains and zero 
for uninfected T. 0. mouse erythrocytes.
On addition of 5.0 X lO-7 mol/1 Monensin, there was a 
rapid efflux of H**", peaking at a value of 14.0 for 
NK 65 infected erythrocytes (14.0- 2.0) and 13.0 for 
RC strain infected and uninfected erythrocytes (13.0-1.5)
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A similar effect was observed when Nigericin was used 
in 154 mM KC1 solution.
Fig 35 is a copy of typical results obtained from the 
potentiometric flatbed recorder.
Fig 36 is a graphical transformation of the recording.
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Fig. 35
10 20
TIME (min)
(A)
(B)
(C)
Effect of ionophores on H+ efflux recorded by potentiometric 
fla t bed recorder.
pH changes recorded as % after calibration  between pH range 
6 - 8  equivalent to 0 - 100. (ie. 100 = 2pH units, 1 = 0.02 pH units)
Erythrocytes were equilibrated in appropriate medium for 10 min. 
before the addition of 10 pi D-glucose 20 mmol/1 ( f irs t  arrow), 
lonophores were added 1 0 minutes later (second arrow).
Effect of 10p i Monensin (5.0 x 10_7mol/l) on H+ efflux by P.berqhei 
RC strain infected T.0. mouse erythrocytes in 154 **»«*i*\/t Nla-CV
Effect of lO p l Monensin (5.0 x 10"^mol/l) on H+ efflux by uninfected 
T.0. mouse erythrocytes (URBC) in  154 mmol/1 NaCl.
Effect of lO p l Nigericin (5.0 x 10“^mol/l) on H+ efflux by unifected 
T.0. mouse erythrocytes in 143 mmol/1 kCl and 12 mmol/1 NaCl.
(D) Effect o f 10 p i Monensin (5.0 x 10- 7mol/l) on H+ efflux by P.berqhei MX65 
infected T.0. mouse erythrocytes in  154 mmol/1 NaCl.
Concentrations given are final concentrations.
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Fig. 36
Effect of Monensin on rate of H+ efflux from T.O. mouse 
erythrocytes.
q  Efflux from P.berghei NK 65 infected T.O. mouse 
erythrocytes"
A Efflux from uninfected T.O. mouse erythrocytes.
+ Control, no erythrocytes present in medium.
The relative H+ efflux is  generated from the slope of the 
curve produced on the print out (fig.35)with units A  pH x 50/min.
D.Glucose (20 mmol/1) and Monensin in (5.0x10-7mol/l)were added at 
the times indicated by arrows.
3.18 INTERNAL pH (pHi) of T. 0. MOUSE RED BLOOD CELLS 
Table 13 summarises the variation of the plasma and 
internal pH of T. 0. mouse red blood cells. The result 
shows that the intracellular pH is appreciably lower 
than the extracellular pH. The mean plasma pH obtained 
was 7.50 for uninfected T. 0. mouse. 7.45, for P.berghei 
NK 65 infected T. 0. mouse and 7.41, for P.berghei RC 
infected T. 0. mouse. (In preliminary experiments, it 
was also found that the mean plasma pH could go down to 
as low as 6.90 if CO^ was used as the anaesthetic)
The intracellular pH values obtained were 7.10, 6.9 
and 6.84 for uninfected, P.berghei NK 65 and RC infected 
T. O. mouse red blood cells respectively. The average 
intracellular pH (pHi) was thus in the order URBC^NK 65> 
RC strain. Though the average intracellular pH of the 
chloroquine sensitive, P.berghei NK 65, infected T. 0. 
mouse red blood cell is slightly higher than the 
resistant one (P.berghei RC), both values were about 0.2 
pH units lower than that for uninfected erythrocytes 
(0.16^0.01) and 0.55 pH units lower than the plasma 
(0.56- 0.01).
189
Table 13. VARIATION OF EXTERNAL AND INTERNAL pH OF 
T. O. MOUSE RED BLOOD CELLS
Strain
Mean*
plasma
pH.
Mean 
Intrace­
llular 
pH (pHi) A PH
Calculated
AH*- at
pH 7.4(mol/l)
Ratio of 
(H+)
(URBC =1.0)
URBC 7.50 7.10 -0.4 3.2x10 1.0
NK 65 7.45 6.90 -0.55 8.62xl0-8 2.2
RC 7.41 6.84 -0.57 10.47X10-8 2.7
( H*) calculated from equation pH = -log ( H+)
* Mean of 3 experiments involving 10 mice per strain 
per experiment, with similar S.D * 0.1 for plasma pH 
and 0.05 for intracellular pH.
Average % Parasitaemia of NK 65 infected red blood cells 
was 60%.
Average % Parasitaemia of RC infected red blood cells was 
40%.
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CHAPTER 4
4. DISCUSSION
4.1 CHARACTERISTICS OF INFECTIONS OF P. BERGHEI
IN T.O. MOUSE AND RELATIONSHIP TO CHLOROQUINE 
UPTAKE.
Results obtained from this project confirm 
that distinct characteristics are exhibited by 
infections of P. berghei NK 65 and RC strains in 
T.O. mice. Changes in the packed cell volume (PCV) 
showed that there is a greater degree of anaemia in 
mice infected with P. berghei RC strain than by NK 
65 strain. Table 1 shows that while NK 65 infected 
T.O. mouse blood had a PCV of 0.23 0.01, the RC
strain infected T.O. mouse blood had a PCV of
O. 172 - 0.04; even though the parasitaemia was less. 
These results confirm part of the work of Palecek
et al (1967). Similarly, variation of the mean 
cell volume of the infected blood cells confirmed 
the association of the chloroquine-resistant RC 
strain with obligatory development in immature 
large red cells. As shown in Table 1, the mean 
cell volume of P. berghei RC strain infected cells, 
corresponded to that of phenylhydrazine-induced 
reticulocytes (63.0 ¿im^ and 65.0 respectively).
P. berghei NK 65 infected blood cells, however, 
had about the same mean volume as those of the
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The rate of development of parasitaemia, 
showed that P. berghei RC strain infection was 
less severe than that of P. berghei NK 65. After 
inoculation of one million parasitised cells intra- 
peritoneally, the NIC 65 strain attains a parasitae­
mia of 27o in about 2.4 days while the RC strain 
takes about 5.4 days. Moreover, within 7 days of 
infection, a fulminating infection of NK 65 strain 
results, with parasitaemia exceeding 80%. This is 
in contrast to the gradual increase of parasitaemia 
of the RC strain, which attains maximal parasitae­
mia of 40% by the 14th day. After this period, 
destruction of red cells is so pronounced that the 
estimated degree of parasitaemia becomes unreliable, 
though the mouse usually dies within the third week.
The accumulation of chloroquine in vitro was 
found to be directly proportional to the degree of 
parasitaemia. At the same parasitaemia, the chloro­
quine resistant strain took up the same amount of 
drug as the sensitive strain. Total uptake of 
( 14C) chloroquine by P. berghei RC strain infected 
erythrocytes, was found to fit the linear regress­
ion line drawn for uptake of radiolabelled drug by 
P. berghei NK 65 infected erythrocytes. The
u n i n f e c t e d  n o r m a l  T . O .  m o u s e  ( 4 0  p m ^  t o  4 6 . 0  p m  3 ) .
similarity in the total uptake of chloroquine 
(after correction for degree of parasitaemia) is 
interesting and appears to agree with the obser­
vation of Warhurst (1965b) that "Resistance to 
chloroquine and quinacrine in P. berghei does not 
appear to be related to changes in drug uptake by 
the cell...... "
Previously, variations in the morphology of chloro- 
quine-resistant P. berghei had been reported.
Peters (1965d) showed that there were up to nine 
food vacuoles in the chloroquine resistant RC 
strain as compared to a single food vacuole in 
P. berghei NK 65. Moreover, there was proliferat­
ion of multilamellate whorls of membranes.
Rudzinska et al (1965) tried to attribute a meta­
bolic function to both the multilamellate whorls 
of membrane and the increased food vacuoles, but 
there has been little evidence to support this 
suggested mitochondrion-like function. Howells et_ 
al (1968a) have also shown the lack of typical 
malaria pigment grains of P. berghei in the chloro­
quine resistant RC strain but correlated this 
observation with the growth of the parasites in 
immature host cells.
Though there are differences in the character
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istics of infection and morphology between the drug 
sensitive and resistant strains, the results 
obtained show that there is similarity of total 
uptake of radioactive chloroquine in vitro.
Analysis of this total uptake into specific (high 
affinity) and nonspecific (low affinity) components, 
shows that there are differences in the specificity 
of uptake of drug in vitro between the sensitive and 
resistant strain. This difference in specificity 
of uptake will be discussed more fully later.
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4.2 TIME COURSE OF UPTAKE OF (14C) CHLOROQUINE.
The time course of uptake of radiolabelled chloroquine by 
infected and uninfected erythrocytes (Fig 15) is similar. 
It is evident that there is an initial rapid 
uptake followed by a slow increase to a saturation 
value in 40 - 45 minutes. It is probable that at 
the saturation value, a state of equilibrium exists 
between the drug left in the medium and the drug 
taken up by the erythrocytes.
From the slopes of the linear portion of the 
graphs, it is also evident that P. berghei infected 
erythrocytes accumulate radiolabelled chloroquine 
at an initial rate 10 times that of uninfected 
erythrocytes; even though saturation appeared to be 
attained uniformly. Because of the uniformity in 
attainment of equilibrium, it was decided to adopt 
45 minutes as the standard time for incubation dur­
ing experiments.
However, it is important to note that the 
attainment of equilibrium will be affected by a 
number of parameters including the final concen­
tration of drug in the incubating medium, the temp­
erature of incubation, the density of erythrocytes 
in the incubation medium etc. In this project, it 
was ensured that conditions of the experiments were
kept constant and varied only when necessary. It 
is possible that variation in these parameters 
could have lead to other investigators obtaining 
higher equilibrium times. For example, Polet and 
Barr (1969), using an incubation medium of Hanks' 
salt solution with 10% dialysed human serum found 
that after 3 hours, the amount of tritiated chloro- 
quine remained about constant. Fitch, (1969) 
using an incubation medium consisting of the follow­
ing (mmol/1) : NaCl, 25, KC1 4.8, MgSO^, 1.2; 
glucose 80; and Na2HP04, 50; at 22°C, found a 
saturation time of about 60 minutes.
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4.3 INFLUENCE OF IONIC COMPOSITION OF INCUBATION
MEDIUM ON UPTAKE OF CHLOROQUINE IN VITRO.
Tables 2 and 3 showed that the variation of 
Na+ and K+ composition of the incubating medium had 
little effect on the uptake of radiolabelled drug 
by P. berghei NK 65 but appreciably affected drug 
uptake by both uninfected and P.berghei RC infected 
T.O. mouse erythrocytes. This effect was reflected 
in a reduction of the "carrier coefficient" of the 
drug uptake system in uninfected and P. berghei RC 
strain infected erythrocytes. The significance of 
this differential effect, might lie in variations 
in the drug pools within the various compartments 
of the erythrocyte-parasite complex. It is inter­
esting to compare this effect with the observation 
that high concentration of K+ releases norepine­
phrine bound by rat brain tissue fractions 
(Baldessarini and Marcella, 1971). Though the 
relationship of this observation to the inhibitory 
effect of high K+ concentration on uptake of ( ^C) 
chloroquine in erythrocytes in vitro is not quite 
clear now, it would appear that ionic interactions 
play a major role in the availability of free 
(unbound) chloroquine in the erythrocyte cytoplasm, 
(see for example Phifer et al, 1966; Kramer and 
Matusik, 1971 and Yuthavong 1980).
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It is known that changes in external concen­
trations of K+ affect the functioning of the enzyme 
Na+/ IC1" ATPase and this requirement for K+ has to be 
fulfilled from the exterior of the membrane 
(Whittam, 1962). Moreover, experiments with 
Ouabain (Na+/K+ ATPase inhibitor - Skou, 1960) 
showed that in the presence of this compound 
(1.0 x 10 ^ mol/1) uptake of radiolabelled drug 
into both uninfected and infected T.O. mouse 
erythrocytes was partially inhibited. The possible 
involvement of Na+/K+ ATPase in the uptake of )
chloroquine is not quite clear, but it would appear 
that proper functioning of the enzyme is necessary 
for adequate regulation of the metabolism of the 
red cell. Since inhibitors of metabolism also 
inhibit chloroquine uptake, (Polet and Barr, 1969, 
Fitch, et al 1979) alteration of the metabolic 
status of the red cell by inhibition of Na+/K+ 
ATPase would affect drug uptake. It is important 
to note however, that ouabain does not completely 
arrest glycolysis, indeed the inhibition of ion 
transport in red cells by cardiac glycosides has 
been shown to have an ATP sparing effect (Davis, 
1973) Moreover, the observation by Fitch and 
coworkers (Fitch et al 1974c) that there was an 
inverse relationship between the amounts of ATP in 
infected erythrocytes and ability to accumulate
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chloroquine from dilute solutions, further high­
lights the probability that the linkage of ATP to 
drug uptake might not be a direct one, but maybe 
via some other metabolism dependent factor which 
is partially vulnerable to ouabain.
The absolute depression of uptake due to 
ouabain is greater in P. berghei infected T.O. mouse 
erythrocytes (1.01 and 0.7 5 umol/kg for RC strain 
and NK 65 respectively as against 0.27 jumol/kg for 
uninfected T.O. mouse) and it might be that active 
Na'1/' K+ ATPase favours uptake of( ^ C) chloroquine 
into erythrocytes and from the erythrocyte cyto­
plasm into the parasite. However, Warhurst and 
Thomas (1978) found no effect of ouabain on chloro­
quine induced pigment clumping (CIPC); this indi­
cates that any effects of ouabain on drug uptake 
are related to the erythrocyte compartment.
It might be important at this stage, to make 
some comments on the uptake ratios obtained in some 
experiments, especially in Tables 2 and 3. see also 
tables 4, 5 and 6. Since the calculated uptake of 
drug is dependent on the percentage of erythrocytes 
parasitised (See Figs 16 and 17), the uptake ratio 
will thus vary and will increase with increasing
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parasitaemia, since less drug will be left in the 
medium. This observation might account for the 
rather high uptake ratios obtained in Tables 2 
and 3.
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4.4 ROLE OF D-GLUCOSE IN UPTAKE OF (14C) 
CHLOROQUINE
(*^C) Chloroquine uptake is enhanced by 
D-glucose in both P. berghei NK 65 and RC strain
infected red blood cells but^does not enhance 
uptake in uninfected T.O. mouse erythrocytes. It 
has been suggested by Fitch and coworkers, that 
the role of D-glucose was to provide energy to 
unmask receptors. The unmasking of receptors 
involved the digestion of haemoglobin (proton dep­
endent) releasing the high affinity receptor con­
sidered to be ferriprotophorphyrin IX (haemin)
(Chou et al 1980). Another role of energy was put 
forward by Warhurst and Thomas (1978) and involved 
the translocation of drug, together with a proton, 
into the parasite, under the influence of a proton- 
gradient maintained by a membrane located energy- 
dependent , proton pump.
It is thus generally agreed that the crucial 
role of D-glucose utilisation was the provision of 
protons or generation of proton gradients which in 
some way modulated drug uptake. However, as shown 
by the production of L-(+)-lactate (Fig 34), both 
P. berghei NK 65 and RC strain infected erythro­
cytes utilise D-glucose via the glycolytic cycle
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to the same extent, but D-glucose does not stimu­
late chloroquine uptake in P. berghei RC strain 
infected erythrocytes as much as in P. berghei 
NK 65 infected erythrocytes. It would thus appear 
that D-glucose stimulates only the component of 
overall drug uptake, which is reduced in P. berghei 
RC infected erythrocytes. Moreover, the marked 
inhibition shown by high concentrations of D-gluc­
ose in P. berghei NK 65 (Fig 18a) and by 2-deoxy- 
D-glucose (Fig 18b), emphasises the tighter link­
age of energy to drug uptake in the chloroquine 
sensitive P. berghei NK 65 strain than in the drug 
resistant RC strain.
It is known that in bacteria, uptake of sub­
strates via membrane carriers can be facilitated 
by a proton gradient (low H+ concentration inside, 
higher concentration outside) maintained by membrane 
proton pumps (Harold, 1977). Examples include 
symport of sugars and amino acids with one or more 
protons, symport of anionic metabolites and the 
extrusion of sodium and calcium by antiport with 
protons (Simoni and Postma, 1975) Symport refers 
to metabolite transport coupled to that of 
another ion in the same direction, while antiport 
is in the opposite direction. Also in the 
eukaryote fungus Neurospora uptake of glucose is
202
by symport with protons (Slayman and Slayman, 1974). 
If uptake of D-glucose into plasmodia is controlled 
by protons, then the inhibition of chloroquine 
uptake in vitro by high concentrations of D-glucose 
can be explained by the excessive inflow of 
protons into the parasite brought about by the 
inward passage of glucose and protons in symport. 
However, 3-0-methy1-D-glucose which utilises the 
same transport system as D-glucose (Teh, 1975,
Regan and Morgan, 1964) does not appreciably 
inhibit uptake of radiolabelled chloroquine suggest­
ing that this may not be the mechanism of inhibition 
by high concentrations of D-glucose.
It is however possible that.as high concen­
trations of D-glucose enter the cell, glucose is 
rapidly phosphorylated thereby causing a precipi­
tous drop in cellular ATP which would otherwise 
have been utilised (by ATPase) to generate the 
protons necessary for drug uptake. This indeed 
might be the case, since O-methyl-D-glucose is not 
known to be phosphorylated appreciably (Schneider 
and Wiley, 1971, Scarborough, 1970) and does not 
inhibit chloroquine uptake. Also, deoxy-D-glucose 
which inhibits drug uptake, uses a tremendous 
amount of ATP for its own phosphorylation (Detwiler, 
1971) and does not replace the lost ATP, since
203
deoxy-D-glucose does not completely go through the 
glycolytic sequence as deoxyglucose phosphate but 
inhibits the phosphohexose isomerase reaction, 
which is the next reaction in glycolysis after the 
phosphorylation of glucose.
However, since an appreciable amount of 
chloroquine is taken up by both uninfected and 
infected erythrocytes in the absence of D-glucose 
in the incubating medium, in vitro, it is most prob­
able, that only "specific uptake" by the parasite 
(see later) is activated by additional D-glucose 
in the incubating medium. This contention is fur­
ther supported by the equivalence of % specific 
uptake to % activation of drug uptake by D-glucose 
in P. berghei NK 65 (55.82% specific uptake and 
65%activation), and (23.87% specific uptake com­
pared to 19% activation) in P. berghei RC infected
erythrocytes. (Tables 5,6 and 11).
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4.5 UPTAKE OF L-GLUCOSE BY T.O. MOUSE ERYTHROCYTES
Uninfected erythrocytes do not accumulate 
(•^C ) L-glucose but on infection with P. berghei 
an appreciable permeability to (^C ) L-glucose is 
found with uptake being proportional to medium 
L-glucose concentrations (Fig 33). This confirms 
previous findings on the alteration of the permea­
bility of erythrocytes on being infected with 
P. berghei (Homewood and Keame,’ 1974, Neame, 
et al, 1975) and with Babesia rodhaini
(Homewood et al, 1975).
The uptake of L-glucose by P. berghei infect­
ed T.O. mouse erythrocytes was not concentrative 
and was not affected by Monensin (Fig 33), Nigericin, 
Valinomycin, Epinephrine or 5HT. These results 
indicate that the altered membrane permeability 
that has given rise to the uptake of L-glucose by 
infected erythrocytes, is not responsible for 
increased chloroquine uptake.
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4.6 VARIATIONS IN INTRACELLULAR pH OF T.O. MOUSE
RED BLOOD CELLS.
The H+ concentration of a cell plays an 
important role in the uptake of chloroquine into 
that cell. Rollo (1968$ had speculated that the 
average intracellular pH of the aqueous compart­
ment in a parasitised erythrocyte is below that 
of the exterior fluid and that basic drugs such as 
chloroquine are concentrated by passive diffusion 
into these acidic regions and bound there by comp­
onents of the cell matrix.
Results from experiments to determine the 
intracellular pH of uninfected and P. berghei 
infected erythrocytes, show that the average intra­
cellular pH values of NK 65 and RC strain infec­
ted erythrocytes are 0.2-0.26 units lower than 
uninfected erythrocytes and 0.55-0.57 units lower 
than the plasma. (Table 13). The intracellular pH 
of uninfected T.O. mouse erythrocytes is 0.4 pH 
units less than the pH of plasma. These results 
show that there is a pH gradient, in favour of the 
red cell interior (ie red cell interior acidic). 
These results appear to be in conflict with the 
work of Williams and Fanimo (1974) using rat blood 
infected with P. berghei who found that "The
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intracellular pH of both the parasitised populations 
(chloroquine sensitive and resistant strains), 
however is somewhat greater than that of the unin­
fected cells." The reason for this discrepancy, 
may lie with the methods used in assessing intra­
cellular pH. Williams and Fanimo used the distri­
bution of the weak acid 5, 5-dimethyloxazolidine-2, 
4-dione (DM0) after equilibration in vitro with 5%
CO2 in air. During preliminary experiments, it 
was found that merely anaesthetising the mice in 
CO2 leads to a decrease in both the plasma pH and 
the intracellular pH. Because of this, CO2 was 
not used in these experiments to determine intra­
cellular pH using micro glass electrodes.
Sanslone and Muntwyler (1964) using a method 
similar to that of Williams and Fanimo, working 
with Wistar rats, found an extracellular pH of 7.4 and 
an intracellular pH of 7.16 for uninfected normal 
Wistar rat. This result thus shows that a pH gradient 
of at least - 0.24 exists in Wistar rat red blood cells.
However, Battaglia and Behrman (1965) have 
critised the use of silicon oil during determina­
tion of intracellular pH, as pH might be slightly 
higher due to loss of CO2 through the oil; though 
valid, this criticism would tend to lend weight to
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the result obtained here that a pH gradient of 
about - 0.4 exists between the plasma and intra­
cellular pH; since loss of CO2 from the red cell 
cytoplasm would have led to higher intracellular 
pH. However, it would appear reasonable that 
loss of CO2 from the plasma would correct for 
corresponding loss of CO2 from the red cell. How­
ever, if the loss of CO2 from the plasma far out­
weighs the loss from the red cell, then the plasma 
pH obtained could be higher than the pH in vivo.
These constraints not withstanding, the 
method of determining intracellular pH by micro- 
glasselectrode after freezing and thawing, is a 
well established method (Waddel and Bates, 1969) 
and the adaption here is suited for the comparison 
of pH between two different red cell populations.
However, the calculated ^ H+ at 7.4 (Table 12) 
shows that the ratio of A H + , is 1:2:2.7 (URBC :
NK 65 : RC strain), it is important to note that 
calculation of H+ concentration by taking the 
reciprocal of the antilog of the pH value; only 
gives a comparative amount of "relative acidity" 
and "makes no statement about absolute hydrogen 
ion concentration" (Waddell and Bates, 1969).
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Though the results obtained here also differ 
from those of Williams and Fanimo in showing that 
a pH gradient exists between the infected red cell 
interior and exterior, we are in agreement that 
the mean intracellular pH values of erythrocytes 
parasitised with either sensitive or resistant 
strains of P. berghei are very similar.
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4.7 THE ROLE OF PROTON GRADIENTS IN UPTAKE OF
CHLOROQUINE.
4 aminoquinolines, have been demonstrated 
to have the greatest basicity among the various 
mono-amino derivatives of quinoline. The 
enhanced basicity (attraction for protons) was 
attributed to the stabilization of the cation 
formed on acceptance of protons. (Irvin and 
Irvin, 1947). At physiological pH, monoproton- 
ated and diprotonated forms will predominate. 
Indeed calculation of the percentage of chloro­
quine ionized using the pKaand pH values (8.06, 
10.16 at pH 7.0) show that the three states exist 
in the following proportions.
The diprotonated form is not permeable 
through membranes and hence only the unprotonated 
and monoprotonated forms can cross membranes 
by virtue of the partition coefficient (oleyl- 
alcohol/water) of 9 at pH 7.0 (Warhurst and 
Mallory, 1973). Having passed through the mem­
brane, these species can traverse back into the 
exterior unless they are further protonated.
Hence H+ in the cytoplasm may play a predominant
CQ
0.03%
^  CQH+ ^  CQ2H+ 
16.6% 83.37%
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role in "trapping" chloroquine within the red 
cell cytoplasm. Note also, that proteins and 
other macromolecules (eg nucleic acids) will 
also "trap" various ionised species especially 
the diprotonated and dipolar forms which can 
interact with charges on macromolecules.
However, calculation of/^H+ (Table 12) gen­
erated at pH 7.4 show that the total internal 
excess concentration of protons available (as 
reflected by pH) is only in the range 0.3 - 
1.0 x IQ"7 mo 1/1; which is not sufficient to 
account for total uptake into infected erythrocytes. 
Moreover, the distribution ratios obtained using 
equation (6), show that only uptake ratios of 
2.31 t 0.14, 3.04 t 0.1 and 3.5 - 0.2 can be 
obtained for uninfected, P. berghei NK 65 and RC 
infected T.0. mouse erythrocytes respectively.
These ratios do not correspond to the obser­
ved distribution ratio for these three models. 
However, since increase in the pH of red cell 
cytoplasm (using ionophores) leads to dose depen­
dent decrease in drug uptake into erythrocytes, 
there is no doubt that at least a proportion of 
drug uptake is intimately linked to the H"*" status
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of the cell. For P. berghei - infected T.O. mouse 
erythrocytes, extra H+ needed to support higher 
uptake of chloroquine might possibly be generated 
by a proton pump, either by sequestration of H+ 
per se (say into lysosomes), or by efflux of 
metabolic endproducts in symport with protons - 
an example of which is the generation of an 
electrochemical proton gradient by lactate efflux 
in membrane vesicles of Escherichia coli (Brink 
and Konings, 1980).
It is clear that proton motive force can be 
used by cells to drive energy consuming processes 
such as secondary solute transport, ATP synthesis 
(Mitchell, 1966) or motility (flagellar motion - 
Manson et al 1977). Whether malaria parasites 
utilise proton gradients in these ways is presently 
not clear and requires further studies.
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4.8 IONOPHORES AND (14Q  CHLOROQUINE UPTAKE.
The carboxylic polyether ionophores, Monensin 
and Nigericin are capable of transporting mono­
valent ions across cell membranes down their 
concentration gradients. Monensin is 10 times 
more selective for Na+ than K+ , while Nigericin 
is 45 times more selective for K"1" than Na+ ; 
charge differences on either side of the membrane 
are not affected as H+ is exchanged for Na+ or 
K+ respectively (Pressman, 1976).
Monensin and Nigericin inhibit (*^C) chloro­
quine uptake, 50% inhibition being shown in med­
ium concentrations of 1.0 x 10“  ^ - 1.0 x 10"^ 
mol/1 depending on the external Na+ concentration 
for Monensin and external K+ concentration for 
Nigericin. (Figs 19-22). Complete inhibition was 
not seen at non-lytic concentrations. Measure­
ments of relative proton efflux (Figs 35 and 36) 
confirm that Monensin (in high Na+ medium) and 
Nigericin (in high K+ medium) cause a marked 
efflux of H+ from uninfected and P. berghei infec­
ted T.O. mouse erythrocytes. This depletion of 
internal H+ may be related to their inhibitory 
effect on drug uptake.
The effect of these ionophores is specific. 
If the relevant mediating ion is changed, the 
inhibition of the ionophore is dramatically re­
duced. For example if Na+ is replaced by K+ in 
the incubating medium, the inhibition of drug 
uptake caused by 5.0 x 10“  ^mol/1 Monensin drops 
from over 50% to 25%. Similarly, if K+ is 
replaced by Na+ , the inhibition of drug uptake 
caused by 2.0 x 10"^ mol/1 Nigericin is reduced 
from 50% to 12%.
Inhibition of chloroquine uptake by these 
ionophores is noncompetitive (Fig 25) and hence 
these agents are unlikely to be linking to chloro 
quine binding sites. Furthermore, the Na+/K+ 
ATPase inhibitor ouabain alleviates the inhib­
itory effect of Monensin in both uninfected and 
infected T.O. mouse erythrocytes in SBI, while 
increasing the inhibitory effect of Nigericin in 
P. berghei NK 65 infected erythrocytes in K+ 
enhanced buffer.
This differential effect of ouabain, is 
dependent on the ionic composition of the incubat 
ing medium. In high Na+ buffer (SBI), ouabain 
alleviates the inhibitory effect of Monensin 
probably by causing the intraerythrocytic sodium
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concentration to be increased (as a result of 
UaV K+ ATPase inactivation) thus reducing the 
amount of intracellular H+ exchanged for sodium 
from the medium. In high K+ buffer, ouabain 
slightly increases the inhibitory effect of 
Nigericin in P. berghei NK 65 infected erythro­
cytes, but has no effect on the inhibition by 
Nigericin in uninfected or P. berghei RC infect­
ed erythrocytes. The slight potentiation of the 
inhibition of Nigericin in P. berghei NK 65 is 
as expected, since Nigericin is specific for K"1" 
and accumulation of Na+ due to ouabain inhibition 
would not be expected appreciably to reverse the 
effect of Nigericin. The situation with RC
strain is more complicated, especially since14high external K^per se .inhibits ( C) chloroquine 
uptake in RC strain infected and uninfected 
erythrocytes.
These results show that in the presence of 
sodium in the external medium, Monensin would 
raise intraerythrocytic pH and inhibit drug up­
take, while Nigericin in the presence of K"*" in 
the medium will have a similar effect. It thus 
appears that chloroquine accumulation in T.O. 
mouse erythrocytes is partially dependent on an 
electrochemical proton gradient (Z5J3h+ ) across
the red cell membrane (internal acidic). Indeed 
results from measurement of intracellular pH of 
red blood cells show that such a proton gradient 
exists.
The electrochemical proton gradient consists 
of an electrical parameter, the membrane potential 
(A"V) an<3 a chemical parameter, the pH difference 
across the red cell membrane (^pH)
A/UH+ = A"V - ZL pH
where Z = 2.3 RT , F is the Faraday, T is temper- 
F
ature in degrees Kelvin, R is the gas constant. 
(Mitchell, 1966).
However, from results of experiments using 
the electrogenic ionophore valinomycin (Tables 8,
9 and 10) it would appear that A pH is the major 
determinant of chloroquine uptake by uninfected 
T.O. mouse erythrocytes, not A Y *
It is likely that a second electrochemical 
proton gradient exists across the limiting mem­
branes of the intracellular P. berghei parasites 
(probably with internal parasite pH greater than 
erythrocyte cytoplasm pH). If this is true, then
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a membrane potential (internal - ve) could regul­
ate the uptake of drug from the erythrocyte into 
the parasite. Whether the parasite membrane 
potential plays a significant role in the uptake 
of chloroquine from the red cell cytoplasm into 
the parasite is not clear and requires further 
study. However, the diminished inhibition of 
Monensin in the presence of ouabain (Tables 8,
9 and 10) could be interpreted to be due to relief 
of the effect of Monensin on membrane potential, 
since Monensin has no effect on membrane poten­
tial in the presence of ouabain (Lichtshtein, et al
1979). If this is true, then, the results obtained
14from the interaction of ionophores with ( C ) 
chloroquine uptake suggest that chloroquine 
accumulation into P. berghei infected T.O. mouse 
erythrocytes can occur in the presence of either 
a transmembrane proton gradient, or a transmem­
brane potential gradient, and that maximal uptake 
is achieved when both components of the proton 
motive force are present.
It would appear that the inhibitory effect 
of high K+ concentration on uptake of (14C ) 
chloroquine further suggests a role for a trans­
membrane potential gradient (internal - ve),
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since excess K+ in the medium would tend to re­
duce the transmembrane potential gradient by 
slowing down outward leakage of K+ . However, a 
proper interpretation of the role of a transmembrane 
potential gradient is hindered by the multicom- 
partmentation of the erythrocyte/parasite complex. 
For example, it is probable that part of the 
uptake of drug is regulated by the lysosome - a 
highly acidic organelle. Similarly, it is prob­
able that part of the effect of electroneutral 
ionophores (monensin, nigericin) can be mani­
fested on the lysosomes by depletion of hydrogen 
ions within the lysosomes. Especially since 
excess hydrogen ions in the lysosomes can trap 
chloroquine within that organelle by protonation 
of the monocation species into the non permeable 
dication species. Further work on the distribution 
of chloroquine within various organelles is need­
ed in order to confirm the role of the lysosome 
as the major reservoir for chloroquine taken up 
by the parasite; since chloroquine is already 
known as a lysosomotropic drug (De Duve et al 1974).
4.9 INTERACTION OF BIOGENIC AMINES WITH (14C) 
CHLOROQUINE UPTAKE IN VITRO.
The biogenic amines L-epinephrine and 5- 
hydroxy tryptamine, showed similar inhibition of 
chloroquine uptake in uninfected and P. berghei 
infected T.O. mouse erythrocytes. It is inter­
esting that the inhibition due to these biogenic 
amines at a medium concentration of 200 nmol/1 
was 0.62 1" 0.10 ¿jmol/kg for all three models.
The implication of the similarity in inhibition 
is probably that the same component of drug uptake 
is being affected. Since the erythrocyte compart­
ment is the only compartment common to all three 
systems, it seems logical, to propose that the 
effect of L-epinephrine and 5HT is purely on the 
erythrocyte compartment. Further evidence 
supporting this proposal is from the observation 
that L-epinephrine had no inhibitory effect on 
chloroquine induced pigment clumping (Warhurst 
and Thomas, 1975) a phenomenon which occurs within 
the parasite. Recently, Warhurst (personal comm­
unication) has also observed that 5HT did not 
inhibit chloroquine induced pigment clumping.
Analysis of the kinetic data obtained from 
double reciprocal plots of epinephrine inhibition
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ofC^C) chloroquine uptake (Fig 25) show that the 
inhibition caused by L-epinephrine is competitive 
and has a KA value of 1.0 - 2.0 x 10-7 mol/1.
This value is similar to the value of 
3.8 x IQ"7 mol/1 found by Warhurst and Thomas 
(1975), for the competitive inhibition of chloro­
quine induced pigment clumping by the lipophilic 
^-blocker dichloroisoproterenol. The competitive 
nature of the inhibition of drug uptake by epine­
phrine, might suggest that L-epinephrine is 
probably accumulated into erythrocytes via the 
same mechanism as chloroquine.
There is further evidence in other systems of 
relationship between chloroquine and biogenic 
amines. It has been known for some time that the 
mechanism of supersensitivity to catecholamines 
following chloroquine administration is via liber­
ation of catecholamines from storage tissues by 
chloroquine (Pandya, et al 1968). It is also known 
that basic drugs accumulate in 5HT storage organ­
elles of rabbit blood platelets (da Prada & Pletcher 1975) 
Indeed while several of the basic compounds which 
release 5HT from platelets are localised in the 
membrane (reseijpine, chlopromazine), others 
(tyramine, chloroquine and mepacrine) are
specifically accumulated in the interior of the 
organelles. (Pletscher and da Prada, 1975).
Recently, it has been shown that accumulation 
of epinephrine by chromaffin granule membrane 
vesicles was via a transmembrane pH gradient 
(interior acid) driven by ATP and inhibited by 
the proton ionophores carbonylcyanide trifluor- 
omethoxy phenylhydrazone and nigericin but
not by valinomycin. (Schuldiner et al. 1978). 
Similarly, it has been shown that 5HT is 
accumulated by resealed bovine chromaffin granule 
"ghosts", if a pH gradient (acid inside) is 
imposed across their membranes; by preincubation 
of the granules at low pH. (Phillips, 1978).
These findings strongly suggest that biogenic 
amines (L-epinephrine and 5HT) are transported 
across membranes in response to a pH gradient and 
may inhibit chloroquine uptake by competition for 
this system.
The probability that L-epinephrine could also 
influence chloroquine uptake in erythrocytes by 
modulating the glycolytic rate, can, however not 
be ruled out. This possibility is supported by 
the finding that epinephrine influences the degra­
dation of cyclic AMP in chicken erythrocytes. 
(Gorin and Dickbuck, 1979).
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4.10 EFFECT OF SULPHYDRYL AGENTS ON DRUG UPTAKE.
The thiol reactive agents PCMB and NEM did 
not show appreciable inhibition of drug uptake 
below 10"3 mol/1. In all models, 10-3 mol/1 PCMB 
and NEM caused inhibition of ( ^ C) chloroquine 
uptake; coupled with lysis of the red blood cells. 
This inhibition of ( ^ C) chloroquine uptake at 
high concentration can be logically attributed to 
lysis of red cells and parasites, leading to 
binding of chloroquine to released proteins and 
nucleic acids in the medium.
It has been shown that high NEM and PCMB 
concentrations cause cation gradients across the 
red cell membrane to be disrupted with a loss of 
cellular K+ , a gain of Na+ and water (Jacobs and 
Jandl, 1962). This influx of water caused by the 
unopposed osmotic pressure of haemoglobin and 
other macromolecules leads to spherocytosis and 
swelling of the red cells, which result eventually 
in the leakage of haemoglobin (haemolysis).
At present, no useful deductions can be made 
from the differential inhibition (ie 38.75% and.14 .67.2%) by PCMB and NEM respectively, on ( C) 
chloroquine uptake in P. berghei NK 65 infected
erythrocytes (see Table 9). It is only probable 
that differential lysis gave rise to this effect; 
but even this contention is further complicated 
by the observation that at 10"^ mol/1, both NEM 
and PCMB show a similar inhibition (16%) of ( ^ C ) 
chloroquine uptake in both P. berghei NK 65 and 
RC infected T.O. mouse erythrocytes.
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4.11 PHARMACOKINETICS OF UPTAKE OF (14C )
CHLOROQUINE♦
Results obtained from experiments to esta­
blish the specificity of uptake of drug into 
infected and uninfected T.O. mouse erythrocytes 
showed that specific uptake (high affinity) is 
predominant only in the chloroquine sensitive 
P. berghei NK 65 infected T.O. mouse erythrocytes. 
This specific uptake accounted for about 60% of 
total uptake into this model, while specific up­
take accounted for less than 30% of total uptake 
into the chloroquine resistant P, berghei RC 
strain infected erythrocytes. Thus nonspecific 
(low affinity) uptake is predominant in the 
chloroquine resistant strain.
The capacity of the erythrocytes determined 
from the intercept on the Y axis of the double 
reciprocal plots (Umax) and calculated by linear 
regression analysis showed that the capacity of 
uninfected erythrocytes and P. berghei RC infected 
erythrocytes were similar (20 ¿unol/kg) while the 
capacity of erythrocytes infected with P. berghei 
NK 65 was 53.5 ¿mol/kg.
The dissociation constant (Kd) of
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O1.0 - 2.0 X 10_o mol/1 (a ssociated with drug- 
receptor interaction during uptake into infected 
erythrocytes) here can also be compared with the 
apparent dissociation constant of 5.0 x 10~® 
mol/1 found by Fitch et al (1974c). Similarly, 
the results here showed the inhibition constants 
(Kj) of quinine and chloroquine to be 2.2 x 10"^ 
mol/1 and 7.7 x 10“  ^mol/1 respectively, while 
Fitch (1972) found apparent of 2.0 x 10-  ^
mol/1 and 5.0 x 10“  ^mol/1 for quinine and chloro­
quine. Though these results are similar, it is 
important to point out that Fitch did not routine­
ly remove white cells from red blood cell prepar­
ations, a purification step which he reports had 
no effect on the outcome of his experiments 
(Fitch et al 1974c). However, the importance of 
including this purification step has been strongly 
advocated, (see Homewood, 1978). Moreover, Fitch 
carried out his experiments at 25°C while the 
experiments here were carried out at 37°C; any 
changes in the temperature of the experiment are 
indicated in the relevant texts.
Experiments with reticulocyte enriched blood
— 8 14cells, showed that at 5.0 - 6.0 x 10 mol/1 ( C) 
chloroquine in the incubating medium, the "specific"
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uptake was 0.59 pmol/kg (45.4%) similar to the 
"specific" uptake by mature uninfected rbcs.0.56 
¿imol/Kg (40.26%) (see Tables 11 and 12). Fitch 
et al 1975 have also shown that uninfected poly- 
chromatophils accumulate chloroquine but not at 
a high affinity. The results here confirm that 
accumulation of chloroquine by uninfected 
erythrocytes is a nonspecific low affinity process 
(Kd = 1.33 x 10“k mol/1) and a dissociation con­
stant for the specific receptor-drug interaction 
(representing the high affinity process) could not 
be determined by the Scatchard plot (Fig 32).
The dissociation constant of the drug-specific 
receptor interaction is about the same for both 
strains 1.0 x 10”® mol/1 (NK 65) and 4.0 x 10”  ^
mol/1 (RC strain) (both values are not signifi­
cantly different P >  0.5, student t test). The 
specific receptor, is therefore present and similar 
in both sensitive and resistant strains. However, 
when the number of receptor sites (n) is compared, 
there are 6 times as many in NK 65 as in RC strain. 
(Fig 32). This observation is important as it 
shows a unique difference in the kinetics of up­
take of chloroquine between the drug sensitive 
and resistant strain. Chou et al (1980) have
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proposed ferriprotoporphyrin IX (haemin) as the 
chloroquine receptor of malaria parasites. In 
equilibrium dialysis experiments, the chloroquine/ 
ferriprotophorphyrin IX complex was found to have 
a dissociation constant of 3.5 x 10”  ^mol/1 which 
is similar to the dissociation constant for chloro­
quine obtained here for the specific receptor.
The similarity of the dissociation constant 
for the specific receptor and that obtained for 
ferriprotoporphyrin IX by equilibrium dialysis, 
suggests that this specific receptor is probably 
identical to ferriprotoporphyrin IX.
From Fig 31, it will be seen that there is 
virtually no specific uptake into the uninfected 
T.O. mouse erythrocytes and the dissociation con­
stant for the specific receptor-drug interaction 
could not be obtained. The absence of specific 
uptake into uninfected erythrocytes suggest' that 
specific uptake is into the parasite. Probably, 
nonspecific uptake represents the proportion of 
drug taken up by the red cell and bound to 
macromolecules (nucleic acids, proteins etc) in 
the red cell cytoplasm. Since, the nonspecific 
uptake is far more in RC strain than in any other
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model (compare for example Figs 28 and 29), 
sequestration of chloroquine due to nonspecific 
binding is probably one of the means by which 
drug resistant P. berghei RC strain in immature 
red cells (which have a higher nucleoprotein con­
centration - see Fig 4) evades the effect of 
chloroquine•
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4.12 MODEL FOR CHLOROQUINE UPTAKE AND RESISTANCE
Fig 37 summarises the proposed model for 
chloroquine uptake and resistance in P. berghei 
infected erythrocytes.
The model proposes that chloroquine uptake 
can be segregated into specific (high affinity) and 
nonspecific (low affinity) uptake. Specific up­
take is apparently into the parasite while non­
specific uptake represents bound drug in erythro­
cyte cytoplasm and membrane. (Total uptake = 
specific uptake + nonspecific uptake). In the 
erythrocyte cytoplasm, nonspecific binding to 
proteins and nucleic acids determines the amount 
of "free" drug available for specific uptake by 
parasite.
A specific receptor (probably ferriproto- 
porphyrin IX) is responsible for mediating specific 
uptake into the parasite and perhaps also acts 
in conjunction with chloroquine in eliciting para- 
siticidal effect, since haemin (ferriprotoporphyrin 
IX) is known to cause damage to membranes (Tappel 
and Zalkin, 1959). It is further proposed that 
negatively charged groups on the receptor bind
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(ferriprotoporphyrin IX) is produced inside a 
parasite organelle, eg in lysosomes. In this case, 
uptake of monoprotonated chloroquine from the 
erythrocyte milieu into the parasite milieu be­
comes very crucial and if a transmembrane poten­
tial regulates the uptake of this monocation, 
then generation of the membrane potential will be 
a crucial step in the uptake of chloroquine.
However, it is still possible that a receptor pro­
duced within one of the parasite's organelles can 
regulate uptake of drug from the erythrocyte cyto­
plasm into the parasite.
The model also proposes two possible mechan­
isms of resistance to chloroquine. One mechanism 
involves the red cell as a site of loss of drug by 
sequestration due to nonspecific binding of chloro­
quine to macromolecules. This site of loss of 
drug is more pronounced in the reticulocyte, prob­
ably because of its high ribonucleoprotein content 
(see Fig 4). It is also possible that increased 
production of haemin binding protein normally 
incorporated into haemozoin (Yamada and Sherman, 
1979) may be responsible for non specific binding 
in the chloroquine-resistant strain. Indeed, 
increase in haemin-binding protein could effectively 
reduce the number of free ferriprotoporphyrin IX
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with the positively charged chloroquine mono or 
dications and the drug-receptor complex permeates 
into the parasite. If the chloroquine cations 
dissociate from the receptor inside the parasite, 
then in regions of high hydrogen ion concentrat­
ion (eg lysosomes), the diprotonated forms will 
remain charged and will not be able to pass back 
into the erythrocyte cytoplasm, whilst the 
monoprotonated forms will become diprotonated and 
also cannot pass back through the membrane.
The model speculates that the role of protons 
includes generation of appropriately charged 
chloroquine cations, receptors and perhaps a 
parasite membrane potential, which could be influ­
ential in attracting the receptor drug complex and/ 
or the monoprotonated drug. A role is further 
envisaged for a proton pump. At present, it is 
not known whether the proton pump probably 
operates by efflux of (H*) per se or by efflux of 
other metabolic products eg Lactate. (Brink and 
Konings, 1980).
It is important to mention that the above 
mechanism for the uptake of chloroquine is a sim­
plification of an inherently complex system. For 
example, it is probable that the receptor
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(ferriprotoporphyrin IX) is produced inside a 
parasite organelle, eg in lysosomes. In this case, 
uptake of monoprotonated chloroquine from the 
erythrocyte milieu into the parasite milieu be­
comes very crucial and if a transmembrane poten­
tial regulates the uptake of this monocation, 
then generation of the membrane potential will be 
a crucial step in the uptake of chloroquine.
However, it is still possible that a receptor pro­
duced within one of the parasite's organelles can 
regulate uptake of drug from the erythrocyte cyto­
plasm into the parasite.
The model also proposes two possible mechan­
isms of resistance to chloroquine. One mechanism 
involves the red cell as a site of loss of drug by 
sequestration due to nonspecific binding of chloro­
quine to macromolecules. This site of loss of 
drug is more pronounced in the reticulocyte, prob­
ably because of its high ribonucleoprotein content 
(see Fig 4). It is also possible that increased 
production of haemin binding protein normally 
incorporated into haemozoin (Yamada and Sherman, 
1979) may be responsible for non specific binding 
in the chloroquine-resistant strain. Indeed, 
increase in haetnin-binding protein could effectively 
reduce the number of free ferriprotoporphyrin IX
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F ig .37
Schematic model fo r  chloroquine uptake into P.berghei infected erythrocyte
232
molecules available for binding chloroquine 
(Warhurst 1980 - WHO report).
The second mechanism of resistance in 
P. berghei RC infected T.O. mouse erythrocytes, 
is the decrease in the number of drug receptors 
available. There are six times more specific 
drug receptors in the erythrocytes infected with 
the chloroquine sensitive strain than in the drug 
resistant strain (See Fig 32). Accordingly, the 
drug sensitive strain can accumulate chloroquine 
"specifically" up to a maximum of 3.4 x 10”^ mol/kg 
while the resistant strain can accumulate a maxi­
mum of 5.7 x 10“^ mol/kg. It is interesting to 
compare the result for the chloroquine sensitive 
strain obtained here with that of Fitch et al 
(1975) who obtained a value of 26 ± 2.4 ^imol/kg 
for maximal accumulation of chloroquine by the 
"saturable" process; estimated from double recipro­
cal graphs. Unfortunately no value was given in 
that same work for the chloroquine resistant 
strain of P. berghei. However, the dissociation 
constant (Kd ) for the interaction of drug with the 
specific receptor 4.0 x 10“^ - 1.0 x 10 ® mol/1 
is identical to the reciprocal of the apparent 
intrinsic association constant (K) of the
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saturable class of binding sites : 0.4 to 
1.6 x 10 ® M~1 obtained by Fitch (1969). The 
higher maximum specific uptake obtained here is 
not surprising, since at 37°C this glucose 
dependent process will be more efficient than at 
22°C - the temperature at which Fitch did his 
experiments.
That the drug receptor is associated with 
ferriprotoporphyrin IX is supported by the follow­
ing observations :
(i) The similarity of dissociation con­
stant for specific receptor-chloroquine interaction 
(1.0 x 10"® - 4.0 x 10"9 mol/1) found here and that 
found in equilibrium dialysis experiments (3.9 x 
10-9 mol/1) for ferriprotophorphyrin - chloroquine 
interaction (Chou et al 1980).
(ii) Erythrocytes infected with chloro­
quine-susceptible P. berghei, degrade haemoglobin 
in normocytes and accumulate malaria pigment 
which contains ferriprotoporphyrin IX, whereas
in reticulocytes, it produces little pigment. In 
addition, when chloroquine resistant lines of 
P. berghei revert to chloroquine sensitivity, 
they also revert to the production of malaria pig­
ment .
Thus, the two lesions contributing to the 
development of resistance to chloroquine, (in­
creased non specific binding and decrease in drug 
receptor sites leading to decrease in specific 
uptake) are uniquely combined in the infection of 
reticulocytes by P. berghei RC strain and can 
explain the linkage of chloroquine resistance in 
P. berghei to infection of immature erythrocytes.
This model for chloroquine uptake and 
resistance accounts for most of the known chara­
cteristics of chloroquine uptake and resistance in 
P. berghei and lends itself to experimental veri­
fication - (see later). It will be interesting 
to see how this model compares with P. falciparum 
infection in man. Of course more research work 
has to be undertaken in order to fully elucidate 
the model. There is need to find out more about 
the mechanisms whereby malaria parasites couple 
their metabolism with uptake of metabolites and 
perhaps drugs, because a better understanding of 
the system could provide further chemotherapeutic 
targets. Also the sequence of events leading to 
the generation of chloroquine receptors in the 
erythrocyte parasite complex needs to be studied.
Further studies of this model should include 
subcellular fractionation of the erythrocyte para­
site complex with a view to :
(i) Investigating the distribution of 
drug into various compartments - erythrocyte 
milieu components and parasite organelles.
(ii) Assessing the nature of binding of 
drug to the subcellular fractions.
Already, some work in this direction shows 
that useful results can be obtained from this 
approach. For example Kramer and Matusik (1971) 
found that by differential lysis of mouse erythro­
cytes parasitised with chloroquine sensitive 
Plasmodium berghei, they could differentiate the 
regions responsible for the saturable chloroquine 
binding process. They found that the highest 
affinity sites (affinity constant = 10®M 
appeared to be associated with the parasite mem­
branes, whereas those with affinity constants of 
about lO-’M"* were associated with the cytoplasmic 
fraction of the parasite.
It is hoped that a more rigorous examination
of distribution of chloroquine into subcellular 
fractions will probably show the location of the 
chloroquine receptor and perhaps the predominant 
target of chloroquine action.
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AMP
ABBREVIATIONS
Adenosine 5'-monophosphate.
ADP - Adenosine 5'-diphosphate.
ATP - Adenosine 5'-triphosphate.
CMP - Cytidine 5 '-monophosphate.
CDP - Cytidine 5'- diphosphate.
CTP - Cytidine 5'- triphosphate.
CIPC - Chloroquine induced Pigment
CQ _
clumping. 
Chloroquine.
CQH+ - Monoprotonated chloroquine.
CQ2H+ - Diprotonated chloroquine.
DDT - Dichlorodiphenyltrichloroethane.
DPM - Disintegrations per minute.
dTMP - Deoxythymidine 5' - monophosphat
dUMP - Deoxyuridine 5' - monophosphate.
DNA - Deoxyribonucleic acid.
f h 2 - Dihydrofolic acid.
FH4 - Tetrahydrafolic acid.
G-6-P - Glucose - 6 - phosphate.
G6P-DH - Glucose - 6 - phosphate
GMP
dehydrogenase.
Gttanosine 5' - monophosphate.
GDP - Guanosine 5' - diphosphate.
GTP - Guanosine 5' - triphosphate.
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AMP
ABBREVIATIONS
Adenosine 5'-monophosphate.
ADP - Adenosine 5'-diphosphate.
ATP - Adenosine 5'-triphosphate.
CMP - Cytidine 5'-monophosphate.
CDP - Cytidine 5'- diphosphate.
CTP - Cytidine 5'- triphosphate.
CIPC - Chloroquine induced Pigment
CQ _
clumping. 
Chloroquine.
CQH+ - Monoprotonated chloroquine.
CQ2H+ - Diprotonated chloroquine.
DDT - Dichlorodiphenyltrichloroe thane.
DPM - Disintegrations per minute.
dTMP - Deoxythymidine 5' - monophosphate
dUMP - Deoxyuridine 5' - monophosphate.
DNA - Deoxyribonucleic acid.
f h2 - Dihydrofolic acid.
f h 4 - Tetrahydrafolic acid.
G-6-P - Glucose - 6 - phosphate.
G6P-DH - Glucose - 6 - phosphate
GMP
dehydrogenase.
Guanosine 5' - monophosphate.
GDP - Guanosine 5' - diphosphate.
GTP - Guanosine 5' - triphosphate.
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HKB - High Potassium buffer.
5 HT - 5 - Hydroxytryptamine.
IMP - Inosine 5' - monophosphate.
I.P - Intraperitoneal.
NAD - Nicotinamide adenine dinucleotide
NADH - Reduced NAD.
NADP Nicotinamide adenine dinucleotide 
phosphate.
NADPH - Reduced NADP.
NEM - N-ethyl maleimide.
pABA - para amino benzoic acid.
pAGA - para amino benzoyl glutamic 
acid.
PH - Phenylhydrazine hydrochloride.
PCMB - para chloromercuri benzoic acid.
PCV - Packed cell volume.
RNA - Ribonucleic acid.
SB1 - Standard buffer 1.
SB2 - Standard buffer 2.
UMP - Uridine 5' - monophosphate.
UDP - Uridine 5' - diphosphate.
UTP - Uridine 5' - triphosphate.
URBC - Uninfected red blood cells.
281
TEXAS Tl-57 PROGRAMMES 
I
PROGRAMME TITLE : Calculation of total disinte­
grations per minute from 
uncorrected radioactivity 
counts. (Texas T 1-57).
Programme :
KEY STEP
LRN 00
- 01
RCL 1 02
= 03
STO 0 04
R/S 05
- 06
RCL 7 07
= 08
STO 6 09
R/S 10
RCL 0 11
- 12
RCL 6 13
X 14
58.4 * 15-18
+/- 19
COMMENTS
Channel 1 (red) back­
ground correction.
Channel 2 (green) 
background correction.
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KEY STEP
= 20
+ 21
101.67 * 22-27
= 28
7 29
100 30-32
= 33
STO 2 34
R/S 35
RCL 6 36
7 37
RCL 3 38
X 39
RCL 4 40
7 41
RCL 5 42
7 43
RCL 2 44
= 45
R/S 46
LRN 47
RST 48
COMMENTS
* slope and intercept 
from quenching correction 
curve.
Relative efficiency of 
counting.
Total Dpm / Extract.
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(USER INSTRUCTIONS.)
STORE CHANNEL 1 BKG COUNTS IN MEMORY BANK 1. 
STORE CHANNEL 2 BKG COUNTS IN MEMORY BANK 7. 
STORE COUNTING TIME IN MINUTES IN MEMORY BANK 3. 
STORE TOTAL VOLUME OF HEPTANE EXTRACT IN MEMORY 
BANK 4.
STORE VOLUME OF EXTRACT ADDED TO EACH COUNTING 
VIAL IN MEMORY BANK 5.
To operate,
Key in counts from channel 1 : R/S gives background
counts correction, Key in counts from channel 2;
R/S gives background correction, R/S gives relative 
efficiency and R/S gives total DPM in extract.
RST (return to start) after each run.
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PROGRAMME
Programme
KEY 
LRN 
STO 0 
R/S
STO 1 
R/S
RCL 0
STC 2 
CLR 
.15 *
x
RCL 1
+/-
+
RCL 2
II
TITLE : Calculation of D.p.m per gramme 
erythrocyte.
STEP
00
01
02
03
04
05
06
07
08 
09
10-12
13
14
15
16
17
18
19
20
COMMENTS
Weight of erythrocyte 
pellet.
Dpm/ml supernatant.
* Calculated average 
"Inulin space".
KEY STEP COMMENTS
.85 21-23
= 24
R/S 25 Dpm/g erythrocyte.
LRN 26
RST 27
To operate,
Key in weight of pellet.R/S, then key in DPM/ml 
supernatant R/S, key in DPM in pellet; R/S gives 
DPM/gm erythrocytes.
Ill
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PROGRAMME TITLE : Calculation of drug concentration
in pmol/kg wet weight erythrocyte.
Programme :
KEY STEP COMMENTS
LRN 00
EE 01
3 02
7 03
RCL 0 04
= 05
7 06
22.2 07-10
= 11
7 12
1 13
EE 14
5 15
= 16
R/S 17 Concentration in >uniol/kg 
or ;umol/l.
LRN 18
RST 19 Return to start.
STORE SPECIFIC ACTIVITY OF RADIOLABELLED COMPOUND 
(jjCiAimole) IN MEMORY BANK O.
287
To operate,
Key in DPM/g or DPM/ml; RS gives concentration of 
radio labelled drug in ¿imol/kg wet weight erythrocyte.
* Programmes supplied by D.C. Warhurst.
287
To operate,
Key in DPM/g or DPM/ml; RS gives concentration of 
radiolabelled drug in jumol/kg wet weight erythrocyte.
* Programmes supplied by D.C. Warhurst.
288
COMPOUND
MONENSIN
NIGERICIN
OUABAIN
EPINEPHRINE
5 - H T
STRUCTURE
HNCH(CH2)3N(C2H5)2
c h 3
CHLOROQUINE
